| Symbol | GEHC |
|---|---|
| Name | GE HEALTHCARE TECHNOLOGIES INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical Electronics |
| Address | 500 WEST MONROE STREET,CHICAGO, ILLINOIS, 60661, ILLINOIS, Illinois, 60661, United States |
| Telephone | 1 203 3604369 |
| Fax | — |
| — | |
| Website | https://www.gehealthcare.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001932393 |
| Description | GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as womens health products. Additional info from NASDAQ: |
2026-06-04 12:00
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
Read more
2026-06-01 12:10
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
Read more
2026-05-29 09:25
New Form SD - GE HealthCare Technologies Inc. <b>Filed:</b> 2026-05-29 <b>AccNo:</b> 0001932393-26-000036 <b>Size:</b> 1 MB
Read more
2026-05-26 22:44
Director Lobo Kevin 🟢 acquired 10.0K shares of GE HealthCare Technologies Inc. (GEHC) at $64.18 Transaction Date: May 22, 2026 | Filing ID: 000011
Read more
2026-05-22 21:00
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Read more
2026-05-22 19:00
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Read more
2026-05-22 17:22
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Read more
2026-05-20 00:00
GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.
Read more
2026-05-19 20:05
Rackliffe Philip 🟢 acquired 16.5K shares of GE HealthCare Technologies Inc. (GEHC) Transaction Date: May 15, 2026 | Filing ID: 000008
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT00730444 | Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Ne… | — | Neuroblastoma | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT07219238 | Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/… | Phase2 | Colorectal Cancer | Recruiting | 2026-10-01 | 2029-08-01 | ClinicalTrials.gov |
| NCT07343362 | Transcutaneous Electrical Stimulation in Patients With Obstructive Sleep Apnoea | Na | Obstructive Sleep Apnea | Not_Yet_Recruiting | 2026-07-16 | 2028-09-01 | ClinicalTrials.gov |
| NCT07309809 | Portrait Mobile Monitoring Solution V2.0 External Evaluation | Na | Monitoring | Not_Yet_Recruiting | 2026-07-01 | 2026-10-01 | ClinicalTrials.gov |
| NCT06024772 | Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate… | Phase3 | Prostate Carcinoma | Not_Yet_Recruiting | 2026-07-01 | 2027-02-01 | ClinicalTrials.gov |
| NCT07538544 | MCE Molecular Imaging for ICI Myocarditis | Early_Phase1 | Immune Checkpoint Inhibitor Myocarditis | Not_Yet_Recruiting | 2026-07-01 | 2030-07-01 | ClinicalTrials.gov |
| NCT07651293 | Using Fenfluramine to Test the Serotonin Deficiency Theory of Depression | Na | Depression - Major Depressive Disorder | Not_Yet_Recruiting | 2026-07-01 | 2028-12-01 | ClinicalTrials.gov |
| NCT07628075 | Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vascul… | Na | Large Vessel Vasculitis | Not_Yet_Recruiting | 2026-07-01 | 2028-01-01 | ClinicalTrials.gov |
| NCT07615881 | Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combinati… | Phase1 | Melanoma (Skin Cancer) | Not_Yet_Recruiting | 2026-07-01 | 2029-07-01 | ClinicalTrials.gov |
| NCT07609225 | Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceuti… | Early_Phase1 | Metastatic Castration-resistant Prostate Cancer | Not_Yet_Recruiting | 2026-07-01 | 2029-07-01 | ClinicalTrials.gov |
| NCT07394140 | NMT EasyFit Sensor and Cable | Na | Neuromuscular Blockade Monitoring | Not_Yet_Recruiting | 2026-06-15 | 2026-12-31 | ClinicalTrials.gov |
| NCT07615738 | SpO2 Infant and Pediatric Study | Na | SpO2 (Peripheral Oxygen Saturation) Measurement Validation | Not_Yet_Recruiting | 2026-06-15 | 2027-12-31 | ClinicalTrials.gov |
| NCT07634185 | Clinical Evaluation of an AI Risk Prediction System (AI-TRiPS) | Early_Phase1 | Trauma | Not_Yet_Recruiting | 2026-06-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT07628296 | Non-Invasive Blood Pressure Accuracy Study for Adult Subjects | Na | Blood Pressure | Recruiting | 2026-05-29 | 2027-06-30 | ClinicalTrials.gov |
| NCT07474584 | OpRESTORE AI-Patient Navigator Study | Na | Veteran | Not_Yet_Recruiting | 2026-05-01 | 2027-11-01 | ClinicalTrials.gov |
| NCT07472491 | A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enha… | Phase2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | Recruiting | 2026-04-01 | 2027-11-30 | ClinicalTrials.gov |
| NCT07169825 | Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Com… | Na | Lu-177 PSMA | Recruiting | 2026-03-30 | 2028-09-01 | ClinicalTrials.gov |
| NCT07272161 | Pilot Evaluation of the StarGuide Next Generation SPECT/CT System | Na | Nuclear Medicine | Enrolling_By_Invitation | 2026-03-25 | 2027-01-01 | ClinicalTrials.gov |
| NCT07386418 | Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds | Na | Angina (Stable) | Recruiting | 2026-02-10 | 2028-12-01 | ClinicalTrials.gov |
| NCT06447064 | Cancer Loyalty Card Study 2 (CLOCS-2) | — | Pancreatic Cancer | Recruiting | 2026-02-04 | 2027-04-01 | ClinicalTrials.gov |
| NCT05634954 | Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Local… | Phase1 | Breast Cancer | Withdrawn | 2026-02-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT06782568 | Avoidance of Insulin-induced Lipohypertophy in People With Diabetes Using Ultra… | Na | Type 1 Diabetes (T1D) | Recruiting | 2026-01-01 | 2027-05-31 | ClinicalTrials.gov |
| NCT07351136 | Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Co… | — | Fabry Disease | Not_Yet_Recruiting | 2026-01-01 | 2026-03-31 | ClinicalTrials.gov |
| NCT07661706 | Data Collection of New Spectral CT Imaging Method | — | Computed Tomography | Recruiting | 2025-12-19 | 2026-08-01 | ClinicalTrials.gov |
| NCT07215845 | Pars Healing on MRI | Na | Pars Interarticularis Stress Fracture | Recruiting | 2025-12-12 | 2028-12-31 | ClinicalTrials.gov |
| NCT07263815 | EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Sc… | Na | Cancer | Active_Not_Recruiting | 2025-11-24 | 2026-12-24 | ClinicalTrials.gov |
| NCT07430553 | Comparing Three Types of Specialist Pacemakers to Improve Heart Function and Re… | Na | Heart Failure and Reduced Ejection Fraction | Recruiting | 2025-11-12 | 2028-10-24 | ClinicalTrials.gov |
| NCT07191678 | Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion Wit… | — | NEC - Necrotizing Enterocolitis | Recruiting | 2025-11-03 | 2027-04-30 | ClinicalTrials.gov |
| NCT06923943 | Predicting Nurse Staffing Requirements From Routinely Collected Data | — | Nursing Workload | Active_Not_Recruiting | 2025-11-01 | 2026-07-31 | ClinicalTrials.gov |
| NCT07243262 | Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR… | — | Pancreatic Cancer | Recruiting | 2025-10-21 | 2028-08-01 | ClinicalTrials.gov |
| NCT07112235 | Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive… | — | COPD (Chronic Obstructive Pulmonary Disease) | Recruiting | 2025-10-08 | 2027-03-31 | ClinicalTrials.gov |
| NCT07147725 | Pulmonary Arterial Hypertension and Associated Cardiovascular Disease Detection… | — | Pulmonary Hypertension | Not_Yet_Recruiting | 2025-10-01 | 2027-08-01 | ClinicalTrials.gov |
| NCT07310758 | Contrast-enhanced Ultrasound for Sentinel Node Detection | Phase2 | Melanoma | Recruiting | 2025-09-18 | 2026-09-18 | ClinicalTrials.gov |
| NCT06702917 | GSI Cardiac on Revolution Apex - US | — | Coronary Computed Tomographic Angiography | Recruiting | 2025-09-10 | 2026-06-01 | ClinicalTrials.gov |
| NCT07046234 | Point of Care Lung Ultrasound Examination in Patients With Shortness of Breath | Na | Lung Disease | Enrolling_By_Invitation | 2025-08-19 | 2025-12-01 | ClinicalTrials.gov |
| NCT07066449 | Clinical Performance Evaluation of a Diagnostic Ultrasound System | — | Echocardiography | Recruiting | 2025-08-12 | 2026-04-01 | ClinicalTrials.gov |
| NCT06246188 | Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or … | — | Coronary Artery Disease | Unknown | 2025-06-01 | 2025-12-31 | ClinicalTrials.gov |
| NCT07024472 | NIBP Cuff Comparison Study | — | Blood Pressure | Completed | 2025-04-25 | 2025-06-23 | ClinicalTrials.gov |
| NCT06620185 | GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung a… | Na | Influenza | Recruiting | 2025-04-16 | 2026-07-31 | ClinicalTrials.gov |
| NCT06934096 | Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification. | Na | Hemostasis | Not_Yet_Recruiting | 2025-04-15 | 2026-05-12 | ClinicalTrials.gov |
| NCT06769594 | Next Generation CT System | — | Computed Tomography | Completed | 2025-04-08 | 2026-03-06 | ClinicalTrials.gov |
| NCT06817174 | Ovarian Cancer Radiomics Approach in CT Led Evaluation | — | Ovarian Cancer | Recruiting | 2025-02-10 | 2032-01-01 | ClinicalTrials.gov |
| NCT06630845 | Comparison of Whole Body DWI to FDG PET | Na | Metastatic Cancer | Recruiting | 2025-02-06 | 2029-10-31 | ClinicalTrials.gov |
| NCT07366619 | Magic Angle Direction Imaging (MADI) ACL Study | — | Anterior Cruciate Ligament Injuries | Recruiting | 2025-01-29 | 2027-06-30 | ClinicalTrials.gov |
| NCT06835647 | Maternal Fetal Device Performance Twins | Na | Pregnancy | Recruiting | 2025-01-21 | 2025-12-31 | ClinicalTrials.gov |
| NCT06639828 | Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-… | Phase4 | Focal Liver Lesions | Recruiting | 2025-01-20 | 2026-10-31 | ClinicalTrials.gov |
| NCT06611306 | BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain… | Na | Brain Metastases, Adult | Not_Yet_Recruiting | 2025-01-06 | 2026-12-01 | ClinicalTrials.gov |
| NCT06186336 | Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of V… | — | Chronic Coronary Syndrome | Not_Yet_Recruiting | 2025-01-01 | 2025-06-01 | ClinicalTrials.gov |
| NCT06383585 | 3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory A… | Na | Inflammatory Arthritis | Recruiting | 2024-12-05 | 2026-12-01 | ClinicalTrials.gov |
| NCT06726343 | Maternal Fetal Device Performance Singleton | Na | Pregnancy | Completed | 2024-10-28 | 2024-12-23 | ClinicalTrials.gov |
| NCT06580379 | Spine Surgery Video Observation Study. The Creation of a Benchmark Video (RGB-D… | — | Spine Fusion | Not_Yet_Recruiting | 2024-10-01 | 2027-10-01 | ClinicalTrials.gov |
| NCT06706856 | Quantitative Ultrasound to Assess Steatotic Liver Disease in Children | — | MASLD | Recruiting | 2024-09-23 | 2029-06-30 | ClinicalTrials.gov |
| NCT06533189 | Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Pro… | — | Whole Body Imaging | Not_Yet_Recruiting | 2024-09-01 | 2026-02-28 | ClinicalTrials.gov |
| NCT06478420 | COVID-19 Omicron BA.5 Subvariant Dose Finding Infection Study | Phase1 | SARS-CoV-2 Infection | Active_Not_Recruiting | 2024-08-08 | 2028-10-31 | ClinicalTrials.gov |
| NCT06449079 | The PICM Risk Prediction Study - Application of AI to Pacing | — | Heart Failure | Not_Yet_Recruiting | 2024-07-30 | 2026-10-30 | ClinicalTrials.gov |
| NCT06931002 | A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses … | Na | Bronchiectasis Adult | Recruiting | 2024-07-24 | 2027-10-30 | ClinicalTrials.gov |
| NCT06501846 | Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleedin… | Na | Endometrial Cancer | Recruiting | 2024-07-23 | 2027-07-23 | ClinicalTrials.gov |
| NCT06398730 | A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Sa… | Phase1 | Healthy Volunteers | Completed | 2024-07-02 | 2026-02-23 | ClinicalTrials.gov |
| NCT06366711 | Remote Telemedicine Fetal Monitoring Feasibility Study | Na | Pregnancy, High Risk | Completed | 2024-06-20 | 2024-09-20 | ClinicalTrials.gov |
| NCT07335315 | Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identificatio… | — | Pituitary Adenoma | Recruiting | 2024-06-19 | 2027-01-01 | ClinicalTrials.gov |
| NCT06264479 | Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for R… | — | Kidney Cancer | Terminated | 2024-06-19 | 2025-07-25 | ClinicalTrials.gov |
| NCT06400290 | Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Diseas… | Na | Stable Angina | Recruiting | 2024-06-13 | 2027-04-01 | ClinicalTrials.gov |
| NCT07024459 | CARESCAPE Monitoring Systems ME Study | Na | Surgery, Intensive Care | Enrolling_By_Invitation | 2024-06-13 | 2025-06-30 | ClinicalTrials.gov |
| NCT05835284 | Clinical Data Collection On Advanced CT System | — | CT Photon Counting | Completed | 2024-06-04 | 2026-02-19 | ClinicalTrials.gov |
| NCT04904484 | A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients | Na | Aerosol Disease | Unknown | 2024-06-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT06182306 | Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluati… | — | Breast Cancer | Recruiting | 2024-04-30 | 2026-06-30 | ClinicalTrials.gov |
| NCT06402617 | Ablation of Focal Activation in Atrial Fibrillation | Na | Atrial Fibrillation | Recruiting | 2024-04-30 | 2026-10-01 | ClinicalTrials.gov |
| NCT06355453 | Evaluation of the Goldcrest Patch Performance | — | Fetal Monitoring | Completed | 2024-04-22 | 2025-03-31 | ClinicalTrials.gov |
| NCT06578988 | Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting | — | Cancer, Breast | Unknown | 2024-03-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT05553899 | Utility of PET-MRI in Surveillance of Paediatric Brain Tumours | Na | Brain Tumor, Pediatric | Unknown | 2024-02-28 | 2026-03-01 | ClinicalTrials.gov |
| NCT06211530 | Wireless Disposable SpO2 Sensor Hypoxia Testing | Na | SpO2 | Completed | 2024-01-30 | 2024-02-08 | ClinicalTrials.gov |
| NCT06264934 | An Investigation Into Dielectric Assessment of Permittivity and Conductivity in… | — | Breast Cancer | Recruiting | 2024-01-25 | 2024-12-01 | ClinicalTrials.gov |
| NCT06715410 | Carbon Dioxide Investigation | Na | Intubation | Completed | 2024-01-16 | 2024-09-16 | ClinicalTrials.gov |
| NCT06163222 | Behavioural Interventions to Improve Equity in Outpatient Access | Na | Behavioural Science Interventions to Improve Health Equity | Completed | 2024-01-08 | 2024-11-20 | ClinicalTrials.gov |
| NCT06072807 | Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer | Phase4 | Breast Cancer | Recruiting | 2023-12-27 | 2027-12-01 | ClinicalTrials.gov |
| NCT05878665 | Low-dose Contrast Media for Low-kVp Abdomen CT | Na | Appendicitis Acute | Recruiting | 2023-12-21 | 2025-12-31 | ClinicalTrials.gov |
| NCT06579417 | ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative … | — | Prostate Cancer | Recruiting | 2023-12-15 | 2029-07-01 | ClinicalTrials.gov |
| NCT05814263 | HIS Alternative II - UK Site | Na | Heart Failure | Recruiting | 2023-12-01 | 2025-01-01 | ClinicalTrials.gov |
| NCT06095024 | INvestigating DIGital Outcomes in the Community | — | Cancer | Unknown | 2023-12-01 | 2025-06-01 | ClinicalTrials.gov |
| NCT06181708 | Diagnostics in the Leg Ulcer Pathway | — | Venous Leg Ulcer | Completed | 2023-11-13 | 2025-05-26 | ClinicalTrials.gov |
| NCT06115720 | Consent in Anaesthesia | Na | Regional Anesthesia | Unknown | 2023-11-01 | 2025-10-31 | ClinicalTrials.gov |
| NCT05935371 | Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Re… | — | Obstetric Complication | Unknown | 2023-10-26 | 2025-10-01 | ClinicalTrials.gov |
| NCT06060951 | Relating Abdominal Complications With Peritoneal Pressure Estimation and Report… | — | Peritoneal Dialysis | Unknown | 2023-10-01 | 2025-07-31 | ClinicalTrials.gov |
| NCT06477458 | Deep Learning for Preoperative Pulmonary Assessment in Thoracic CT | — | Elective Thoracic Surgery | Recruiting | 2023-10-01 | 2024-12-30 | ClinicalTrials.gov |
| NCT05949138 | Clinical Data Collection and Evaluation of ECG-Less Cardiac CT | — | Cardiac CT | Completed | 2023-09-11 | 2023-11-03 | ClinicalTrials.gov |
| NCT05838482 | Clinical Feasibility and Evaluation of Silicon Photon Counting CT | — | CT Photon-Counting | Completed | 2023-09-07 | 2026-04-30 | ClinicalTrials.gov |
| NCT05870150 | Challenge Non-Typhoidal Salmonella (CHANTS) Study | Na | Salmonella Infections | Active_Not_Recruiting | 2023-08-31 | 2026-02-28 | ClinicalTrials.gov |
| NCT05897905 | Improving Follow up Care for People After Minor Stroke | Na | Stroke, Acute | Unknown | 2023-07-24 | 2024-08-31 | ClinicalTrials.gov |
| NCT05792423 | Conditionally Increased Output (CIO) Enhanced Ultrasound System | Na | Nonalcoholic Fatty Liver | Completed | 2023-06-30 | 2024-05-31 | ClinicalTrials.gov |
| NCT05457998 | BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers | — | Alzheimer Disease | Enrolling_By_Invitation | 2023-06-14 | 2028-06-01 | ClinicalTrials.gov |
| NCT05917574 | A Study to Evaluate the Introduction of New Staffing Models in Intensive Care: … | — | Critical Illness | Unknown | 2023-06-14 | 2025-04-30 | ClinicalTrials.gov |
| NCT06233890 | The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid… | — | Chronic Myeloid Leukemia | Active_Not_Recruiting | 2023-05-12 | 2026-05-12 | ClinicalTrials.gov |
| NCT05636852 | Altropane Dose for Imaging Patients With Suspected Parkinson's Disease | Phase2 | Parkinson Disease | Terminated | 2023-04-24 | 2024-06-08 | ClinicalTrials.gov |
| NCT05867745 | The National Transition Evaluation Study | — | Young People With All Long-term Health Conditions | Unknown | 2023-04-21 | 2024-05-31 | ClinicalTrials.gov |
| NCT05492110 | Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstruct… | Na | Refractory Angina | Recruiting | 2023-04-17 | 2026-03-06 | ClinicalTrials.gov |
| NCT05806190 | Hypoglycaemia (Low Blood Sugar) in Adults With Diabetes and Adrenal Failure | — | Diabetes Mellitus, Type 1 | Completed | 2023-04-17 | 2023-09-15 | ClinicalTrials.gov |
| NCT05625659 | Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Brea… | Na | Breast Cancer | Recruiting | 2023-03-24 | 2027-07-31 | ClinicalTrials.gov |
| NCT04073797 | PET Imaging of Inflammation and Lipid Lowering Study | Na | Hypercholesterolemia | Recruiting | 2023-03-20 | 2026-03-01 | ClinicalTrials.gov |
| NCT05662124 | ILD: Health Outcomes in Remote Digital Monitoring Versus Usual Care | Na | Interstitial Lung Disease | Active_Not_Recruiting | 2023-03-07 | 2025-04-01 | ClinicalTrials.gov |
| NCT06022601 | Post Delivery Intervention in Women With Previous Gestational Diabetes Mellitus… | Na | Gestational Diabetes | Unknown | 2023-03-01 | 2024-09-30 | ClinicalTrials.gov |
| NCT05914168 | Clinical Data Collection in Breast Tomosynthesis (COBRIS) | Na | Breast Cancer | Unknown | 2023-02-15 | 2024-02-01 | ClinicalTrials.gov |
| NCT06526091 | Cerebral Oxygen Saturation Monitoring During Optimum Cord Management in Preterm… | — | Pre-Term | Recruiting | 2023-02-15 | 2024-10-01 | ClinicalTrials.gov |
| NCT05629689 | A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used… | Phase1 | Malignant Solid Tumor | Recruiting | 2023-01-27 | 2029-03-10 | ClinicalTrials.gov |
| NCT06453226 | Non-invasive Detection of Volatile Metabolites in Parkinson's Disease | — | Parkinson Disease | Recruiting | 2023-01-25 | 2025-01-30 | ClinicalTrials.gov |
| NCT05068726 | Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients | — | Metastatic Breast Cancer | Terminated | 2023-01-05 | 2024-06-01 | ClinicalTrials.gov |
| NCT05727020 | Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma | — | PDAC - Pancreatic Ductal Adenocarcinoma | Recruiting | 2022-12-15 | 2028-08-01 | ClinicalTrials.gov |
| NCT03886675 | Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection | Na | Stroke | Unknown | 2022-11-14 | 2024-10-01 | ClinicalTrials.gov |
| NCT05171764 | Dual Energy Cardiac CT Data Collection and Evaluation | — | Cardiovascular Diseases | Completed | 2022-11-14 | 2023-10-13 | ClinicalTrials.gov |
| NCT05354947 | Ultrasound Effects on Glycemic Control in T2DM | Na | Type 2 Diabetes | Recruiting | 2022-11-01 | 2026-05-01 | ClinicalTrials.gov |
| NCT05789849 | Data Collection for Validation of an NIBP Algorithm in Pregnant Women | Na | Blood Pressure | Unknown | 2022-09-14 | 2023-09-01 | ClinicalTrials.gov |
| NCT05580835 | PET / MR With PSMA for Diagnosis and Staging of Hepatocellular Carcinoma | Na | Carcinoma, Hepatocellular | Unknown | 2022-09-05 | 2024-09-04 | ClinicalTrials.gov |
| NCT05569278 | Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers | Phase1 | Pharmacokinetics | Completed | 2022-08-22 | 2022-11-29 | ClinicalTrials.gov |
| NCT03915691 | The RIPPLE AT-PLUS Study | Na | Atrial Tachycardia | Active_Not_Recruiting | 2022-08-16 | 2026-04-01 | ClinicalTrials.gov |
| NCT05376514 | Central Blood Pressure and Variability Evaluation | — | AAA | Completed | 2022-06-07 | 2024-06-30 | ClinicalTrials.gov |
| NCT05340244 | GE CVUS Device Evaluation | Na | Echocardiography | Completed | 2022-06-01 | 2022-07-26 | ClinicalTrials.gov |
| NCT05154877 | Evaluation of a New Generation of PET-CT OMNI | — | Oncology | Completed | 2022-05-30 | 2023-12-18 | ClinicalTrials.gov |
| NCT05330234 | Usability Study of OnTrack Tools | Na | Research With Clinical Staff in Stroke Rehabilitation | Completed | 2022-05-12 | 2022-06-30 | ClinicalTrials.gov |
| NCT05307887 | Does Virtual Reality Technology Reduce Pain and Anxiety During Outpatient Hyste… | Na | Anxiety | Completed | 2022-04-25 | 2022-10-11 | ClinicalTrials.gov |
| NCT04974710 | Developing an US-MRI Biomarker Fusion Model for Endometriosis | — | Endometriosis | Completed | 2022-03-18 | 2023-03-31 | ClinicalTrials.gov |
| NCT03631771 | Pediatric Risk of Hypothyroidism With Iodinated Contrast Media | Phase4 | Hypothyroidism | Withdrawn | 2022-03-01 | 2025-02-01 | ClinicalTrials.gov |
| NCT05412758 | Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Can… | Na | Volatile Organic Compounds | Recruiting | 2022-02-28 | 2025-10-01 | ClinicalTrials.gov |
| NCT05668689 | URAISE: Ultrasound Regional Anaesthesia Interpretation Skill Evaluation | Na | Anesthesia | Unknown | 2022-02-13 | 2025-04-01 | ClinicalTrials.gov |
| NCT05486182 | Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic … | Phase4 | Metastatic Breast Cancer | Active_Not_Recruiting | 2022-02-08 | 2026-01-01 | ClinicalTrials.gov |
| NCT04594941 | A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Qu… | Phase2 | Coronary Artery Disease (CAD) | Completed | 2022-01-27 | 2022-05-26 | ClinicalTrials.gov |
| NCT05057260 | LOng COvid Multidisciplinary Consortium: Optimising Treatments and servIces Acr… | — | COVID-19 | Unknown | 2022-01-18 | 2024-12-31 | ClinicalTrials.gov |
| NCT05182099 | High Resolution HBA-MRI Using Deep Learning Reconstruction | Na | Liver Diseases | Unknown | 2022-01-10 | 2023-09-30 | ClinicalTrials.gov |
| NCT04265209 | [18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkin… | Phase3 | Parkinson Disease | Completed | 2021-12-01 | 2024-08-02 | ClinicalTrials.gov |
| NCT05393999 | SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS… | Phase2 | SARS-CoV2 Infection | Withdrawn | 2021-11-29 | 2022-03-04 | ClinicalTrials.gov |
| NCT05122715 | Demonstration Of A Next Generation PET CT System | Na | Oncology | Unknown | 2021-11-09 | 2022-09-01 | ClinicalTrials.gov |
| NCT05099627 | Machine Learning Diagnosis and Prediction for Cervical Myelopathy | — | Cervical Myelopathy | Unknown | 2021-10-31 | 2022-12-31 | ClinicalTrials.gov |
| NCT04724512 | SUSY Study (SUture StudY) Comparing Scarring With Polypropylene vs Polyglactin … | Phase4 | Entropion | Suspended | 2021-10-25 | 2024-10-01 | ClinicalTrials.gov |
| NCT04959136 | Feasibility Study Of Ambulatory Monitoring System | Na | Patient Monitoring | Unknown | 2021-09-01 | 2024-12-30 | ClinicalTrials.gov |
| NCT04792411 | Adherence and Acceptability of a Remote, Home-based, Pre-surgery Programme for … | Na | Aortic Aneurysm, Abdominal | Completed | 2021-09-01 | 2023-10-01 | ClinicalTrials.gov |
| NCT05146037 | INTERvention With Cerebral Embolic Protection in Transcatheter Aortic Valve Imp… | Na | Stroke | Unknown | 2021-09-01 | 2023-12-01 | ClinicalTrials.gov |
| NCT05046496 | Transplant Renal Artery Stenosis: Observation Versus Stenting | Na | Transplant Renal Artery Stenosis | Unknown | 2021-08-28 | 2025-08-01 | ClinicalTrials.gov |
| NCT05215938 | Evaluation of Intra Organ Sodium Levels by Magnetic Resonance Imaging | — | Image, Body | Completed | 2021-07-07 | 2021-12-10 | ClinicalTrials.gov |
| NCT05221762 | Accelerated Stress CMR in Coronary Artery Disease | — | Coronary Artery Disease | Active_Not_Recruiting | 2021-07-01 | 2025-11-30 | ClinicalTrials.gov |
| NCT04619732 | Real-time Monitoring of Kidney Grafts on Hypothermic Machine Perfusion | Na | Transplant;Failure,Kidney | Unknown | 2021-07-01 | 2023-04-30 | ClinicalTrials.gov |
| NCT04635449 | Psycho-educational Tool to Prevent Psychological Sequelae Following Paediatric … | Phase2 | PTSD | Unknown | 2021-07-01 | 2023-06-01 | ClinicalTrials.gov |
| NCT04876664 | Evaluation of Continuous Non Invasive Blood Pressure With Adult Volunteers | Na | Blood Pressure | Unknown | 2021-06-01 | 2021-09-01 | ClinicalTrials.gov |
| NCT04892537 | Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvas… | Na | Refractory Angina | Unknown | 2021-05-21 | 2024-01-01 | ClinicalTrials.gov |
| NCT04604782 | A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric… | Phase1 | Myocardial Ischemia | Recruiting | 2021-05-20 | 2026-12-01 | ClinicalTrials.gov |
| NCT04564092 | A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, … | Phase1 | Healthy Subjects (HS) | Completed | 2021-05-13 | 2021-09-04 | ClinicalTrials.gov |
| NCT04830033 | ENO Breathe vs Usual Care in COVID-19 Recovery | Na | COVID-19 Recovery | Completed | 2021-04-28 | 2021-09-23 | ClinicalTrials.gov |
| NCT04781296 | Spectral CT With Advanced CT Technology | Na | CT Photon-Counting | Completed | 2021-04-19 | 2022-12-14 | ClinicalTrials.gov |
| NCT04903340 | Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear… | — | Carcinoma, Hepatocellular | Completed | 2021-04-12 | 2021-12-10 | ClinicalTrials.gov |
| NCT04732780 | Avoidance of Hyperglycaemia in People With Type 1 Diabetes | — | Diabetes Mellitus, Type 1 | Completed | 2021-03-02 | 2022-04-20 | ClinicalTrials.gov |
| NCT04472208 | AMS Evaluation Study | Na | Patient Monitoring | Completed | 2021-02-26 | 2021-10-14 | ClinicalTrials.gov |
| NCT04582500 | Virtual Colonoscopy Using Omnipaque as a Contrast Agent | — | Colorectal Cancer | Completed | 2021-02-15 | 2025-03-31 | ClinicalTrials.gov |
| NCT04587934 | Time to Accurate Heart Rate on Neonatal Outcomes | Na | Premature Infant | Completed | 2021-02-01 | 2021-12-10 | ClinicalTrials.gov |
| NCT04647474 | Mental Wellbeing and Quality of Life in Prostate Cancer | — | Prostate Cancer | Completed | 2021-01-15 | 2023-03-29 | ClinicalTrials.gov |
| NCT04909385 | TB PCR in BAL and EBUS-TBNA | — | Tuberculosis | Completed | 2021-01-15 | 2024-02-29 | ClinicalTrials.gov |
| NCT04622683 | Effects of Hepatic Ultrasound on Metabolic Homeostasis | Na | Healthy | Completed | 2021-01-01 | 2023-09-13 | ClinicalTrials.gov |
| NCT03668821 | Frailty in Vascular Patients Undergoing Surgery | — | Vascular Diseases | Unknown | 2021-01-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT04661657 | COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Seque… | — | Covid19 | Completed | 2020-12-28 | 2022-01-22 | ClinicalTrials.gov |
| NCT04739956 | Psychological Impact of Pregnancy of Unknown Location | — | Pregnancy of Unknown Location | Completed | 2020-12-02 | 2022-03-31 | ClinicalTrials.gov |
| NCT04720690 | Bioimpedence and Arterial Function Monitoring at Birth and in Infants | — | Arterial Stiffness | Recruiting | 2020-12-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT03740997 | Study to Determine Safety and Dosage of OPTISON in Pediatric Participants | Phase4 | Transthoracic Echocardiography | Completed | 2020-12-01 | 2023-03-30 | ClinicalTrials.gov |
| NCT05299450 | Pre-conception Interventions to Reduce Blood Pressure Before Pregnancy | Na | Blood Pressure | Completed | 2020-12-01 | 2021-07-31 | ClinicalTrials.gov |
| NCT04435821 | PET/MRI in the Diagnosis of Pediatric Chronic Pain | Phase1 | Chronic Pain | Completed | 2020-11-19 | 2024-10-31 | ClinicalTrials.gov |
| NCT05399524 | Functional and Ultrasound Guided Resection of Glioblastoma | Na | Glioma Glioblastoma Multiforme | Unknown | 2020-11-01 | 2025-11-01 | ClinicalTrials.gov |
| NCT04142021 | Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascu… | — | Coronary Artery Disease | Unknown | 2020-09-01 | 2022-12-31 | ClinicalTrials.gov |
| NCT07071272 | Non-inferiority Study of Contrast-enhanced Digital Mammography (CEDM) vs Magnet… | Na | Breast Cancer | Recruiting | 2020-09-01 | 2026-12-31 | ClinicalTrials.gov |
| NCT04193527 | A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Inject… | Phase3 | Parkinsonian Syndrome | Completed | 2020-06-28 | 2021-12-20 | ClinicalTrials.gov |
| NCT04444609 | PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort | — | COVID-19 | Unknown | 2020-06-18 | 2023-06-01 | ClinicalTrials.gov |
| NCT04409119 | Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients Wit… | Na | Heart Failure | Completed | 2020-06-01 | 2026-02-01 | ClinicalTrials.gov |
| NCT04510441 | Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Usin… | — | Coronavirus | Unknown | 2020-05-26 | 2022-05-01 | ClinicalTrials.gov |
| NCT04382508 | Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adu… | — | Immune Suppression | Unknown | 2020-03-22 | 2021-03-21 | ClinicalTrials.gov |
| NCT05026788 | Impact of COVID-19 Pandemic on Orthopaedic Practice | — | Covid19 | Unknown | 2020-03-17 | 2022-04-30 | ClinicalTrials.gov |
| NCT04355507 | Computed Tomography for COVID-19 Diagnosis | — | COVID-19 | Completed | 2020-03-01 | 2020-10-16 | ClinicalTrials.gov |
| NCT04605380 | Learning Management of Open Fractures on Virtual Patient | — | Educational Problems | Suspended | 2020-03-01 | 2026-06-01 | ClinicalTrials.gov |
| NCT04109287 | Blood Flow Changes in Femoral-popliteal Bypass Grafts After Neuromuscular Elect… | Na | Peripheral Arterial Disease | Withdrawn | 2020-02-11 | 2022-10-05 | ClinicalTrials.gov |
| NCT04280575 | Symptomatic Trial of Angina Assessment Prior to Revascularization | — | Coronary Artery Disease | Completed | 2020-01-16 | 2023-05-01 | ClinicalTrials.gov |
| NCT03878875 | Does Sound Conditioning Protect Against Temporary Hearing Damage | — | Hearing Loss, Noise-Induced | Completed | 2020-01-01 | 2020-04-01 | ClinicalTrials.gov |
| NCT03994653 | Cancer Loyalty Card Study | — | Ovarian Neoplasms | Completed | 2019-11-04 | 2022-07-28 | ClinicalTrials.gov |
| NCT04064177 | Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study | — | Cardiac Output, Low | Recruiting | 2019-10-24 | 2024-12-31 | ClinicalTrials.gov |
| NCT04179734 | Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder | Phase4 | Hypoactive Sexual Desire Disorder | Completed | 2019-10-07 | 2020-10-06 | ClinicalTrials.gov |
| NCT03992534 | The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk o… | Phase1 | Preterm Labor | Unknown | 2019-09-16 | 2021-10-01 | ClinicalTrials.gov |
| NCT03931161 | Effect of Evolocumab on Carotid Plaque Composition in Asymptomatic Carotid Arte… | Phase4 | Carotid Artery Stenosis | Unknown | 2019-09-04 | 2024-05-06 | ClinicalTrials.gov |
| NCT03851263 | Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfu… | Phase4 | Coronary Artery Disease | Withdrawn | 2019-08-30 | 2023-02-24 | ClinicalTrials.gov |
| NCT03911297 | DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction… | — | Polycystic Ovary Syndrome | Recruiting | 2019-08-14 | 2027-12-01 | ClinicalTrials.gov |
| NCT03944486 | On-Track Feasibility Study of a Rehabilitation System for Stroke Patients | Na | Cerebrovascular Accident | Completed | 2019-08-13 | 2021-03-31 | ClinicalTrials.gov |
| NCT03159806 | Detecting Markers of Kidney Function With Intravenous Microdialysis | — | Kidney Diseases | Withdrawn | 2019-07-01 | 2019-12-01 | ClinicalTrials.gov |
| NCT04020523 | Advanced MR Techniques for Breast Cancer Detection | Na | Breast Cancer | Withdrawn | 2019-07-01 | 2024-07-01 | ClinicalTrials.gov |
| NCT03851276 | A Multicentre, Pilot Study to Evaluate the Safety and the Feasibility of Planni… | Phase4 | Multivessel Coronary Artery Disease | Withdrawn | 2019-06-28 | 2020-03-30 | ClinicalTrials.gov |
| NCT03996772 | PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrill… | Phase3 | Atrial Fibrillation | Completed | 2019-06-03 | 2024-05-31 | ClinicalTrials.gov |
| NCT04097366 | Breast Screening - Risk Adaptive Imaging for Density | Na | Breast Cancer | Active_Not_Recruiting | 2019-05-28 | 2025-10-31 | ClinicalTrials.gov |
| NCT04389593 | Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastogra… | — | Nonalcoholic Fatty Liver | Completed | 2019-05-21 | 2024-07-12 | ClinicalTrials.gov |
| NCT02549235 | 3D Ultrasound Uterine Characteristics of Women Undergoing IVF/ICSI Treatment | — | Infertility | Unknown | 2019-05-01 | 2020-09-30 | ClinicalTrials.gov |
| NCT03997201 | Ripple Mapping Guided Ablation of Ischaemic Ventricular Tachycardia. | Na | Ventricular Tachycardia | Completed | 2019-04-18 | 2022-06-30 | ClinicalTrials.gov |
| NCT03958149 | Measurements of Angulation of the C-spine | Na | Cervical Spine | Completed | 2019-04-13 | 2019-06-02 | ClinicalTrials.gov |
| NCT04058626 | TEsting for Arterial Disease in Diabetes (TrEAD) Study | — | Diabetic Foot | Completed | 2019-03-04 | 2019-10-18 | ClinicalTrials.gov |
| NCT03847051 | EPIMix Versus CT Brain Pediatric Study | — | Brain Diseases | Completed | 2019-02-15 | 2022-07-30 | ClinicalTrials.gov |
| NCT03983707 | A Evaluation of the Utilisation, Effectiveness and Safety of Purastat® in the M… | — | Gastrointestinal Bleeding | Completed | 2019-01-23 | 2021-10-31 | ClinicalTrials.gov |
| NCT03794557 | The Effect of Inhaled PUL-042 on Rhinovirus-induced Symptoms in Smokers With GO… | Phase2 | COPD | Completed | 2019-01-21 | 2021-03-23 | ClinicalTrials.gov |
| NCT04362449 | Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Vers… | Phase2 | Gallbladder Cancer | Unknown | 2019-01-02 | 2023-02-02 | ClinicalTrials.gov |
| NCT03856450 | Use of Digital Tomosynthesis for Detection and Case Management of Scaphoid and … | Na | Distal Radius Fracture | Unknown | 2018-12-20 | 2021-09-01 | ClinicalTrials.gov |
| NCT03455283 | Post-marketing Safety Study in Participants of All Pathologies Who Receive Gado… | — | Magnetic Resonance Imaging (MRI) | Completed | 2018-12-17 | 2019-11-11 | ClinicalTrials.gov |
| NCT04773015 | A Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training Programme in … | — | Cognitive Impairment | Completed | 2018-12-11 | 2021-12-07 | ClinicalTrials.gov |
| NCT03671603 | Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEM… | — | Coronary Artery Disease | Completed | 2018-11-05 | 2021-06-07 | ClinicalTrials.gov |
| NCT04066686 | Evaluation of Comfort in a Spinal Collar | — | Neck Injuries | Completed | 2018-10-26 | 2019-05-29 | ClinicalTrials.gov |
| NCT03427749 | Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood… | — | Coronary Artery Disease | Completed | 2018-10-12 | 2022-10-01 | ClinicalTrials.gov |
| NCT03702439 | Prostate Cancer Screening Trial Using Imaging | — | Prostate Neoplasm | Completed | 2018-10-10 | 2019-08-22 | ClinicalTrials.gov |
| NCT03616457 | Automated Breast Ultrasound as an Adjunct to Screening Digital Breast Tomosynth… | — | Breast Cancer | Withdrawn | 2018-08-01 | 2021-08-01 | ClinicalTrials.gov |
| NCT03556137 | PET/MRI in the Diagnosis of Chronic Pain | Phase1 | Neuropathic Pain | Unknown | 2018-07-16 | 2024-12-31 | ClinicalTrials.gov |
| NCT03417024 | Automated Breast Ultrasound Case Collection Registry | — | Breast Cancer | Terminated | 2018-07-12 | 2019-01-25 | ClinicalTrials.gov |
| NCT04110366 | Nasal and Systemic Immune Responses to Nasal Influenza Vaccine | Na | Influenza | Completed | 2018-06-14 | 2020-05-29 | ClinicalTrials.gov |
| NCT03354273 | An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Inj… | Phase3 | Coronary Artery Disease (CAD) | Completed | 2018-06-05 | 2022-05-05 | ClinicalTrials.gov |
| NCT07235579 | Understanding Cauda Equina Syndrome | — | Cauda Equina Syndrome | Completed | 2018-06-01 | 2022-01-08 | ClinicalTrials.gov |
| NCT03690713 | International Collaboration of Comprehensive Physiologic Assessment | — | Stable Angina | Completed | 2018-06-01 | 2018-09-26 | ClinicalTrials.gov |
| NCT02733029 | Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection | Phase2 | Renal Transplant Rejection | Completed | 2018-05-30 | 2023-02-01 | ClinicalTrials.gov |
| NCT03482557 | Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening | Na | Breast Cancer | Completed | 2018-05-17 | 2023-08-30 | ClinicalTrials.gov |
| NCT03505372 | Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biop… | Na | Atypical Ductal Hyperplasia | Terminated | 2018-05-10 | 2019-06-28 | ClinicalTrials.gov |
| NCT03674528 | Technical Validation of MR Biomarkers of Obesity-Associated NAFLD | — | Non-Alcoholic Fatty Liver Disease | Completed | 2018-05-04 | 2024-06-11 | ClinicalTrials.gov |
| NCT03766633 | Accuracy of the LiverVision® Semi-automated Liver Volumetry Software | — | Liver Diseases | Unknown | 2018-04-29 | 2021-03-31 | ClinicalTrials.gov |
| NCT03417713 | Clinical Evaluation of the OEC Elite MD for Vascular Procedures at Hamilton Gen… | — | Interventional Vascular Conditions | Completed | 2018-04-04 | 2018-05-29 | ClinicalTrials.gov |
| NCT03387670 | Multiple Sclerosis-Simvastatin Trial 2 | Phase3 | Secondary Progressive Multiple Sclerosis (SPMS) | Completed | 2018-03-28 | 2024-08-25 | ClinicalTrials.gov |
| NCT03128268 | The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works | Na | Cardiac Disease | Active_Not_Recruiting | 2018-02-20 | 2023-06-20 | ClinicalTrials.gov |
| NCT03119662 | A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patien… | Phase4 | Chronic Kidney Diseases | Terminated | 2018-02-08 | 2018-10-19 | ClinicalTrials.gov |
| NCT03872960 | A Randomised Trial of Expedited Transfer to a Cardiac Arrest Centre for Non-ST … | Na | Out-Of-Hospital Cardiac Arrest | Completed | 2018-02-02 | 2024-04-30 | ClinicalTrials.gov |
| NCT03318380 | Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients Wit… | Na | Liver Cirrhosis | Completed | 2018-01-19 | 2022-11-03 | ClinicalTrials.gov |
| NCT03456427 | Patient-Assisted Compression in 3D - Impact on Image Quality and Workflow | Na | Breast Cancer | Completed | 2018-01-04 | 2018-01-09 | ClinicalTrials.gov |
| NCT03517813 | CESM ABMR Breast Cancer Screening Trial | — | Breast Cancer Screening | Completed | 2018-01-03 | 2022-12-31 | ClinicalTrials.gov |
| NCT03366662 | The Effect of Frontal Electromyogram (F-EMG) Activity on the Entropy Index Beha… | — | Anesthesia, General | Withdrawn | 2017-12-19 | 2018-12-31 | ClinicalTrials.gov |
| NCT03245255 | Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultr… | Phase2 | Cardiac Catheterization | Completed | 2017-12-04 | 2023-06-07 | ClinicalTrials.gov |
| NCT03928886 | Discomfort Assessment of Senographe Pristina Patient-assisted Versus Standard C… | Na | Mammography Related Discomfort | Unknown | 2017-12-01 | 2020-12-01 | ClinicalTrials.gov |
| NCT03338270 | Clinical Validation Study of Multi-EPI Mix | — | Brain Diseases | Completed | 2017-12-01 | 2018-05-07 | ClinicalTrials.gov |
| NCT03861663 | Venue Ultrasound Evaluation - Israel | Na | Ultrasound Exam in Emergency/Medical Care | Completed | 2017-12-01 | 2018-01-29 | ClinicalTrials.gov |
| NCT03617419 | Vscan Access R2 Feasibility Evaluation | Na | Gather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd Trimester | Completed | 2017-11-14 | 2018-02-26 | ClinicalTrials.gov |
| NCT04003181 | The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and t… | Na | Colon Adenocarcinoma | Completed | 2017-09-28 | 2021-05-26 | ClinicalTrials.gov |
| NCT05058300 | Prospective Registry for Patients With Chest Pain in Emergency Department | — | Chest Pain | Unknown | 2017-09-20 | 2024-10-11 | ClinicalTrials.gov |
| NCT03383757 | U-TruSignal SpO2 Testing in Neonates | Na | Pulse Oximetry | Completed | 2017-09-14 | 2019-11-01 | ClinicalTrials.gov |
| NCT03103490 | 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation | Phase2 | Cardiac Sarcoidosis | Terminated | 2017-08-02 | 2021-09-28 | ClinicalTrials.gov |
| NCT02894749 | Evaluation of 3D Rotational Angiography After EVAR | Na | Radiation Burn | Withdrawn | 2017-08-01 | 2019-07-01 | ClinicalTrials.gov |
| NCT03196635 | Patient-Assisted Compression - Impact on Image Quality and Workflow | Na | Breast Cancer | Completed | 2017-06-19 | 2017-06-29 | ClinicalTrials.gov |
| NCT03096483 | Clinical Evaluation of the OEC Elite Vascular Mobile Fluoroscopy System | Na | Interventional Vascular Conditions | Terminated | 2017-06-19 | 2017-07-07 | ClinicalTrials.gov |
| NCT03653572 | Clinical Evaluation of the Next Generation Venue Ultrasound System, Components,… | Na | Ultrasound Use in Emergency/Medical Care | Completed | 2017-06-14 | 2017-08-02 | ClinicalTrials.gov |
| NCT02972892 | Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared… | Na | Et Control Performance in Adult Population Surgery | Completed | 2017-06-09 | 2018-09-05 | ClinicalTrials.gov |
| NCT03211507 | Idiopathic Pulmonary Fibrosis Job Exposures Study | — | IPF | Completed | 2017-05-01 | 2019-10-05 | ClinicalTrials.gov |
| NCT03128255 | Fusion UltraSound Imaging Of the Thyroid GlaNd With I-124 PET. Evaluation of No… | — | Thyroid Nodule | Unknown | 2017-04-26 | 2018-04-01 | ClinicalTrials.gov |
| NCT03057275 | Performance of the Monica Novii Wireless Patch System in Pre-term Labor | — | Premature Labor | Completed | 2017-04-20 | 2019-09-20 | ClinicalTrials.gov |
| NCT03085342 | Evaluation of Hepatic Fibrosis on Multiparametric MRI | Na | Cirrhosis | Unknown | 2017-04-04 | 2021-12-01 | ClinicalTrials.gov |
| NCT03170817 | Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT | — | Coronary Artery Disease | Completed | 2017-03-29 | 2021-09-01 | ClinicalTrials.gov |
| NCT03156608 | Novii External Fetal Monitoring Device | Na | Pregnancy Related | Completed | 2017-03-06 | 2017-06-28 | ClinicalTrials.gov |
| NCT03265912 | Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussi… | — | Concussion, Mild | Completed | 2017-01-26 | 2018-01-16 | ClinicalTrials.gov |
| NCT04540107 | Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lowe… | Phase1 | Recurrent World Health Organization (WHO) Grade II Glioma | Recruiting | 2017-01-11 | 2027-01-31 | ClinicalTrials.gov |
| NCT02946242 | Development Of Medical Ultrasound Systems, Accessories, And Components - GE Ban… | Na | Ultrasound Exams | Completed | 2016-11-29 | 2021-12-17 | ClinicalTrials.gov |
| NCT05249439 | Investigation of a New Diet for the Treatment of Obesity in the NHS | Na | Obesity | Completed | 2016-11-29 | 2019-05-02 | ClinicalTrials.gov |
| NCT02927327 | Clinical Evaluation Of MP26 Features in Adults | Na | Brain Imaging | Completed | 2016-11-01 | 2017-09-20 | ClinicalTrials.gov |
| NCT02946229 | Data Collection for Next Generation Ultrasound Technology Development | Na | Endstage Renal Disease | Completed | 2016-10-26 | 2016-12-06 | ClinicalTrials.gov |
| NCT02537340 | PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR | — | Rectal Neoplasms | Completed | 2016-09-01 | 2019-05-01 | ClinicalTrials.gov |
| NCT02872363 | Does the Wording of Text Message Reminders Improve Uptake in Breast Screening? | Na | Breast Cancer | Terminated | 2016-08-09 | 2017-02-20 | ClinicalTrials.gov |
| NCT03757598 | ePartogram Effectiveness Study in Kenya | Na | Obstetric Complication | Completed | 2016-08-01 | 2017-05-30 | ClinicalTrials.gov |
| NCT02813473 | SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Sca… | — | Coronary Artery Diseases | Completed | 2016-06-27 | 2018-03-26 | ClinicalTrials.gov |
| NCT04515368 | A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity | Na | Positron-Emission Tomography | Completed | 2016-06-10 | 2020-09-03 | ClinicalTrials.gov |
| NCT02731937 | Clinical Evaluation of a Dual Energy CT System | Na | General CT Imaging | Completed | 2016-04-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02764801 | Contrast-enhanced Ultrasound Evaluation of Chemoembolization | Phase3 | Hepatocellular Carcinoma | Completed | 2016-04-01 | 2023-02-01 | ClinicalTrials.gov |
| NCT02785588 | Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care… | Na | Neonatal Neuroimaging | Completed | 2016-03-22 | 2018-04-20 | ClinicalTrials.gov |
| NCT02479100 | Contrast Enhanced Spectral Mammography (CESM) Study | Na | Breast Cancer | Unknown | 2016-03-22 | 2022-12-31 | ClinicalTrials.gov |
| NCT02786004 | Image Quality Assessment for Screening and Diagnostic Mammography | Na | Breast Health | Completed | 2016-02-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02524405 | BEAM: Brain-Eye Amyloid Memory Study | — | Alzheimer's Disease | Recruiting | 2016-02-01 | 2025-03-01 | ClinicalTrials.gov |
| NCT02771938 | Primary Radiotherapy And DIEP flAp Reconstruction Trial | Na | Breast Cancer | Completed | 2016-01-14 | 2021-12-31 | ClinicalTrials.gov |
| NCT02652923 | Contrast Ultrasound Detection of Sentinel Lymph Nodes | Phase1 | Breast Cancer | Completed | 2016-01-01 | 2022-01-12 | ClinicalTrials.gov |
| NCT02656329 | International Study to Determine if AdreView Heart Function Scan Can be Used to… | Phase3 | Heart Failure | Terminated | 2015-12-30 | 2018-05-04 | ClinicalTrials.gov |
| NCT03419078 | Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT) | — | Allogeneic Stem Cell Transplant | Completed | 2015-12-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02596854 | Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Rec… | Na | Clinical Indication for Brain MRI | Completed | 2015-11-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT02556177 | Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 | Na | Concussion | Completed | 2015-11-01 | 2018-01-31 | ClinicalTrials.gov |
| NCT02590458 | Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for… | Early_Phase1 | Breast Cancer | Completed | 2015-10-26 | 2020-11-24 | ClinicalTrials.gov |
| NCT03062917 | Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis | Na | Bronchiolitis | Completed | 2015-10-02 | 2018-06-30 | ClinicalTrials.gov |
| NCT03043976 | Using Step Count to Enhance Daily Physical Activity in Pulmonary Hypertension | Na | Hypertension, Pulmonary | Terminated | 2015-10-01 | 2019-01-01 | ClinicalTrials.gov |
| NCT02807025 | Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients … | — | IPF | Unknown | 2015-09-01 | 2017-12-31 | ClinicalTrials.gov |
| NCT03229772 | Demonstration of the "SPECT/CT System With CZT Detectors" Imaging Performance i… | Na | Cancer | Completed | 2015-09-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02538861 | Acute Chest Pain Imaging in the ED With the Combine CCTA and CT Perfusion | — | Chest Pain | Completed | 2015-09-01 | 2019-06-06 | ClinicalTrials.gov |
| NCT02555527 | Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Asse… | — | Cardiomyopathies | Completed | 2015-09-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT03470844 | Perioperative Research Into Memory: Cognitive Outcome Following Major Burns | — | Major Injury | Completed | 2015-08-05 | 2017-10-30 | ClinicalTrials.gov |
| NCT02386176 | Assessment of Automated Breast Ultrasound | — | Breast Cancer | Completed | 2015-08-01 | 2020-03-01 | ClinicalTrials.gov |
| NCT02540083 | Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthes… | Na | Breast Cancer | Terminated | 2015-08-01 | 2017-05-30 | ClinicalTrials.gov |
| NCT02707757 | Treatment Response in Dialysis Anaemia | Phase4 | Anaemia | Completed | 2015-07-01 | 2017-04-01 | ClinicalTrials.gov |
| NCT02321527 | Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph N… | Na | Breast Cancer | Completed | 2015-07-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02241668 | Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Res… | Na | Brain Tumor | Withdrawn | 2015-06-01 | — | ClinicalTrials.gov |
| NCT02279030 | Use of MIBG Scan Images in PVC Ablations | — | Premature Ventricular Contractions | Completed | 2015-06-01 | 2019-12-31 | ClinicalTrials.gov |
| NCT02560116 | The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgi… | — | Hypertension, Pulmonary | Withdrawn | 2015-06-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02232009 | Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care… | Na | Image Evaluation | Terminated | 2015-05-07 | 2016-11-30 | ClinicalTrials.gov |
| NCT02306265 | Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthes… | Na | Breast Cancer | Completed | 2015-05-01 | 2017-07-07 | ClinicalTrials.gov |
| NCT02279459 | Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas | — | Head and Neck Squamous Cell Carcinoma | Completed | 2015-04-14 | 2019-04-15 | ClinicalTrials.gov |
| NCT02479152 | The Haemodynamic Effects of Mechanical Standard and Active Chest Compression-de… | Na | Cardiac Arrest | Completed | 2015-04-01 | 2017-04-01 | ClinicalTrials.gov |
| NCT02430038 | Transperineal Ultrasound to Assess the Progress of Labour | — | Placenta Praevia | Completed | 2015-04-01 | 2018-01-19 | ClinicalTrials.gov |
| NCT02425956 | Non-invasive Quantification of Liver Iron With MRI | Na | Iron Overload | Completed | 2015-04-01 | 2016-06-30 | ClinicalTrials.gov |
| NCT02324205 | Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthes… | Na | Breast Cancer | Terminated | 2015-03-01 | 2017-08-29 | ClinicalTrials.gov |
| NCT02332070 | Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac … | — | Acute Kidney Injury | Completed | 2015-01-01 | 2018-02-01 | ClinicalTrials.gov |
| NCT04738370 | Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy | — | Pregnancy of Unknown Location | Unknown | 2014-12-08 | 2024-12-31 | ClinicalTrials.gov |
| NCT03195270 | Use of PET/MR Imaging in Chronic Pain | Phase1 | Chronic Pain | Completed | 2014-11-24 | 2022-01-20 | ClinicalTrials.gov |
| NCT02275871 | Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening… | Na | Breast Cancer | Terminated | 2014-11-01 | 2020-01-01 | ClinicalTrials.gov |
| NCT02280941 | Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF) | Na | Coronary Heart Disease | Completed | 2014-10-30 | 2022-09-02 | ClinicalTrials.gov |
| NCT03340870 | A Study to Evaluate Pharmacokinetics of Sonazoid™ Following Intravenous Bolus I… | Phase1 | Healthy | Completed | 2014-10-20 | 2014-11-20 | ClinicalTrials.gov |
| NCT02188901 | Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinom… | Na | Hepatocellular Carcinoma (HCC) | Completed | 2014-10-15 | 2016-08-03 | ClinicalTrials.gov |
| NCT02234336 | Assessment of Wall Thickness in Hypertrophic Cardiomyopathy | — | Hypertrophic Cardiomyopathy | Completed | 2014-10-01 | 2017-07-25 | ClinicalTrials.gov |
| NCT02224339 | New Technologies to Determine Carotid Plaque Vulnerability | — | Atherosclerosis | Completed | 2014-09-01 | 2019-01-01 | ClinicalTrials.gov |
| NCT02218216 | TBI MR Study 3 Houston Methodist | Na | Traumatic Brain Injury | Terminated | 2014-09-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02193672 | A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational A… | Phase1 | Advanced Cancers | Withdrawn | 2014-08-01 | — | ClinicalTrials.gov |
| NCT02141360 | Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF | Na | Traumatic Brain Injury | Terminated | 2014-07-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02138682 | Validation of DaTscan for Detection of Parkinson Disease Related Disorders | — | Parkinson Disease | Unknown | 2014-07-01 | — | ClinicalTrials.gov |
| NCT02164643 | Longitudinal Study of Brain Amyloid imaGing in MEMENTO | Phase3 | Alzheimer's Disease (AD) and Related Disorders | Completed | 2014-06-10 | 2019-10-09 | ClinicalTrials.gov |
| NCT03409146 | Accuracy and Reliability of Novii: Fetal Heart Rate (FHR), Maternal Heart Rate … | — | Term Labour | Completed | 2014-05-28 | 2017-02-13 | ClinicalTrials.gov |
| NCT06456723 | Evaluation of [18F]Fluoroethyl Triazole Labelled [Tyr3]-Octreotate Analogues fo… | Phase1 | Neuroendocrine Tumors | Completed | 2014-05-14 | 2018-10-17 | ClinicalTrials.gov |
| NCT03335566 | An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Foc… | Phase3 | Liver Lesions | Completed | 2014-05-11 | 2015-04-09 | ClinicalTrials.gov |
| NCT02042456 | Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared… | — | Breast Cancer | Terminated | 2014-04-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01990625 | A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in L… | Na | Pregnancy | Completed | 2014-04-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT02125331 | Measurement of NonInvasive Blood Pressure in Neonates Through Adults and Specia… | — | Blood Pressure | Terminated | 2014-04-01 | 2019-03-01 | ClinicalTrials.gov |
| NCT03238040 | Biomarkers of Acute Serious Illness in Children | — | Critical Illness | Completed | 2014-04-01 | 2017-12-31 | ClinicalTrials.gov |
| NCT01977586 | Functional Imaging in the Assessment of mRCC Response to Sunitinib | Na | Metastatic Renal Cell Carcinoma | Withdrawn | 2014-04-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02305706 | Right or Left for Colonoscopy? | Na | Colonoscopy | Completed | 2014-04-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02070588 | Advanced MRI Applications for Mild Traumatic Brain Injury | Na | Mild Traumatic Brain Injury | Terminated | 2014-02-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02127307 | Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy fo… | — | Heart Failure (HF) | Completed | 2014-02-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT02071706 | Clinical Evaluation of an Integrated PET/MRI System | Na | Subjects With Clinical Indication for PET/CT | Completed | 2014-01-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01986985 | Comparison of 18F FDG PET/CT TO PET MRI | Na | Any Condition With a Clinical Indication for PET/CT Exam | Completed | 2014-01-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02043522 | 123I-mIBG SPECT Imaging | Phase3 | Heart Failure | Completed | 2013-12-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01868841 | 123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a S… | Phase4 | Heart Failure | Completed | 2013-12-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT02002455 | Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With… | Phase2 | Prostate Carcinoma | Completed | 2013-12-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01928875 | Comparison of Adequacy of Anesthesia Monitoring With Standard Clinical Practice… | Na | Surgical Procedure, Unspecified | Completed | 2013-12-01 | — | ClinicalTrials.gov |
| NCT01992354 | Development of an Integrated Positron Emission Tomography/Magnetic Resonance (P… | Na | Indication for a PET CT Exam | Terminated | 2013-11-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02088320 | Measurement of Pulmonary Transit Time by Echocardiography: Comparison With Card… | — | Patients Undergoing Cardiac Surgery | Completed | 2013-11-01 | 2018-10-01 | ClinicalTrials.gov |
| NCT02264743 | Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Th… | Phase4 | Venous Thrombosis | Unknown | 2013-11-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01998932 | Predictive of Biomarkers of Healing in Chronic Venous Ulceration of the Lower L… | — | Varicose Ulcer | Completed | 2013-11-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01902693 | Prospective HIV Chemotherapy Cohort Study | — | HIV | Completed | 2013-10-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT06240871 | Contrast Enhanced PA Pressure Measurements | — | Pulmonary Hypertension | Completed | 2013-09-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02309723 | Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints. | Na | Alzheimer's Disease | Completed | 2013-09-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01961583 | [18F]Fluciclatide PET Imaging of Pazopanib Response | Phase2 | Kidney Neoplasm | Terminated | 2013-09-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT02090855 | Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuri… | — | Cognitive Impairment | Completed | 2013-09-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01885143 | A Case Collection Study for Digital Breast Tomosynthesis (DBT) Using the Senogr… | — | Image Correction | Completed | 2013-08-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01936649 | Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measure… | Phase4 | Heart Failure (HF) | Completed | 2013-08-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01952678 | Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of … | — | Essential Tremor | Completed | 2013-07-30 | 2016-05-01 | ClinicalTrials.gov |
| NCT01853163 | Long-Term Retention of Gadolinium in Bone | Na | Focus: Long-term Retention of Gadolinium-based Contrast Agent | Completed | 2013-05-06 | 2018-12-17 | ClinicalTrials.gov |
| NCT01909180 | Clinical Evaluation for General Electric (GE) CT System | Na | CT Scanners X Ray | Completed | 2013-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01492192 | RGD-PET-CT in Cancer Angiogenesis | Phase2 | Carcinoma, Renal Cell | Terminated | 2013-05-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01856504 | Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic Accur… | — | Coronary Artery Disease | Completed | 2013-05-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01864083 | FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Br… | Early_Phase1 | Breast Cancer | Completed | 2013-05-01 | 2017-08-29 | ClinicalTrials.gov |
| NCT02751164 | Evaluation of the Association Between Day and Time of Admission to Critical Car… | — | Critical Illness | Completed | 2013-04-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01738347 | Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging P… | Phase1 | Relapsing-remitting Multiple Sclerosis (rrMS) | Completed | 2013-04-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT03861130 | Genetic Determinants of Kawasaki Disease | — | Kawasaki Disease | Unknown | 2013-02-25 | 2022-12-30 | ClinicalTrials.gov |
| NCT01790139 | Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Im… | Na | Colorectal Neoplasms | Completed | 2013-02-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01839825 | Comparative Study of QuietCare | Na | Elderly People | Completed | 2012-12-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01810198 | Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization | Na | Coronary Artery Disease | Completed | 2012-12-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01715649 | Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes | Na | Diabetes Mellitus, Type 2 | Completed | 2012-11-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02813070 | Comparison of PET Amyloid Imaging in Japanese and Western Subjects | Phase2 | Mild Cognitive Impairment | Completed | 2012-10-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01724216 | Magnetic Resonance Imaging Using Innovative Pulse Sequences | Na | Clinical Indication for a Head MRI | Completed | 2012-10-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01687790 | The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From … | Na | Breast Abnormalities | Completed | 2012-09-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01489176 | Regadenoson Real Time Perfusion Imaging Trial-Optison | Phase3 | Coronary Artery Disease | Completed | 2012-07-31 | 2014-12-01 | ClinicalTrials.gov |
| NCT01672996 | Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use… | Phase1 | Healthy | Completed | 2012-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT02067416 | PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer | Phase2 | Breast Cancer | Withdrawn | 2012-07-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01672827 | Effectiveness of an Electronic Training Program for Orienting and Interpreting … | Phase3 | Alzheimer's Disease | Completed | 2012-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01613222 | SpO2 System Accuracy Testing With Different Sensors | Na | Pulse Oximetry | Completed | 2012-06-19 | 2013-02-15 | ClinicalTrials.gov |
| NCT01788696 | Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects | Phase1 | Parkinson Disease | Completed | 2012-06-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01634451 | Development and Evaluation of Strategies to Improve Sedation Quality in InTensi… | Na | Critical Illness | Completed | 2012-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01196793 | Hospital Admissions in Children Aged 3 Months to 5 Years Presenting With Fever … | — | Fever | Completed | 2012-04-30 | 2014-07-03 | ClinicalTrials.gov |
| NCT01585025 | Obeticholic Acid in Bile Acid Diarrhoea | Phase2 | Primary Bile Acid Malabsorption | Completed | 2012-04-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01516281 | Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury | — | Traumatic Brain Injury | Completed | 2012-03-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01570543 | MRI Scanning of People With MR Safe Orthopedic Implants That Are Made of Metal | — | Implants | Withdrawn | 2012-03-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01546285 | B40 Non-Invasive Blood Pressure Equivalency Study | Na | Blood Pressure | Completed | 2012-03-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01522378 | Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging | Phase1 | Congestive Heart Failure | Terminated | 2012-02-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01457170 | Effects of Apelin on the Lung Circulation in Pulmonary Hypertension | Na | Pulmonary Arterial Hypertension | Unknown | 2012-01-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01530477 | DXA Precision and Accuracy Comparison Study | Na | Osteopenia | Terminated | 2012-01-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01485120 | Accuracy Study of a Non-Invasive Blood Pressure Cuff in Comparison to an Invasi… | Na | Blood Pressure | Completed | 2011-12-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01482325 | SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement | Na | Blood Pressure (Low, Normal, High) | Terminated | 2011-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01475097 | Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patient… | Phase4 | Drug Safety | Completed | 2011-10-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01432626 | Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG | Na | Stress Induced Cardiomyopathy | Completed | 2011-09-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01431378 | Pilot Study of Model Based Iterative Reconstruction Using 64-Slice | — | Posterior Fossa Hemorrhage | Terminated | 2011-09-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01440517 | Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus … | Phase2 | Diabetes Mellitus | Terminated | 2011-08-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01348958 | Evaluation of Orthopedic Knee Measurement Using Lunar iDXA | Na | Hemi Knee Arthroplasty | Completed | 2011-07-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01358474 | Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism | — | Parkinson Disease | Completed | 2011-07-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT01394926 | Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Det… | Phase2 | Carotid Artery Disease | Terminated | 2011-06-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01376089 | Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed To… | Phase4 | Patient Comfort and Safety | Completed | 2011-05-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00673842 | Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction | Phase3 | Myocardial Infarction | Completed | 2011-04-18 | 2024-10-31 | ClinicalTrials.gov |
| NCT01326676 | Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial | Phase3 | Cardiovascular Disease | Withdrawn | 2011-02-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT02021877 | Evidence Based Diagnostics and Treatment Planning Solution for Traumatic Brain … | — | Traumatic Brain Injury | Completed | 2011-02-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01284270 | Lipid Rich Necrotic Core Lesion Detected by Cardiac Magnetic Resonance Imaging … | Na | Coronary Disease | Withdrawn | 2011-01-01 | — | ClinicalTrials.gov |
| NCT01265394 | Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Youn… | Phase3 | Healthy | Completed | 2010-12-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01252810 | Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elder… | Phase2 | Chronic Renal Insufficiency | Completed | 2010-11-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01229618 | Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer | Phase1 | Prostate Cancer | Completed | 2010-10-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01246297 | Effect of Pulmonary Rehabilitation in Lung Cancer Survivors | Na | Lung Cancer | Completed | 2010-10-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01163526 | Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Mali… | — | Neuroendocrine Tumors | Terminated | 2010-09-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01246258 | Otolith Function in Patients With Primary Ciliary Dyskinesia | — | Primary Ciliary Dyskinesia | Completed | 2010-09-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01795456 | Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis | — | Takayasu's Arteritis | Completed | 2010-08-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01243710 | Taurolidine in Haemodialysis Catheter Related Bacteraemia | Phase4 | Renal Dialysis | Completed | 2010-08-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01176500 | A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation … | Phase1 | Colon Cancer | Withdrawn | 2010-07-28 | 2011-11-18 | ClinicalTrials.gov |
| NCT02165514 | Cobb Angle Measurement of Kyphosis and Scoliosis | Na | Kyphosis | Completed | 2010-07-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01176513 | GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) I… | Phase2 | Prostate Cancer | Terminated | 2010-07-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01181596 | NICU-TECH RM9L-RS Probe ME Feasibility Study | — | Neonates | Terminated | 2010-06-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT02667756 | Predicting Osteoarthritis Risk Following Knee Injury. | — | Osteoarthritis | Unknown | 2010-06-01 | 2020-09-01 | ClinicalTrials.gov |
| NCT01165554 | Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mo… | Phase3 | Brain Fibrillarab Levels | Completed | 2010-05-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01303419 | Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Manage… | Na | Breast Cancer | Terminated | 2010-04-01 | 2012-06-30 | ClinicalTrials.gov |
| NCT01052493 | A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in… | Phase1 | Obesity | Completed | 2010-04-01 | 2010-10-18 | ClinicalTrials.gov |
| NCT01092546 | Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydroc… | Phase3 | Normal Pressure Hydrocephalus | Terminated | 2010-03-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01250912 | Imaging With a Radio Tracer to Guide VT Ablations | Na | Ventricular Tachycardia | Completed | 2010-03-01 | 2019-07-01 | ClinicalTrials.gov |
| NCT01103336 | Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-I… | Phase4 | Chronic Renal Failure | Completed | 2010-03-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01086514 | Digital Mammography for the Detection and Preoperative Staging of Breast Cancer | Na | Breast Cancer | Completed | 2010-03-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01041924 | Dynamic Carbon Dioxide (CO2) Administration for Sleep Apnoea | Phase2 | Sleep Apnea, Central | Unknown | 2010-02-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01076296 | A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imagi… | — | Left Ventricular Dysfunction | Completed | 2010-02-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01052441 | Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Unde… | — | Coronary Arteriosclerosis | Completed | 2010-01-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01047150 | The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Be… | — | Myocardial Ischemia | Unknown | 2010-01-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT01110161 | Technical Validation of Lunar iDXA Visceral Fat Tool | — | Obesity | Completed | 2010-01-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01052766 | Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver… | Na | Lung Cancer | Terminated | 2010-01-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT00995865 | Trial of Yellow Fever Inactivated Vaccine | Phase1 | Yellow Fever | Completed | 2010-01-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01011855 | Radiant Warmer Trial | Na | Body Temperature Changes | Withdrawn | 2009-12-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00987298 | Technical Validation of Lunar iDXA (GE Healthcare) Visceral Fat Tool | — | Obesity | Completed | 2009-12-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01028053 | Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifyin… | Phase3 | Mild Cognitive Impairment | Completed | 2009-12-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01053312 | PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus | Phase3 | Normal Pressure Hydrocephalus | Completed | 2009-12-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00982072 | Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease | Phase4 | Minimal Change Disease | Completed | 2009-12-01 | 2019-10-10 | ClinicalTrials.gov |
| NCT01361230 | IMPROVE Critical Care Study (Pilot) | Na | Sedated ICU Patients | Completed | 2009-12-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01056640 | Telemonitoring Versus Usual Care | Phase2 | Health Care Quality | Completed | 2009-11-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01097239 | Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in R… | Phase1 | Rectal Cancer | Withdrawn | 2009-11-01 | 2018-09-01 | ClinicalTrials.gov |
| NCT01011647 | Prevalence of Sleep Disordered Breathing | — | Unstable Angina | Terminated | 2009-11-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01004770 | Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers U… | Phase1 | Healthy | Completed | 2009-10-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00734357 | Comparative Investigation of Intravenously Administered Omnipaque and Isovue: E… | Na | Kidney Disease | Completed | 2009-10-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00913380 | Diagnosis of Acute Appendicitis: Low-dose Computed Tomography (CT) Versus Stand… | Phase3 | Appendicitis | Completed | 2009-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00963651 | GE Healthcare VolumeRAD Lung Nodule Detection Study | — | Pulmonary Nodule, Solitary | Completed | 2009-08-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00918281 | Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intra… | Phase2 | Solid Tumors | Completed | 2009-06-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00908310 | Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who R… | Phase4 | Chronic Kidney Disease | Completed | 2009-05-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT00802529 | Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease | Phase2 | Meniere's Disease | Completed | 2009-04-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT00843856 | Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idi… | Phase4 | Glomerulonephritis, Membranous | Completed | 2009-03-03 | 2018-09-18 | ClinicalTrials.gov |
| NCT00843219 | Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Ga… | — | Lung Cancer | Completed | 2009-03-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00878878 | Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pul… | Phase4 | Pulmonary Hypertension | Completed | 2009-03-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT06403319 | Otitis Media With Effusion and Type 2 Inflammation Diseases | — | Otitis Media With Effusion | Completed | 2009-01-01 | 2020-12-31 | ClinicalTrials.gov |
| NCT00807144 | Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Indu… | Phase4 | End-stage Renal Failure | Completed | 2008-12-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT00785694 | Recurrence of Bladder Cancer After Transurethral Resection With Hexvix | Phase4 | Bladder Cancer | Withdrawn | 2008-12-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01022359 | Comparison of Tesio and LifeCath Twin Permanent Dialysis Catheters | Na | Hemodialysis | Completed | 2008-10-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00776126 | Digital Breast Tomosynthesis Preference Study | — | Breast Cancer | Completed | 2008-10-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00785759 | Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognit… | Phase2 | Alzheimer's Disease | Completed | 2008-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00783302 | Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as… | — | Coronary Artery Disease (CAD) | Completed | 2008-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00785044 | Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Wi… | — | Congestive Heart Failure | Completed | 2008-05-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00730964 | A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical … | Phase4 | Echocardiography | Completed | 2008-05-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00888589 | Detection of Aggressive Breast Tumors Using Tc-99m-NC100692 | — | Breast Cancer | Completed | 2008-05-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT00635375 | Comparative Study of Phototherapy for Hyperbilirubinemia | Na | Hyperbilirubinemia | Completed | 2008-03-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00634621 | Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of … | — | Bladder Cancer | Completed | 2008-02-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00567684 | Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients … | Na | Bladder Cancer | Active_Not_Recruiting | 2007-11-15 | 2034-11-30 | ClinicalTrials.gov |
| NCT00603486 | SuperSTAT Noninvasive Blood Pressure Monitor Evaluation | — | Non-Invasive Blood Pressure | Unknown | 2007-11-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00565721 | A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to… | Phase2 | High-grade Glioma | Completed | 2007-11-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT02876263 | Noninvasive Neuromonitoring of Surgery of the Thoracic Aorta | — | Cardiopulmonary Arrest | Completed | 2007-09-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT00478556 | Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT | Phase4 | Healthy | Completed | 2007-08-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00535184 | Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Ca… | — | Breast Cancer | Completed | 2007-08-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00535327 | Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breas… | — | Breast Cancer | Completed | 2007-08-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00494637 | The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy | Na | Contrast Induced Nephropathy | Terminated | 2007-07-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00486447 | Perfusion Imaging and CT -Understanding Relative Efficacy | Na | Coronary Artery Disease | Terminated | 2007-06-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00535678 | Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast … | — | Breast Cancer | Completed | 2007-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00548392 | Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placem… | — | Breast Cancer | Completed | 2007-05-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00443001 | Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysr… | Na | Healthy | Completed | 2007-04-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00464724 | 3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging o… | Na | Prostate Cancer | Terminated | 2007-03-01 | 2019-12-12 | ClinicalTrials.gov |
| NCT04915976 | TAVI and Gender Outcomes Aortic Stenosis Undergoing Transfemoral Transcatheter … | — | Aortic Stenosis | Suspended | 2007-01-01 | 2025-01-01 | ClinicalTrials.gov |
| NCT00382967 | A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subje… | Phase4 | Parkinsonian Syndromes | Completed | 2006-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00773292 | Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/… | Phase2 | HTLV I Associated Myelopathy | Completed | 2006-08-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00855231 | Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain | — | Chest Pain | Completed | 2006-07-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00381316 | Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial… | Phase4 | Coronary Artery Disease | Completed | 2006-07-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00348608 | Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced C… | Phase3 | Coronary Artery Disease | Terminated | 2006-06-01 | 2006-12-02 | ClinicalTrials.gov |
| NCT00335101 | Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Underg… | Phase4 | Coronary Artery Disease (CAD) | Withdrawn | 2006-06-01 | — | ClinicalTrials.gov |
| NCT00348569 | A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages… | Na | Coronary Artery Disease | Completed | 2006-05-01 | 2007-01-31 | ClinicalTrials.gov |
| NCT00335335 | Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced C… | Phase3 | Coronary Artery Disease | Terminated | 2006-05-01 | 2006-12-02 | ClinicalTrials.gov |
| NCT00588614 | High Risk Screening Breast MR Using a Rapid Imaging Exam | — | Breast Cancer | Completed | 2006-04-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00712946 | Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients … | — | Arteriosclerosis Obliterans | Completed | 2006-03-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00285506 | The Effect of Contrast Media on Erythrocytes in Healthy Volunteers | — | Healthy Volunteers | Completed | 2006-01-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT01878305 | Neuromonitoring of Hepatic Encephalopathy | — | Liver Failure, Acute | Completed | 2005-12-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00350506 | A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Car… | Na | Coronary Artery Disease | Terminated | 2005-10-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00126412 | Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated f… | Phase3 | Pheochromocytoma | Completed | 2005-08-02 | 2006-09-27 | ClinicalTrials.gov |
| NCT00209430 | Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Co… | Phase4 | Coronary Artery Disease | Completed | 2005-08-01 | — | ClinicalTrials.gov |
| NCT00126438 | Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Hear… | Phase3 | Heart Failure, Congestive | Completed | 2005-07-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00126425 | Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure an… | Phase3 | Heart Failure, Congestive | Completed | 2005-07-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00209404 | Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-C… | Phase4 | Coronary Artery Disease | Completed | 2005-07-01 | — | ClinicalTrials.gov |
| NCT00200629 | Both Exercise and Adenosine Stress Testing | Phase4 | Coronary Artery Disease | Terminated | 2005-06-01 | — | ClinicalTrials.gov |
| NCT01200303 | Evaluation of Computer-assisted, Non-cathartic CT Colonography | Phase2 | Colonic Polyps | Completed | 2005-06-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00209417 | Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Co… | Phase4 | Renal Insufficiency | Terminated | 2005-06-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00129181 | Study of the Effects of Dopaminergic Medications on Dopamine Transporter Densit… | Na | Parkinson Disease | Completed | 2005-01-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00639548 | ERPS, BIS and Entropy for Neuromonitoring in ICU Patients | — | Deep Sedation | Completed | 2004-11-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00209443 | A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-ili… | Phase3 | Aorto-iliac Stenosis | Completed | 2004-09-01 | 2006-02-28 | ClinicalTrials.gov |
| NCT00282711 | The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN? | — | Coronary Artery Disease | Completed | 2004-06-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00641563 | Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Ele… | Na | Conscious Sedation | Completed | 2004-03-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00209456 | Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy B… | Phase3 | Lewy Body Dementia | Completed | 2003-11-01 | — | ClinicalTrials.gov |
| NCT00213746 | Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT … | — | Coronary Arteriosclerosis | Completed | 2003-10-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00209391 | A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arter… | Phase3 | Renal Artery Stenosis | Completed | 2003-09-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00730119 | Evaluation Of The GE Monitor Product Line | — | Non-invasive Blood Pressure | Withdrawn | 2001-10-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00399503 | Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhy… | — | Myocardial Infarction | Completed | 2001-09-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00007657 | Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation | Phase3 | Myocardial Ischemia | Completed | 1998-12-01 | 2006-06-01 | ClinicalTrials.gov |
Total clinical trials: 480
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Research CT | Other | Preclinical | Computed Tomography | RECRUITING | NCT07661706 |
| CT Photon-Counting | Other | Preclinical | CT Photon-Counting | COMPLETED | NCT05838482 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) | Other | Phase PHASE2 | Colorectal Cancer | RECRUITING | NCT07219238 |
| Placebo | Other | Approved | Depression - Major Depressive Disorder | NOT_YET_RECRUITING | NCT07651293 |
| [11C]Cimbi-36 | Other | Approved | Depression - Major Depressive Disorder | NOT_YET_RECRUITING | NCT07651293 |
| Fenfluramine Hydrochloride | Other | Approved | Depression - Major Depressive Disorder | NOT_YET_RECRUITING | NCT07651293 |
| Continuous Monitoring | Other | Approved | Monitoring | NOT_YET_RECRUITING | NCT07309809 |
| AI-TRiPS Device | Device | Phase EARLY_PHASE1 | Trauma | NOT_YET_RECRUITING | NCT07634185 |
| NIBP Measurement | Other | Approved | Blood Pressure | RECRUITING | NCT07628296 |
| NIBP Measurement | Other | Approved | Blood Pressure | RECRUITING | NCT07628296 |
| Biopsy of Prostate | Other | Phase PHASE3 | Prostate Carcinoma | NOT_YET_RECRUITING | NCT06024772 |
| Transrectal Ultrasound | Other | Phase PHASE3 | Prostate Carcinoma | NOT_YET_RECRUITING | NCT06024772 |
| Perflutren lipid microsphere | Other | Phase PHASE3 | Prostate Carcinoma | NOT_YET_RECRUITING | NCT06024772 |
| ultiparametric Magnetic Resonance Imaging | Other | Phase PHASE3 | Prostate Carcinoma | NOT_YET_RECRUITING | NCT06024772 |
| MR Angiogram | Other | Approved | Large Vessel Vasculitis | NOT_YET_RECRUITING | NCT07628075 |
| CT Angiogram | Other | Approved | Large Vessel Vasculitis | NOT_YET_RECRUITING | NCT07628075 |
| [18F]FDG Long-Axial Field of View (LAFOV)-PET/CT | Other | Approved | Large Vessel Vasculitis | NOT_YET_RECRUITING | NCT07628075 |
| Collection of NMT Technology | Other | Approved | Neuromuscular Blockade Monitoring | NOT_YET_RECRUITING | NCT07394140 |
| Group 2 - Conventional treatment | Drug | Phase PHASE1 | Melanoma (Skin Cancer) | NOT_YET_RECRUITING | NCT07615881 |
| Group 1 - Intradermal ipilimumab | Other | Phase PHASE1 | Melanoma (Skin Cancer) | NOT_YET_RECRUITING | NCT07615881 |
| SpO2 Sensor | Other | Approved | SpO2 (Peripheral Oxygen Saturation) Measurement Validation | NOT_YET_RECRUITING | NCT07615738 |
| Outpatient MRI | Other | Preclinical | Endometriosis | COMPLETED | NCT04974710 |
| Chemical-shift-encoded MRI | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| 3'-Deoxy-3'-[18F]-fluorothymidine | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| Chemical-shift-encoded MRI | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| 3'-Deoxy-3'-[18F]-fluorothymidine | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| Chemical-shift-encoded MRI | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| 3'-Deoxy-3'-[18F]-fluorothymidine | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| Chemical-shift-encoded MRI | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| 3'-Deoxy-3'-[18F]-fluorothymidine | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| Chemical-shift-encoded MRI | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| 3'-Deoxy-3'-[18F]-fluorothymidine | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| Chemical-shift-encoded MRI | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| 3'-Deoxy-3'-[18F]-fluorothymidine | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| Chemical-shift-encoded MRI | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| 3'-Deoxy-3'-[18F]-fluorothymidine | Other | Phase EARLY_PHASE1 | Metastatic Castration-resistant Prostate Cancer | NOT_YET_RECRUITING | NCT07609225 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | RECRUITING | NCT07472491 |
| DatSCAN | Other | Phase PHASE3 | Lewy Body Dementia | COMPLETED | NCT00209456 |
| DatSCAN | Other | Phase PHASE3 | Lewy Body Dementia | COMPLETED | NCT00209456 |
| Iodixanol 320 mgI/mL | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00209430 |
| Iodixanol 320 mgI/mL | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00209430 |
| Iodixanol 320 mg I/Ml | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00209404 |
| Iodixanol 320 mg I/Ml | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00209404 |
| Iodixanol 320 mg I/Ml | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00209404 |
| Thallous Chloride T1-201 | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00381316 |
| Technetium Tc99m Tetrofosmin injections | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00381316 |
| Thallous Chloride T1-201 | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00381316 |
| Technetium Tc99m Tetrofosmin injections | Other | Phase PHASE4 | Coronary Artery Disease | COMPLETED | NCT00381316 |
| Iobenguane I 123 Injection | Other | Preclinical | Neuroblastoma | APPROVED_FOR_MARKETING | NCT00730444 |
| Visceral fat mass measurement | Other | Preclinical | Obesity | COMPLETED | NCT00987298 |
| GE DINAMAP with SuperSTAT algorithm monitor | Other | Preclinical | Non-Invasive Blood Pressure | UNKNOWN | NCT00603486 |
| GE DINAMAP with SuperSTAT algorithm monitor | Other | Preclinical | Non-Invasive Blood Pressure | UNKNOWN | NCT00603486 |
| Metal halide plus LED fiberoptic blanket phototherapy (BiliSoft and Spot PT) | Drug | Approved | Hyperbilirubinemia | COMPLETED | NCT00635375 |
| LED bank phototherapy (Natus neoBlue LED bank phototherapy) | Drug | Approved | Hyperbilirubinemia | COMPLETED | NCT00635375 |
| Metal halide phototherapy (Spot PT metal halide phototherapy) | Drug | Approved | Hyperbilirubinemia | COMPLETED | NCT00635375 |
| LED fiberoptic blanket phototherapy (BiliSoft blue LED fiberoptic blanket phototherapy) | Drug | Approved | Hyperbilirubinemia | COMPLETED | NCT00635375 |
| Metal halide plus LED fiberoptic blanket phototherapy (BiliSoft and Spot PT) | Drug | Approved | Hyperbilirubinemia | COMPLETED | NCT00635375 |
| LED bank phototherapy (Natus neoBlue LED bank phototherapy) | Drug | Approved | Hyperbilirubinemia | COMPLETED | NCT00635375 |
| Metal halide phototherapy (Spot PT metal halide phototherapy) | Drug | Approved | Hyperbilirubinemia | COMPLETED | NCT00635375 |
| LED fiberoptic blanket phototherapy (BiliSoft blue LED fiberoptic blanket phototherapy) | Drug | Approved | Hyperbilirubinemia | COMPLETED | NCT00635375 |
| sodium bicarbonate | Other | Approved | Contrast Induced Nephropathy | TERMINATED | NCT00494637 |
| sodium bicarbonate | Other | Approved | Contrast Induced Nephropathy | TERMINATED | NCT00494637 |
| sodium bicarbonate | Other | Approved | Contrast Induced Nephropathy | TERMINATED | NCT00494637 |
| Iobenguane I 123 Injection | Other | Preclinical | Neuroblastoma | APPROVED_FOR_MARKETING | NCT00730444 |
| AH110690 (18F) Injection | Other | Phase PHASE2 | Alzheimer's Disease | COMPLETED | NCT00785759 |
| AH110690 (18F) Injection | Other | Phase PHASE2 | Alzheimer's Disease | COMPLETED | NCT00785759 |
| Carbon dioxide | Other | Phase PHASE2 | Sleep Apnea, Central | UNKNOWN | NCT01041924 |
| Carbon dioxide | Other | Phase PHASE2 | Sleep Apnea, Central | UNKNOWN | NCT01041924 |
| Visceral fat mass measurement | Other | Preclinical | Obesity | COMPLETED | NCT01110161 |
| Visceral fat mass measurement | Other | Preclinical | Obesity | COMPLETED | NCT01110161 |
| Visceral fat mass measurement | Other | Preclinical | Obesity | COMPLETED | NCT01110161 |
| "Sedation Trial Monitor" is the name of the device used. | Device | Approved | Sedated ICU Patients | COMPLETED | NCT01361230 |
| "Sedation Trial Monitor" is the name of the device used. | Device | Approved | Sedated ICU Patients | COMPLETED | NCT01361230 |
| Diagnostic CT | Other | Phase PHASE3 | Appendicitis | COMPLETED | NCT00913380 |
| Diagnostic CT | Other | Phase PHASE3 | Appendicitis | COMPLETED | NCT00913380 |
| Remifentanil | Other | Approved | Conscious Sedation | COMPLETED | NCT00641563 |
| Midazolam | Other | Approved | Conscious Sedation | COMPLETED | NCT00641563 |
| Dexmedetomidine | Other | Approved | Conscious Sedation | COMPLETED | NCT00641563 |
| Remifentanil | Other | Approved | Conscious Sedation | COMPLETED | NCT00641563 |
| Midazolam | Other | Approved | Conscious Sedation | COMPLETED | NCT00641563 |
| Dexmedetomidine | Other | Approved | Conscious Sedation | COMPLETED | NCT00641563 |
| pretreatment with intravenous nicorandil vs. placebo before coronary angiography | Drug | Phase PHASE4 | Chronic Renal Failure | COMPLETED | NCT01103336 |
| pretreatment with intravenous nicorandil vs. placebo before coronary angiography | Drug | Phase PHASE4 | Chronic Renal Failure | COMPLETED | NCT01103336 |
| PET/CT and BH PET/CT | Other | Approved | Lung Cancer | TERMINATED | NCT01052766 |
| PET/CT and BH PET/CT | Other | Approved | Lung Cancer | TERMINATED | NCT01052766 |
| Visipaque (iodixanol) Injection | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01004770 |
| GE-145 (AN113111) Injection | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01004770 |
| [18F] Flutemetamol | Other | Phase PHASE3 | Normal Pressure Hydrocephalus | COMPLETED | NCT01053312 |
| Perflutren Protein-Type A Microspheres Injectable Suspension, United States Pharmacopeia (USP) | Other | Phase PHASE4 | Echocardiography | COMPLETED | NCT00730964 |
| Perflutren Protein-Type A Microspheres Injectable Suspension, United States Pharmacopeia (USP) | Other | Phase PHASE4 | Echocardiography | COMPLETED | NCT00730964 |
| DaTSCAN SPECT imaging | Other | Phase PHASE4 | Parkinsonian Syndromes | COMPLETED | NCT00382967 |
| DaTSCAN SPECT imaging | Other | Phase PHASE4 | Parkinsonian Syndromes | COMPLETED | NCT00382967 |
| Usual Care | Other | Phase PHASE2 | Health Care Quality | COMPLETED | NCT01056640 |
| Intel Health Guide | Other | Phase PHASE2 | Health Care Quality | COMPLETED | NCT01056640 |
| Usual Care | Other | Phase PHASE2 | Health Care Quality | COMPLETED | NCT01056640 |
| Intel Health Guide | Other | Phase PHASE2 | Health Care Quality | COMPLETED | NCT01056640 |
| Blood Pressure Readings on B40 Patient Monitor | Other | Approved | Blood Pressure | COMPLETED | NCT01546285 |
| Blood Pressure Readings on B40 Patient Monitor | Other | Approved | Blood Pressure | COMPLETED | NCT01546285 |
| Omniscan | Other | Phase PHASE4 | Chronic Kidney Disease | COMPLETED | NCT00908310 |
| Omniscan | Other | Phase PHASE4 | Chronic Kidney Disease | COMPLETED | NCT00908310 |
| Omniscan | Other | Phase PHASE4 | Chronic Kidney Disease | COMPLETED | NCT00908310 |
| Iopamidol 300-Arm 2 | Other | Phase PHASE4 | Renal Insufficiency | TERMINATED | NCT00209417 |
| Iodixanol 320-Arm 1 | Other | Phase PHASE4 | Renal Insufficiency | TERMINATED | NCT00209417 |
| Iopamidol 300-Arm 2 | Other | Phase PHASE4 | Renal Insufficiency | TERMINATED | NCT00209417 |
| Iodixanol 320-Arm 1 | Other | Phase PHASE4 | Renal Insufficiency | TERMINATED | NCT00209417 |
| Iopamidol 300-Arm 2 | Other | Phase PHASE4 | Renal Insufficiency | TERMINATED | NCT00209417 |
| Iodixanol 320-Arm 1 | Other | Phase PHASE4 | Renal Insufficiency | TERMINATED | NCT00209417 |
| Molecular Adsorbent Recirculating System (MARS) | Other | Preclinical | Liver Failure, Acute | COMPLETED | NCT01878305 |
| Molecular Adsorbent Recirculating System (MARS) | Other | Preclinical | Liver Failure, Acute | COMPLETED | NCT01878305 |
| [18F] Flutemetamol | Other | Phase PHASE3 | Healthy | COMPLETED | NCT01265394 |
| [18F] Flutemetamol | Other | Phase PHASE3 | Healthy | COMPLETED | NCT01265394 |
| Saline (Placebo) | Other | Approved | Pulmonary Arterial Hypertension | UNKNOWN | NCT01457170 |
| Apelin | Other | Approved | Pulmonary Arterial Hypertension | UNKNOWN | NCT01457170 |
| Saline (Placebo) | Other | Approved | Pulmonary Arterial Hypertension | UNKNOWN | NCT01457170 |
| Apelin | Other | Approved | Pulmonary Arterial Hypertension | UNKNOWN | NCT01457170 |
| Saline (Placebo) | Other | Approved | Pulmonary Arterial Hypertension | UNKNOWN | NCT01457170 |
| Apelin | Other | Approved | Pulmonary Arterial Hypertension | UNKNOWN | NCT01457170 |
| Chest tomosynthesis and X-ray | Other | Preclinical | Pulmonary Nodule, Solitary | COMPLETED | NCT00963651 |
| Chest tomosynthesis and X-ray | Other | Preclinical | Pulmonary Nodule, Solitary | COMPLETED | NCT00963651 |
| [18F] Flutemetamol | Other | Phase PHASE3 | Brain Fibrillarab Levels | COMPLETED | NCT01165554 |
| [18F] Flutemetamol | Other | Phase PHASE3 | Brain Fibrillarab Levels | COMPLETED | NCT01165554 |
| [18F]Flutemetamol | Other | Phase PHASE3 | Normal Pressure Hydrocephalus | TERMINATED | NCT01092546 |
| [18F]Flutemetamol | Other | Phase PHASE3 | Normal Pressure Hydrocephalus | TERMINATED | NCT01092546 |
| Iopamidol | Other | Phase PHASE4 | Patient Comfort and Safety | COMPLETED | NCT01376089 |
| Iodixanol | Other | Phase PHASE4 | Patient Comfort and Safety | COMPLETED | NCT01376089 |
| Iopamidol | Other | Phase PHASE4 | Patient Comfort and Safety | COMPLETED | NCT01376089 |
| Iodixanol | Other | Phase PHASE4 | Patient Comfort and Safety | COMPLETED | NCT01376089 |
| [18F]Flutemetamol | Other | Phase PHASE3 | Alzheimer's Disease | COMPLETED | NCT01672827 |
| [18F]Flutemetamol | Other | Phase PHASE3 | Alzheimer's Disease | COMPLETED | NCT01672827 |
| Tc99m-Maraciclatide | Other | Phase PHASE2 | Diabetes Mellitus | TERMINATED | NCT01440517 |
| Tc99m-Maraciclatide | Other | Phase PHASE2 | Diabetes Mellitus | TERMINATED | NCT01440517 |
| GE-148 (18F) | Other | Phase PHASE2 | Prostate Cancer | TERMINATED | NCT01176513 |
| GE-148 (18F) | Other | Phase PHASE2 | Prostate Cancer | TERMINATED | NCT01176513 |
| GE-148 (18F) | Other | Phase PHASE2 | Prostate Cancer | TERMINATED | NCT01176513 |
| Oral simethicone | Other | Approved | Colorectal Neoplasms | COMPLETED | NCT01790139 |
| Oral simethicone | Other | Approved | Colorectal Neoplasms | COMPLETED | NCT01790139 |
| Optison | Other | Phase PHASE2 | Carotid Artery Disease | TERMINATED | NCT01394926 |
| Optison | Other | Phase PHASE2 | Carotid Artery Disease | TERMINATED | NCT01394926 |
| Iopamidol 300 mgI/mL | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01672996 |
| Ioforminol 200 mgI/mL | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01672996 |
| Ioforminol 160 mgI/mL | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01672996 |
| Iopamidol 300 mgI/mL | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01672996 |
| Ioforminol 200 mgI/mL | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01672996 |
| Ioforminol 160 mgI/mL | Other | Phase PHASE1 | Healthy | COMPLETED | NCT01672996 |
| Iopamidol | Other | Phase PHASE4 | Drug Safety | COMPLETED | NCT01475097 |
| Iodixanol | Other | Phase PHASE4 | Drug Safety | COMPLETED | NCT01475097 |
| Iopamidol | Other | Phase PHASE4 | Drug Safety | COMPLETED | NCT01475097 |
| Iodixanol | Other | Phase PHASE4 | Drug Safety | COMPLETED | NCT01475097 |
| Blood work | Other | Approved | Kidney Disease | COMPLETED | NCT00734357 |
| Blood work | Other | Approved | Kidney Disease | COMPLETED | NCT00734357 |
| Lunar iDXA x-ray scan | Other | Approved | Kyphosis | COMPLETED | NCT02165514 |
| Lunar iDXA x-ray scan | Other | Approved | Kyphosis | COMPLETED | NCT02165514 |
| l-123 Ioflupane | Other | Preclinical | Parkinson Disease | UNKNOWN | NCT02138682 |
| l-123 Ioflupane | Other | Preclinical | Parkinson Disease | UNKNOWN | NCT02138682 |
| Phone Calls | Other | Phase PHASE1 | Advanced Cancers | WITHDRAWN | NCT02193672 |
| PET/CT Scan | Other | Phase PHASE1 | Advanced Cancers | WITHDRAWN | NCT02193672 |
| [18F] Fluciclatide | Other | Phase PHASE1 | Advanced Cancers | WITHDRAWN | NCT02193672 |
| Phone Calls | Other | Phase PHASE1 | Advanced Cancers | WITHDRAWN | NCT02193672 |
| PET/CT Scan | Other | Phase PHASE1 | Advanced Cancers | WITHDRAWN | NCT02193672 |
| [18F] Fluciclatide | Other | Phase PHASE1 | Advanced Cancers | WITHDRAWN | NCT02193672 |
| Fluciclatide Injection - (AH111585 (F18)) | Other | Phase PHASE2 | High-grade Glioma | COMPLETED | NCT00565721 |
| Fluciclatide Injection - (AH111585 (F18)) | Other | Phase PHASE2 | High-grade Glioma | COMPLETED | NCT00565721 |
| Fluciclatide Injection - (AH111585 (F18)) | Other | Phase PHASE2 | High-grade Glioma | COMPLETED | NCT00565721 |
| Hexaminolevulinate (Hexvix) | Other | Preclinical | Bladder Cancer | COMPLETED | NCT00634621 |
| Hexaminolevulinate (Hexvix) | Other | Preclinical | Bladder Cancer | COMPLETED | NCT00634621 |
| Flutemetamol (18F) Injection | Other | Phase PHASE3 | Mild Cognitive Impairment | COMPLETED | NCT01028053 |
| Flutemetamol (18F) Injection | Other | Phase PHASE3 | Mild Cognitive Impairment | COMPLETED | NCT01028053 |
| QuietCare | Other | Approved | Elderly People | COMPLETED | NCT01839825 |
| QuietCare | Other | Approved | Elderly People | COMPLETED | NCT01839825 |
| EVOREL® CONTI | Other | Phase PHASE4 | Venous Thrombosis | UNKNOWN | NCT02264743 |
| Femoston Conti | Other | Phase PHASE4 | Venous Thrombosis | UNKNOWN | NCT02264743 |
| EVOREL® CONTI | Other | Phase PHASE4 | Venous Thrombosis | UNKNOWN | NCT02264743 |
| Femoston Conti | Other | Phase PHASE4 | Venous Thrombosis | UNKNOWN | NCT02264743 |
| Hyperpolarized Pyruvate (13C) injection | Other | Phase PHASE1 | Prostate Cancer | COMPLETED | NCT01229618 |
| Hyperpolarized Pyruvate (13C) injection | Other | Phase PHASE1 | Prostate Cancer | COMPLETED | NCT01229618 |
| Utricular centrifugation test | Other | Preclinical | Primary Ciliary Dyskinesia | COMPLETED | NCT01246258 |
| Vestibular evoked myogenic potentials (VEMPs) | Other | Preclinical | Primary Ciliary Dyskinesia | COMPLETED | NCT01246258 |
| Utricular centrifugation test | Other | Preclinical | Primary Ciliary Dyskinesia | COMPLETED | NCT01246258 |
| Vestibular evoked myogenic potentials (VEMPs) | Other | Preclinical | Primary Ciliary Dyskinesia | COMPLETED | NCT01246258 |
| Signal Averaged ECG | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Deceleration Capacity | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Heart Rate Turbulence | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Heart Rate Variability | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Baroreceptor Sensitivity | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Modified Moving Average T Wave Alternans | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Spectral T Wave Alternans | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Signal Averaged ECG | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Deceleration Capacity | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Heart Rate Turbulence | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Heart Rate Variability | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Baroreceptor Sensitivity | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Modified Moving Average T Wave Alternans | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Spectral T Wave Alternans | Other | Preclinical | Myocardial Infarction | COMPLETED | NCT00399503 |
| Radioisotope | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT02043522 |
| Radioisotope | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT02043522 |
| Radioisotope | Other | Phase PHASE3 | Heart Failure | COMPLETED | NCT02043522 |
| MRI | Other | Preclinical | Brain Diseases | COMPLETED | NCT03338270 |
| Digital Breast Tomosynthesis | Other | Approved | Breast Health | COMPLETED | NCT02786004 |
| Full Field Digital Mammography | Other | Approved | Breast Health | COMPLETED | NCT02786004 |
| Digital Breast Tomosynthesis | Other | Approved | Breast Health | COMPLETED | NCT02786004 |
| Full Field Digital Mammography | Other | Approved | Breast Health | COMPLETED | NCT02786004 |
| Fluoroscopic imaging with the OEC Elite Device | Device | Preclinical | Interventional Vascular Conditions | COMPLETED | NCT03417713 |
| Fluoroscopic imaging with the OEC Elite Device | Device | Preclinical | Interventional Vascular Conditions | COMPLETED | NCT03417713 |
| DBT and FFDM | Other | Approved | Breast Cancer | TERMINATED | NCT02540083 |
| DBT and FFDM | Other | Approved | Breast Cancer | TERMINATED | NCT02540083 |
| Ultrasound | Other | Approved | Ultrasound Exam in Emergency/Medical Care | COMPLETED | NCT03861663 |
| Nasal and Bronchial Sampling | Other | Approved | Bronchiolitis | COMPLETED | NCT03062917 |
| Nasal and Bronchial Sampling | Other | Approved | Bronchiolitis | COMPLETED | NCT03062917 |
| LACTIN-V | Other | Phase PHASE1 | Preterm Labor | UNKNOWN | NCT03992534 |
| Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT01715649 |
| Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT01715649 |
| Digital Breast Tomosynthesis | Other | Preclinical | Image Correction | COMPLETED | NCT01885143 |
| Digital Breast Tomosynthesis | Other | Preclinical | Image Correction | COMPLETED | NCT01885143 |
| starting position in colonoscopy | Other | Approved | Colonoscopy | COMPLETED | NCT02305706 |
| starting position in colonoscopy | Other | Approved | Colonoscopy | COMPLETED | NCT02305706 |
| hexaminolevulinate | Other | Phase PHASE4 | Bladder Cancer | WITHDRAWN | NCT00785694 |
| Responsiveness monitoring; novel sedation monitor | Other | Approved | Critical Illness | COMPLETED | NCT01634451 |
| Sedation specific outcome process feedback | Other | Approved | Critical Illness | COMPLETED | NCT01634451 |
| Bespoke on-line sedation education package | Other | Approved | Critical Illness | COMPLETED | NCT01634451 |
| Responsiveness monitoring; novel sedation monitor | Other | Approved | Critical Illness | COMPLETED | NCT01634451 |
| Sedation specific outcome process feedback | Other | Approved | Critical Illness | COMPLETED | NCT01634451 |
| Bespoke on-line sedation education package | Other | Approved | Critical Illness | COMPLETED | NCT01634451 |
| Group B - Delayed Imaging | Other | Phase PHASE1 | Parkinson Disease | COMPLETED | NCT01788696 |
| Group A - Early Imaging | Other | Phase PHASE1 | Parkinson Disease | COMPLETED | NCT01788696 |
| Group B - Delayed Imaging | Other | Phase PHASE1 | Parkinson Disease | COMPLETED | NCT01788696 |
| Group A - Early Imaging | Other | Phase PHASE1 | Parkinson Disease | COMPLETED | NCT01788696 |
| non-cathartic CTC | Other | Phase PHASE2 | Colonic Polyps | COMPLETED | NCT01200303 |
| non-cathartic CTC | Other | Phase PHASE2 | Colonic Polyps | COMPLETED | NCT01200303 |
| GEHC IWS 4400 & Giraffe warmer beds | Other | Approved | Body Temperature Changes | WITHDRAWN | NCT01011855 |
| GEHC IWS 4400 & Giraffe Warmer beds | Other | Approved | Body Temperature Changes | WITHDRAWN | NCT01011855 |
| GEHC IWS 4400 & Giraffe warmer beds | Other | Approved | Body Temperature Changes | WITHDRAWN | NCT01011855 |
| GEHC IWS 4400 & Giraffe Warmer beds | Other | Approved | Body Temperature Changes | WITHDRAWN | NCT01011855 |
| GEHC IWS 4400 & Giraffe warmer beds | Other | Approved | Body Temperature Changes | WITHDRAWN | NCT01011855 |
| GEHC IWS 4400 & Giraffe Warmer beds | Other | Approved | Body Temperature Changes | WITHDRAWN | NCT01011855 |
| Dual Energy Contrast Enhanced Digital Mammography (DE CEDM) | Other | Approved | Breast Cancer | COMPLETED | NCT01086514 |
| Dual Energy Contrast Enhanced Digital Mammography (DE CEDM) | Other | Approved | Breast Cancer | COMPLETED | NCT01086514 |
| Dual Energy Contrast Enhanced Digital Mammography (DE CEDM) | Other | Approved | Breast Cancer | COMPLETED | NCT01086514 |
| Full Field Digital Mammography | Other | Preclinical | Breast Cancer | TERMINATED | NCT02042456 |
| Automated Whole Breast Ultrasound | Other | Preclinical | Breast Cancer | TERMINATED | NCT02042456 |
| Digital Breast Tomosynthesis | Other | Preclinical | Breast Cancer | TERMINATED | NCT02042456 |
| Full Field Digital Mammography | Other | Preclinical | Breast Cancer | TERMINATED | NCT02042456 |
| Automated Whole Breast Ultrasound | Other | Preclinical | Breast Cancer | TERMINATED | NCT02042456 |
| Digital Breast Tomosynthesis | Other | Preclinical | Breast Cancer | TERMINATED | NCT02042456 |
| pulse sequences | Other | Approved | Clinical Indication for a Head MRI | COMPLETED | NCT01724216 |
| pulse sequences | Other | Approved | Clinical Indication for a Head MRI | COMPLETED | NCT01724216 |
| Magnetic Resonance Imaging (MRI) | Other | Approved | Metastatic Renal Cell Carcinoma | WITHDRAWN | NCT01977586 |
| Magnetic Resonance Imaging (MRI) | Other | Approved | Metastatic Renal Cell Carcinoma | WITHDRAWN | NCT01977586 |
| PET/CT Scan | Other | Preclinical | Lung Cancer | COMPLETED | NCT00843219 |
| PET/CT Scan | Other | Preclinical | Lung Cancer | COMPLETED | NCT00843219 |
| PET/CT Scan | Other | Preclinical | Lung Cancer | COMPLETED | NCT00843219 |
| 3'-Deoxy-3'-18f-Fluorothymidine | Other | Approved | Brain Tumor | WITHDRAWN | NCT02241668 |
| PET Scan | Other | Approved | Brain Tumor | WITHDRAWN | NCT02241668 |
| 18F-Fluciclatide | Other | Phase PHASE2 | Kidney Neoplasm | TERMINATED | NCT01961583 |
| PET/MRI system | Other | Approved | Any Condition With a Clinical Indication for PET/CT Exam | COMPLETED | NCT01986985 |
| PET/MRI system | Other | Approved | Any Condition With a Clinical Indication for PET/CT Exam | COMPLETED | NCT01986985 |
| I-123 radiolabeled metaiodobenzylguanidine cardiac imaging | Other | Approved | Stress Induced Cardiomyopathy | COMPLETED | NCT01432626 |
| I-123 radiolabeled metaiodobenzylguanidine cardiac imaging | Other | Approved | Stress Induced Cardiomyopathy | COMPLETED | NCT01432626 |
| I-123 radiolabeled metaiodobenzylguanidine cardiac imaging | Other | Approved | Stress Induced Cardiomyopathy | COMPLETED | NCT01432626 |
| Revolution CT Scanner | Other | Approved | CT Scanners X Ray | COMPLETED | NCT01909180 |
| Revolution CT Scanner | Other | Approved | CT Scanners X Ray | COMPLETED | NCT01909180 |
| Placebo | Other | Phase PHASE1 | Yellow Fever | COMPLETED | NCT00995865 |
| XRX-001 Inactivated yellow fever vaccine | Other | Phase PHASE1 | Yellow Fever | COMPLETED | NCT00995865 |
| Day/time of admission to the critical care unit | Other | Preclinical | Critical Illness | COMPLETED | NCT02751164 |
| Day/time of admission to the critical care unit | Other | Preclinical | Critical Illness | COMPLETED | NCT02751164 |
| Day/time of admission to the critical care unit | Other | Preclinical | Critical Illness | COMPLETED | NCT02751164 |
| Day/time of admission to the critical care unit | Other | Preclinical | Critical Illness | COMPLETED | NCT02751164 |
| Discovery A (Hologic | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| Lunar iDXA (GEHC) | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| Lunar Prodigy (GEHC) | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| Discovery A (Hologic | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| Lunar iDXA (GEHC) | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| Lunar Prodigy (GEHC) | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| Discovery A (Hologic | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| Lunar iDXA (GEHC) | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| Lunar Prodigy (GEHC) | Other | Approved | Osteopenia | TERMINATED | NCT01530477 |
| molecular breast imaging (Discovery) | Other | Approved | Breast Abnormalities | COMPLETED | NCT01687790 |
| molecular breast imaging (Discovery) | Other | Approved | Breast Abnormalities | COMPLETED | NCT01687790 |
| Antenatal Ultrasound Scan | Other | Approved | Pregnancy | COMPLETED | NCT01990625 |
| Antenatal Ultrasound Scan | Other | Approved | Pregnancy | COMPLETED | NCT01990625 |
| Blood pressure monitoring with GE Healthcare DASH2500 Patient Monitor | Other | Approved | Blood Pressure (Low, Normal, High) | TERMINATED | NCT01482325 |
| Blood pressure monitoring with GE Healthcare DASH2500 Patient Monitor | Other | Approved | Blood Pressure (Low, Normal, High) | TERMINATED | NCT01482325 |
| Blood pressure monitoring with GE Healthcare DASH2500 Patient Monitor | Other | Approved | Blood Pressure (Low, Normal, High) | TERMINATED | NCT01482325 |
| AdreView (Iobenguane I 123 Injection) | Other | Phase PHASE4 | Heart Failure (HF) | COMPLETED | NCT01936649 |
| AdreView (Iobenguane I 123 Injection) | Other | Phase PHASE4 | Heart Failure (HF) | COMPLETED | NCT01936649 |
| AdreView (Iobenguane I 123 Injection) | Other | Phase PHASE4 | Heart Failure (HF) | COMPLETED | NCT01936649 |
| 123I-mIBG (meta-iodobenzylguanidine) | Other | Phase PHASE3 | Heart Failure, Congestive | COMPLETED | NCT00126425 |
| 123I-mIBG (meta-iodobenzylguanidine) | Other | Phase PHASE3 | Heart Failure, Congestive | COMPLETED | NCT00126425 |
| Arm 1 - GEH120714 (18F) Injection | Other | Phase PHASE1 | Relapsing-remitting Multiple Sclerosis (rrMS) | COMPLETED | NCT01738347 |
| Arm 1 - GEH120714 (18F) Injection | Other | Phase PHASE1 | Relapsing-remitting Multiple Sclerosis (rrMS) | COMPLETED | NCT01738347 |
| Digital Breast Tomosynthesis Exam | Other | Preclinical | Breast Cancer | COMPLETED | NCT00776126 |
| Digital Breast Tomosynthesis Exam | Other | Preclinical | Breast Cancer | COMPLETED | NCT00776126 |
| Invasive Coronary Angiography | Other | Approved | Coronary Artery Disease | COMPLETED | NCT01810198 |
| Cardiac CT | Other | Approved | Coronary Artery Disease | COMPLETED | NCT01810198 |
| Beta amyloid imaging | Other | Approved | Alzheimer's Disease | COMPLETED | NCT02309723 |
| Beta amyloid imaging | Other | Approved | Alzheimer's Disease | COMPLETED | NCT02309723 |
| Beta amyloid imaging | Other | Approved | Alzheimer's Disease | COMPLETED | NCT02309723 |
| Gastroview | Other | Phase PHASE4 | Healthy | COMPLETED | NCT00478556 |
| Omnipaque | Other | Phase PHASE4 | Healthy | COMPLETED | NCT00478556 |
| 123 iodine metaiodobenzylguanidine | Other | Phase PHASE1 | Congestive Heart Failure | TERMINATED | NCT01522378 |
| 123 iodine metaiodobenzylguanidine | Other | Phase PHASE1 | Congestive Heart Failure | TERMINATED | NCT01522378 |
| I-123 mIBG | Other | Preclinical | Congestive Heart Failure | COMPLETED | NCT00785044 |
| I-123 mIBG | Other | Preclinical | Congestive Heart Failure | COMPLETED | NCT00785044 |
| I-123 mIBG | Other | Preclinical | Congestive Heart Failure | COMPLETED | NCT00785044 |
| Routine (Standard) Anesthesia Monitoring | Other | Approved | Surgical Procedure, Unspecified | COMPLETED | NCT01928875 |
| AoA Monitoring | Other | Approved | Surgical Procedure, Unspecified | COMPLETED | NCT01928875 |
| Routine (Standard) Anesthesia Monitoring | Other | Approved | Surgical Procedure, Unspecified | COMPLETED | NCT01928875 |
| AoA Monitoring | Other | Approved | Surgical Procedure, Unspecified | COMPLETED | NCT01928875 |
| Assessment of already preacquired I-124 PET/US | Other | Preclinical | Thyroid Nodule | UNKNOWN | NCT03128255 |
| Assessment of already preacquired I-124 PET/US | Other | Preclinical | Thyroid Nodule | UNKNOWN | NCT03128255 |
| GE Healthcare Revolution CT Scanner (CT Scanner) | Other | Approved | General CT Imaging | COMPLETED | NCT02731937 |
| GE Healthcare Revolution CT Scanner (CT Scanner) | Other | Approved | General CT Imaging | COMPLETED | NCT02731937 |
| GE Healthcare Revolution CT Scanner (CT Scanner) | Other | Approved | General CT Imaging | COMPLETED | NCT02731937 |
| [18F] Flutemetamol | Other | Phase PHASE2 | Mild Cognitive Impairment | COMPLETED | NCT02813070 |
| [18F] Flutemetamol | Other | Phase PHASE2 | Mild Cognitive Impairment | COMPLETED | NCT02813070 |
| [18F] Flutemetamol | Other | Phase PHASE2 | Mild Cognitive Impairment | COMPLETED | NCT02813070 |
| Phone Call | Other | Approved | Breast Cancer | COMPLETED | NCT02321527 |
| Biopsy + Radioactive Seed Placement | Other | Approved | Breast Cancer | COMPLETED | NCT02321527 |
| Contrast-Enhanced Ultrasound (CEUS) | Other | Approved | Breast Cancer | COMPLETED | NCT02321527 |
| Perflutren Protein-Type A Microspheres Injectable Suspension | Other | Approved | Breast Cancer | COMPLETED | NCT02321527 |
| iDXA knee software | Other | Approved | Hemi Knee Arthroplasty | COMPLETED | NCT01348958 |
| (18)Fluciclatide | Other | Phase PHASE1 | Colon Cancer | WITHDRAWN | NCT01176500 |
| (18)Fluciclatide | Other | Phase PHASE1 | Colon Cancer | WITHDRAWN | NCT01176500 |
| MRI | Other | Approved | Mild Traumatic Brain Injury | TERMINATED | NCT02070588 |
| GE Optima/Discovery® MRI data of the liver | Other | Approved | Iron Overload | COMPLETED | NCT02425956 |
| GE Optima/Discovery® MRI data of the liver | Other | Approved | Iron Overload | COMPLETED | NCT02425956 |
| GE Optima/Discovery® MRI data of the liver | Other | Approved | Iron Overload | COMPLETED | NCT02425956 |
| MRI Diagnostic | Other | Approved | Traumatic Brain Injury | TERMINATED | NCT02218216 |
| MRI Diagnostic | Other | Approved | Traumatic Brain Injury | TERMINATED | NCT02218216 |
| MRI Diagnostic | Other | Approved | Traumatic Brain Injury | TERMINATED | NCT02141360 |
| MRI Diagnostic | Other | Approved | Traumatic Brain Injury | TERMINATED | NCT02141360 |
| Discovery NM/CT 670 CZT Imaging Scan | Other | Approved | Cancer | COMPLETED | NCT03229772 |
| Discovery NM/CT 670 CZT Imaging Scan | Other | Approved | Cancer | COMPLETED | NCT03229772 |
| LUCAS2 AD | Other | Approved | Cardiac Arrest | COMPLETED | NCT02479152 |
| LUCAS2 AD | Other | Approved | Cardiac Arrest | COMPLETED | NCT02479152 |
| 64 Channel VCT | Other | Approved | Coronary Artery Disease | TERMINATED | NCT00486447 |
| 64 Channel VCT | Other | Approved | Coronary Artery Disease | TERMINATED | NCT00486447 |
| 64 Channel VCT | Other | Approved | Coronary Artery Disease | TERMINATED | NCT00486447 |
| Positron emission mammography (PEM) When available | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| Fluorine-18 labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC) | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| Positron Emission Tomography (PET) | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| Positron emission mammography (PEM) When available | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| Fluorine-18 labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC) | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| Positron Emission Tomography (PET) | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| Positron emission mammography (PEM) When available | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| Fluorine-18 labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC) | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| Positron Emission Tomography (PET) | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT01864083 |
| External fetal heart rate monitoring | Other | Approved | Pregnancy Related | COMPLETED | NCT03156608 |
| Novii ECG/EKG System | Other | Approved | Pregnancy Related | COMPLETED | NCT03156608 |
| External fetal heart rate monitoring | Other | Approved | Pregnancy Related | COMPLETED | NCT03156608 |
| Novii ECG/EKG System | Other | Approved | Pregnancy Related | COMPLETED | NCT03156608 |
| 18F-RGD-PET-CT and perfusion CT scans on 3 occasions | Other | Phase PHASE2 | Carcinoma, Renal Cell | TERMINATED | NCT01492192 |
| 18F-RGD-PET-CT and perfusion CT scans on 3 occasions | Other | Phase PHASE2 | Carcinoma, Renal Cell | TERMINATED | NCT01492192 |
| Sonazoid™ | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03340870 |
| Sonazoid™ | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03340870 |
| Sonazoid™ | Other | Phase PHASE1 | Healthy | COMPLETED | NCT03340870 |
| 3D rotational angiography (3DRA) | Other | Approved | Radiation Burn | WITHDRAWN | NCT02894749 |
| Single Photon Emission Computed Tomography | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT01868841 |
| AdreView | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT01868841 |
| Single Photon Emission Computed Tomography | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT01868841 |
| AdreView | Other | Phase PHASE4 | Heart Failure | COMPLETED | NCT01868841 |
| cardiac surgery | Procedure | Preclinical | Acute Kidney Injury | COMPLETED | NCT02332070 |
| cardiac surgery | Procedure | Preclinical | Acute Kidney Injury | COMPLETED | NCT02332070 |
| 123I-mIBG (meta-iodobenzylguanidine) | Other | Phase PHASE3 | Heart Failure, Congestive | COMPLETED | NCT00126438 |
| 123I-mIBG (meta-iodobenzylguanidine) | Other | Phase PHASE3 | Heart Failure, Congestive | COMPLETED | NCT00126438 |
| 123I-mIBG (meta-iodobenzylguanidine) | Other | Phase PHASE3 | Heart Failure, Congestive | COMPLETED | NCT00126438 |
| Quality of Life Self-Assessment data | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| fMRI | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Psychological screening | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Face-to-face neurocognitive tests | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Quality of Life Self-Assessment data | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| fMRI | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Psychological screening | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Face-to-face neurocognitive tests | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Quality of Life Self-Assessment data | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| fMRI | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Psychological screening | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Face-to-face neurocognitive tests | Other | Preclinical | Major Injury | COMPLETED | NCT03470844 |
| Sonazoid-enhanced ultrasonography | Other | Approved | Hepatocellular Carcinoma (HCC) | COMPLETED | NCT02188901 |
| Sonazoid-enhanced ultrasonography | Other | Approved | Hepatocellular Carcinoma (HCC) | COMPLETED | NCT02188901 |
| Non-interventional | Other | Preclinical | Osteoarthritis | UNKNOWN | NCT02667756 |
| Non-interventional | Other | Preclinical | Osteoarthritis | UNKNOWN | NCT02667756 |
| DaTscan™ - Caucasian Participants | Other | Preclinical | Essential Tremor | COMPLETED | NCT01952678 |
| DaTscan™ - Non-Caucasian Participants | Other | Preclinical | Essential Tremor | COMPLETED | NCT01952678 |
| GE-145 | Other | Phase PHASE2 | Chronic Renal Insufficiency | COMPLETED | NCT01252810 |
| GE-145 | Other | Phase PHASE2 | Chronic Renal Insufficiency | COMPLETED | NCT01252810 |
| GE-145 | Other | Phase PHASE2 | Chronic Renal Insufficiency | COMPLETED | NCT01252810 |
| Ultrasound exam | Other | Approved | Ultrasound Use in Emergency/Medical Care | COMPLETED | NCT03653572 |
| Ultrasound exam | Other | Approved | Ultrasound Use in Emergency/Medical Care | COMPLETED | NCT03653572 |
| Technologist-Controlled (TC) Breast Compression | Other | Approved | Breast Cancer | COMPLETED | NCT03196635 |
| Patient-Assisted (PA) Breast Compression | Other | Approved | Breast Cancer | COMPLETED | NCT03196635 |
| Technologist-Controlled (TC) Breast Compression | Other | Approved | Breast Cancer | COMPLETED | NCT03196635 |
| Patient-Assisted (PA) Breast Compression | Other | Approved | Breast Cancer | COMPLETED | NCT03196635 |
| Fractional flow reserve, coronary flow reserve, and index of microcirculatory resistance | Other | Preclinical | Stable Angina | COMPLETED | NCT03690713 |
| Fractional flow reserve, coronary flow reserve, and index of microcirculatory resistance | Other | Preclinical | Stable Angina | COMPLETED | NCT03690713 |
| MRI | Other | Preclinical | Brain Diseases | COMPLETED | NCT03338270 |
| Automated Breast Ultrasound (ABUS) | Other | Preclinical | Breast Cancer | WITHDRAWN | NCT03616457 |
| SonoVue® | Other | Phase PHASE3 | Liver Lesions | COMPLETED | NCT03335566 |
| Sonazoid™ | Other | Phase PHASE3 | Liver Lesions | COMPLETED | NCT03335566 |
| SonoVue® | Other | Phase PHASE3 | Liver Lesions | COMPLETED | NCT03335566 |
| Sonazoid™ | Other | Phase PHASE3 | Liver Lesions | COMPLETED | NCT03335566 |
| Ultrasound scan | Other | Approved | Endstage Renal Disease | COMPLETED | NCT02946229 |
| Ultrasound scan | Other | Approved | Endstage Renal Disease | COMPLETED | NCT02946229 |
| Q.Static (Q. MRAC) for respiratory motion correction | Other | Approved | Brain Imaging | COMPLETED | NCT02927327 |
| Zero Echo Time (ZTE) scan for head attenuation | Other | Approved | Brain Imaging | COMPLETED | NCT02927327 |
| Q.Static (Q. MRAC) for respiratory motion correction | Other | Approved | Brain Imaging | COMPLETED | NCT02927327 |
| Zero Echo Time (ZTE) scan for head attenuation | Other | Approved | Brain Imaging | COMPLETED | NCT02927327 |
| DBT | Other | Approved | Breast Cancer | COMPLETED | NCT02306265 |
| FFDM | Other | Approved | Breast Cancer | COMPLETED | NCT02306265 |
| DBT | Other | Approved | Breast Cancer | COMPLETED | NCT02306265 |
| FFDM | Other | Approved | Breast Cancer | COMPLETED | NCT02306265 |
| 3.0 T Neonatal MRI Scanner | Other | Approved | Image Evaluation | TERMINATED | NCT02232009 |
| 3.0 T Neonatal MRI Scanner | Other | Approved | Image Evaluation | TERMINATED | NCT02232009 |
| Cardiac magnetic resonance imaging | Other | Preclinical | Hypertrophic Cardiomyopathy | COMPLETED | NCT02234336 |
| Contrast Echocardiography | Other | Preclinical | Hypertrophic Cardiomyopathy | COMPLETED | NCT02234336 |
| Noncontrast echocardiography | Other | Preclinical | Hypertrophic Cardiomyopathy | COMPLETED | NCT02234336 |
| Cardiac magnetic resonance imaging | Other | Preclinical | Hypertrophic Cardiomyopathy | COMPLETED | NCT02234336 |
| Contrast Echocardiography | Other | Preclinical | Hypertrophic Cardiomyopathy | COMPLETED | NCT02234336 |
| Noncontrast echocardiography | Other | Preclinical | Hypertrophic Cardiomyopathy | COMPLETED | NCT02234336 |
| Pulse oximetry | Other | Approved | Pulse Oximetry | COMPLETED | NCT01613222 |
| DBT and FFDM | Other | Approved | Breast Cancer | TERMINATED | NCT02324205 |
| DBT and FFDM | Other | Approved | Breast Cancer | TERMINATED | NCT02324205 |
| PET MR Device | Device | Approved | Indication for a PET CT Exam | TERMINATED | NCT01992354 |
| OEC Elite system | Other | Approved | Interventional Vascular Conditions | TERMINATED | NCT03096483 |
| OEC Elite system | Other | Approved | Interventional Vascular Conditions | TERMINATED | NCT03096483 |
| Technologist-Controlled (TC) Compression | Other | Approved | Breast Cancer | COMPLETED | NCT03456427 |
| Patient-Assisted Compression (PAC) | Other | Approved | Breast Cancer | COMPLETED | NCT03456427 |
| Technologist-Controlled (TC) Compression | Other | Approved | Breast Cancer | COMPLETED | NCT03456427 |
| Patient-Assisted Compression (PAC) | Other | Approved | Breast Cancer | COMPLETED | NCT03456427 |
| Technologist-Controlled (TC) Compression | Other | Approved | Breast Cancer | COMPLETED | NCT03456427 |
| Patient-Assisted Compression (PAC) | Other | Approved | Breast Cancer | COMPLETED | NCT03456427 |
| PET/MRI system | Other | Approved | Subjects With Clinical Indication for PET/CT | COMPLETED | NCT02071706 |
| DE-CEDM | Other | Approved | Breast Cancer | TERMINATED | NCT01303419 |
| CE-BMRI | Other | Approved | Breast Cancer | TERMINATED | NCT01303419 |
| Intervention B - Priority | Other | Approved | Breast Cancer | TERMINATED | NCT02872363 |
| Intervention A - Behavioural Regulation | Other | Approved | Breast Cancer | TERMINATED | NCT02872363 |
| Intervention B - Priority | Other | Approved | Breast Cancer | TERMINATED | NCT02872363 |
| Intervention A - Behavioural Regulation | Other | Approved | Breast Cancer | TERMINATED | NCT02872363 |
| iodixanol | Other | Phase PHASE3 | Coronary Artery Disease | TERMINATED | NCT00348608 |
| iodixanol | Other | Phase PHASE3 | Coronary Artery Disease | TERMINATED | NCT00335335 |
| iodixanol | Other | Phase PHASE3 | Coronary Artery Disease | TERMINATED | NCT00335335 |
| Gadodiamide Injection | Other | Phase PHASE3 | Aorto-iliac Stenosis | COMPLETED | NCT00209443 |
| Gadodiamide Injection | Other | Phase PHASE3 | Aorto-iliac Stenosis | COMPLETED | NCT00209443 |
| Gadodiamide Injection | Other | Phase PHASE3 | Aorto-iliac Stenosis | COMPLETED | NCT00209443 |
| Gadodiamide Injection | Other | Phase PHASE3 | Renal Artery Stenosis | COMPLETED | NCT00209391 |
| bilateral two-view (CC and MLO) FFDM (full field digital mammography) using standard compression mode | Other | Approved | Mammography Related Discomfort | UNKNOWN | NCT03928886 |
| bilateral two-view (CC and MLO) FFDM (full field digital mammography) using patient-assisted compression mode | Other | Approved | Mammography Related Discomfort | UNKNOWN | NCT03928886 |
| bilateral two-view (CC and MLO) FFDM (full field digital mammography) using standard compression mode | Other | Approved | Mammography Related Discomfort | UNKNOWN | NCT03928886 |
| bilateral two-view (CC and MLO) FFDM (full field digital mammography) using patient-assisted compression mode | Other | Approved | Mammography Related Discomfort | UNKNOWN | NCT03928886 |
| 64 Channel VCT | Other | Approved | Coronary Artery Disease | COMPLETED | NCT00348569 |
| 64 Channel VCT | Other | Approved | Coronary Artery Disease | COMPLETED | NCT00348569 |
| Iodixanol, Ioversol, Iopromide | Other | Phase PHASE4 | Coronary Artery Disease (CAD) | WITHDRAWN | NCT00335101 |
| 64 Channel VCT | Other | Approved | Coronary Artery Disease | TERMINATED | NCT00350506 |
| 64 Channel VCT | Other | Approved | Coronary Artery Disease | TERMINATED | NCT00350506 |
| 64 Channel VCT | Other | Approved | Coronary Artery Disease | TERMINATED | NCT00350506 |
| BP monitoring using two methods | Other | Approved | Blood Pressure | COMPLETED | NCT01485120 |
| BP monitoring using two methods | Other | Approved | Blood Pressure | COMPLETED | NCT01485120 |
| BP monitoring using two methods | Other | Approved | Blood Pressure | COMPLETED | NCT01485120 |
| 123I-mIBG (meta-iodobenzylguanidine) | Other | Phase PHASE3 | Pheochromocytoma | COMPLETED | NCT00126412 |
| 123I-mIBG (meta-iodobenzylguanidine) | Other | Phase PHASE3 | Pheochromocytoma | COMPLETED | NCT00126412 |
| Ultrasound | Other | Preclinical | Infertility | UNKNOWN | NCT02549235 |
| Ultrasound | Other | Preclinical | Infertility | UNKNOWN | NCT02549235 |
| Gentamicin | Other | Phase PHASE2 | Meniere's Disease | COMPLETED | NCT00802529 |
| Methylprednisolone | Other | Phase PHASE2 | Meniere's Disease | COMPLETED | NCT00802529 |
| Gentamicin | Other | Phase PHASE2 | Meniere's Disease | COMPLETED | NCT00802529 |
| Methylprednisolone | Other | Phase PHASE2 | Meniere's Disease | COMPLETED | NCT00802529 |
| GE Corometrics 170 Series Fetal Monitor | Other | Approved | Gather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd Trimester | COMPLETED | NCT03617419 |
| GE VScan Access R2 Ultrasound System | Other | Approved | Gather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd Trimester | COMPLETED | NCT03617419 |
| Digital Breast Tomosynthesis | Other | Preclinical | Breast Cancer | TERMINATED | NCT03417024 |
| Automated Breast Ultrasound | Other | Preclinical | Breast Cancer | TERMINATED | NCT03417024 |
| Digital Breast Tomosynthesis | Other | Preclinical | Breast Cancer | TERMINATED | NCT03417024 |
| Automated Breast Ultrasound | Other | Preclinical | Breast Cancer | TERMINATED | NCT03417024 |
| Digital Breast Tomosynthesis | Other | Preclinical | Breast Cancer | TERMINATED | NCT03417024 |
| Automated Breast Ultrasound | Other | Preclinical | Breast Cancer | TERMINATED | NCT03417024 |
| 3.0 T Neonatal MRI scanner | Other | Approved | Neonatal Neuroimaging | COMPLETED | NCT02785588 |
| 3.0 T Neonatal MRI scanner | Other | Approved | Neonatal Neuroimaging | COMPLETED | NCT02785588 |
| Gadolinium-Based Contrast Agents | Other | Preclinical | Magnetic Resonance Imaging (MRI) | COMPLETED | NCT03455283 |
| Clariscan | Other | Preclinical | Magnetic Resonance Imaging (MRI) | COMPLETED | NCT03455283 |
| Gadolinium-Based Contrast Agents | Other | Preclinical | Magnetic Resonance Imaging (MRI) | COMPLETED | NCT03455283 |
| Clariscan | Other | Preclinical | Magnetic Resonance Imaging (MRI) | COMPLETED | NCT03455283 |
| Gadolinium-Based Contrast Agents | Other | Preclinical | Magnetic Resonance Imaging (MRI) | COMPLETED | NCT03455283 |
| Clariscan | Other | Preclinical | Magnetic Resonance Imaging (MRI) | COMPLETED | NCT03455283 |
| ePartogram use | Other | Approved | Obstetric Complication | COMPLETED | NCT03757598 |
| ePartogram use | Other | Approved | Obstetric Complication | COMPLETED | NCT03757598 |
| Genetic analysis | Other | Preclinical | IPF | COMPLETED | NCT03211507 |
| Computer-assisted telephone interview | Other | Preclinical | IPF | COMPLETED | NCT03211507 |
| Genetic analysis | Other | Preclinical | IPF | COMPLETED | NCT03211507 |
| Computer-assisted telephone interview | Other | Preclinical | IPF | COMPLETED | NCT03211507 |
| tacrolimus and mycophenolate mofetil | Other | Phase PHASE4 | Glomerulonephritis, Membranous | COMPLETED | NCT00843856 |
| tacrolimus | Other | Phase PHASE4 | Glomerulonephritis, Membranous | COMPLETED | NCT00843856 |
| tacrolimus and mycophenolate mofetil | Other | Phase PHASE4 | Glomerulonephritis, Membranous | COMPLETED | NCT00843856 |
| tacrolimus | Other | Phase PHASE4 | Glomerulonephritis, Membranous | COMPLETED | NCT00843856 |
| Placebos | Other | Phase PHASE4 | Chronic Kidney Diseases | TERMINATED | NCT03119662 |
| Visipaque | Other | Phase PHASE4 | Chronic Kidney Diseases | TERMINATED | NCT03119662 |
| Placebos | Other | Phase PHASE4 | Chronic Kidney Diseases | TERMINATED | NCT03119662 |
| Visipaque | Other | Phase PHASE4 | Chronic Kidney Diseases | TERMINATED | NCT03119662 |
| Placebos | Other | Phase PHASE4 | Chronic Kidney Diseases | TERMINATED | NCT03119662 |
| Visipaque | Other | Phase PHASE4 | Chronic Kidney Diseases | TERMINATED | NCT03119662 |
| Contrast enhanced mammography | Other | Approved | Atypical Ductal Hyperplasia | TERMINATED | NCT03505372 |
| Contrast enhanced mammography | Other | Approved | Atypical Ductal Hyperplasia | TERMINATED | NCT03505372 |
| Monitoring of frontal electrical muscle activity | Other | Preclinical | Anesthesia, General | WITHDRAWN | NCT03366662 |
| Monitoring of frontal electrical muscle activity | Other | Preclinical | Anesthesia, General | WITHDRAWN | NCT03366662 |
| CESM | Other | Approved | Breast Cancer | TERMINATED | NCT02275871 |
| MRI | Other | Approved | Breast Cancer | TERMINATED | NCT02275871 |
| CESM | Other | Approved | Breast Cancer | TERMINATED | NCT02275871 |
| MRI | Other | Approved | Breast Cancer | TERMINATED | NCT02275871 |
| Questionnaire | Other | Preclinical | Immune Suppression | UNKNOWN | NCT04382508 |
| Questionnaire | Other | Preclinical | Immune Suppression | UNKNOWN | NCT04382508 |
| LACTIN-V | Other | Phase PHASE1 | Preterm Labor | UNKNOWN | NCT03992534 |
| Device: Blood pressure monitoring with GE Healthcare CARESCAPE B650 Patient Monitor-Patient Side Module (PSM) or Patient Data Module (PDM) | Device | Preclinical | Blood Pressure | TERMINATED | NCT02125331 |
| Device: Blood pressure monitoring with GE Healthcare CARESCAPE B650 Patient Monitor-Patient Side Module (PSM) or Patient Data Module (PDM) | Device | Preclinical | Blood Pressure | TERMINATED | NCT02125331 |
| Taurolidine with heparin (500 units/ ml) | Other | Phase PHASE4 | Renal Dialysis | COMPLETED | NCT01243710 |
| Taurolidine with heparin (500 units/ ml) | Other | Phase PHASE4 | Renal Dialysis | COMPLETED | NCT01243710 |
| Immunization | Other | Approved | Positron-Emission Tomography | COMPLETED | NCT04515368 |
| Immunization | Other | Approved | Positron-Emission Tomography | COMPLETED | NCT04515368 |
| MRI or CT | Other | Approved | Distal Radius Fracture | UNKNOWN | NCT03856450 |
| X-ray | Other | Approved | Distal Radius Fracture | UNKNOWN | NCT03856450 |
| DTS | Other | Approved | Distal Radius Fracture | UNKNOWN | NCT03856450 |
| Microdialysis sampling | Other | Preclinical | Kidney Diseases | WITHDRAWN | NCT03159806 |
| Microdialysis sampling | Other | Preclinical | Kidney Diseases | WITHDRAWN | NCT03159806 |
| Liver MRI | Other | Approved | Cirrhosis | UNKNOWN | NCT03085342 |
| Liver MRI | Other | Approved | Cirrhosis | UNKNOWN | NCT03085342 |
| Liver volumetry of the graft on CT | Other | Preclinical | Liver Diseases | UNKNOWN | NCT03766633 |
| Liver volumetry of the graft on CT | Other | Preclinical | Liver Diseases | UNKNOWN | NCT03766633 |
| Sonablate 500 (High Intensity Focused Ultrasound (HIFU)) | Other | Phase PHASE1 | Rectal Cancer | WITHDRAWN | NCT01097239 |
| Sonablate 500 (High Intensity Focused Ultrasound (HIFU)) | Other | Phase PHASE1 | Rectal Cancer | WITHDRAWN | NCT01097239 |
| Questionnaire | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT02590458 |
| Short Breast MRI (SBMRI) | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT02590458 |
| Questionnaire | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT02590458 |
| Short Breast MRI (SBMRI) | Other | Phase EARLY_PHASE1 | Breast Cancer | COMPLETED | NCT02590458 |
| SpO2 Sensor application & blood draw | Other | Approved | Pulse Oximetry | COMPLETED | NCT03383757 |
| Monica Novii Wireless Patch System | Other | Preclinical | Term Labour | COMPLETED | NCT03409146 |
| Monica Novii Wireless Patch System | Other | Preclinical | Term Labour | COMPLETED | NCT03409146 |
| Monica Novii Wireless Patch System | Other | Preclinical | Term Labour | COMPLETED | NCT03409146 |
| Abdominal fetal/maternal monitoring | Other | Preclinical | Premature Labor | COMPLETED | NCT03057275 |
| Abdominal fetal/maternal monitoring | Other | Preclinical | Premature Labor | COMPLETED | NCT03057275 |
| Placebo | Other | Phase PHASE1 | Obesity | COMPLETED | NCT01052493 |
| PP 1420 | Other | Phase PHASE1 | Obesity | COMPLETED | NCT01052493 |
| Placebo | Other | Phase PHASE1 | Obesity | COMPLETED | NCT01052493 |
| PP 1420 | Other | Phase PHASE1 | Obesity | COMPLETED | NCT01052493 |
| Erythopoietin stimulating agent | Other | Phase PHASE4 | Anaemia | COMPLETED | NCT02707757 |
| Iron sucrose | Other | Phase PHASE4 | Anaemia | COMPLETED | NCT02707757 |
| Erythopoietin stimulating agent | Other | Phase PHASE4 | Anaemia | COMPLETED | NCT02707757 |
| Iron sucrose | Other | Phase PHASE4 | Anaemia | COMPLETED | NCT02707757 |
| LifeCath Twin | Other | Approved | Hemodialysis | COMPLETED | NCT01022359 |
| TesioCath | Other | Approved | Hemodialysis | COMPLETED | NCT01022359 |
| LifeCath Twin | Other | Approved | Hemodialysis | COMPLETED | NCT01022359 |
| TesioCath | Other | Approved | Hemodialysis | COMPLETED | NCT01022359 |
| LifeCath Twin | Other | Approved | Hemodialysis | COMPLETED | NCT01022359 |
| TesioCath | Other | Approved | Hemodialysis | COMPLETED | NCT01022359 |
| prednisolone | Other | Phase PHASE4 | Minimal Change Disease | COMPLETED | NCT00982072 |
| tacrolimus | Other | Phase PHASE4 | Minimal Change Disease | COMPLETED | NCT00982072 |
| prednisolone | Other | Phase PHASE4 | Minimal Change Disease | COMPLETED | NCT00982072 |
| tacrolimus | Other | Phase PHASE4 | Minimal Change Disease | COMPLETED | NCT00982072 |
| measuring blood pressure with noninvasive blood pressure device | Device | Approved | Blood Pressure | UNKNOWN | NCT04876664 |
| PUL-042 Inhalation Solution | Other | Phase PHASE2 | COPD | COMPLETED | NCT03794557 |
| Sterile Water Injection | Other | Phase PHASE2 | COPD | COMPLETED | NCT03794557 |
| PUL-042 Inhalation Solution | Other | Phase PHASE2 | COPD | COMPLETED | NCT03794557 |
| Sterile Water Injection | Other | Phase PHASE2 | COPD | COMPLETED | NCT03794557 |
| Ambulatory Monitoring Solution | Other | Approved | Patient Monitoring | UNKNOWN | NCT04959136 |
| Ambulatory Monitoring Solution | Other | Approved | Patient Monitoring | UNKNOWN | NCT04959136 |
| Kidney transplant maintenance immunosuppression | Other | Phase PHASE4 | End-stage Renal Failure | COMPLETED | NCT00807144 |
| Tacrolimus (Kidney transplant maintenance immunosuppression) | Other | Phase PHASE4 | End-stage Renal Failure | COMPLETED | NCT00807144 |
| Kidney transplant maintenance immunosuppression | Other | Phase PHASE4 | End-stage Renal Failure | COMPLETED | NCT00807144 |
| Tacrolimus (Kidney transplant maintenance immunosuppression) | Other | Phase PHASE4 | End-stage Renal Failure | COMPLETED | NCT00807144 |
| Nil intervention | Other | Preclinical | Coronavirus | UNKNOWN | NCT04510441 |
| Nil intervention | Other | Preclinical | Coronavirus | UNKNOWN | NCT04510441 |
| Ankle Brachial Pressure Index (ABPI) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Duplex Assist | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Podiatry Ankle Duplex scan (PAD-scan) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Toe Brachial Pressure Index (TBPI) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Transcutaneous pressure of oxygen (TcPO2) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Ankle Brachial Pressure Index (ABPI) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Duplex Assist | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Podiatry Ankle Duplex scan (PAD-scan) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Toe Brachial Pressure Index (TBPI) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Transcutaneous pressure of oxygen (TcPO2) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Ankle Brachial Pressure Index (ABPI) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Duplex Assist | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Podiatry Ankle Duplex scan (PAD-scan) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Toe Brachial Pressure Index (TBPI) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| Transcutaneous pressure of oxygen (TcPO2) | Other | Preclinical | Diabetic Foot | COMPLETED | NCT04058626 |
| spinal collar | Other | Approved | Cervical Spine | COMPLETED | NCT03958149 |
| spinal collar | Other | Approved | Cervical Spine | COMPLETED | NCT03958149 |
| spinal collar | Other | Approved | Cervical Spine | COMPLETED | NCT03958149 |
| Bile Acid Binder | Other | Approved | Colon Adenocarcinoma | COMPLETED | NCT04003181 |
| Antibiotics | Other | Approved | Colon Adenocarcinoma | COMPLETED | NCT04003181 |
| ciclosporin | Other | Phase PHASE2 | HTLV I Associated Myelopathy | COMPLETED | NCT00773292 |
| ciclosporin | Other | Phase PHASE2 | HTLV I Associated Myelopathy | COMPLETED | NCT00773292 |
| type of treatment | Drug | Preclinical | Covid19 | UNKNOWN | NCT05026788 |
| type of treatment | Drug | Preclinical | Covid19 | UNKNOWN | NCT05026788 |
| MRI sequence | Other | Approved | Breast Cancer | WITHDRAWN | NCT04020523 |
| Regadenoson | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT03170817 |
| N-13 ammonia | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT03170817 |
| Cardiac Perfusion Rest/Stress Digital PET/CT | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT03170817 |
| JOACMEQ questionnaire and mJOA | Other | Preclinical | Cervical Myelopathy | UNKNOWN | NCT05099627 |
| The retrospective questionnaire "CSM early diagnosis questionnaire" | Other | Preclinical | Cervical Myelopathy | UNKNOWN | NCT05099627 |
| The questionnaire "Cervical myelopathy treatment outcome questionnaire" | Drug | Preclinical | Cervical Myelopathy | UNKNOWN | NCT05099627 |
| JOACMEQ questionnaire and mJOA | Other | Preclinical | Cervical Myelopathy | UNKNOWN | NCT05099627 |
| The retrospective questionnaire "CSM early diagnosis questionnaire" | Other | Preclinical | Cervical Myelopathy | UNKNOWN | NCT05099627 |
| The questionnaire "Cervical myelopathy treatment outcome questionnaire" | Drug | Preclinical | Cervical Myelopathy | UNKNOWN | NCT05099627 |
| Ambulatory monitoring solution | Other | Approved | Patient Monitoring | COMPLETED | NCT04472208 |
| Ambulatory monitoring solution | Other | Approved | Patient Monitoring | COMPLETED | NCT04472208 |
| suture | Other | Phase PHASE4 | Entropion | SUSPENDED | NCT04724512 |
| suture | Other | Phase PHASE4 | Entropion | SUSPENDED | NCT04724512 |
| suture | Other | Phase PHASE4 | Entropion | SUSPENDED | NCT04724512 |
| ENO Breathe group | Other | Approved | COVID-19 Recovery | COMPLETED | NCT04830033 |
| ENO Breathe group | Other | Approved | COVID-19 Recovery | COMPLETED | NCT04830033 |
| Vehicle control | Other | Approved | Influenza | COMPLETED | NCT04110366 |
| Live attenuated influenza vaccine | Other | Approved | Influenza | COMPLETED | NCT04110366 |
| Vehicle control | Other | Approved | Influenza | COMPLETED | NCT04110366 |
| Live attenuated influenza vaccine | Other | Approved | Influenza | COMPLETED | NCT04110366 |
| Iodixanol | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT03671603 |
| Iodixanol | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT03671603 |
| 123I-metaiodobenzylguanidine | Other | Approved | Ventricular Tachycardia | COMPLETED | NCT01250912 |
| Florbetapir (18F) | Other | Phase PHASE3 | Alzheimer's Disease (AD) and Related Disorders | COMPLETED | NCT02164643 |
| Flutemetamol (18F) | Other | Phase PHASE3 | Alzheimer's Disease (AD) and Related Disorders | COMPLETED | NCT02164643 |
| Florbetapir (18F) | Other | Phase PHASE3 | Alzheimer's Disease (AD) and Related Disorders | COMPLETED | NCT02164643 |
| Flutemetamol (18F) | Other | Phase PHASE3 | Alzheimer's Disease (AD) and Related Disorders | COMPLETED | NCT02164643 |
| MIBG nuclear scan | Other | Preclinical | Premature Ventricular Contractions | COMPLETED | NCT02279030 |
| MIBG nuclear scan | Other | Preclinical | Premature Ventricular Contractions | COMPLETED | NCT02279030 |
| Omnipolar Eletroanatomical mapping | Other | Preclinical | Atrial Flutter Typical | UNKNOWN | NCT04900831 |
| Omnipolar Eletroanatomical mapping | Other | Preclinical | Atrial Flutter Typical | UNKNOWN | NCT04900831 |
| Contrast Enhanced Spectral Mammogram | Other | Approved | Breast Cancer | UNKNOWN | NCT02479100 |
| Contrast Enhanced Spectral Mammogram | Other | Approved | Breast Cancer | UNKNOWN | NCT02479100 |
| Usual post operative care | Other | Approved | Lung Cancer | COMPLETED | NCT01246297 |
| Pulmonary Rehabilitation | Other | Approved | Lung Cancer | COMPLETED | NCT01246297 |
| Usual post operative care | Other | Approved | Lung Cancer | COMPLETED | NCT01246297 |
| Pulmonary Rehabilitation | Other | Approved | Lung Cancer | COMPLETED | NCT01246297 |
| Usual post operative care | Other | Approved | Lung Cancer | COMPLETED | NCT01246297 |
| Pulmonary Rehabilitation | Other | Approved | Lung Cancer | COMPLETED | NCT01246297 |
| MRI examination | Other | Preclinical | Image, Body | COMPLETED | NCT05215938 |
| Age-specific information booklet and targeted telephone call | Other | Phase PHASE2 | PTSD | UNKNOWN | NCT04635449 |
| Age-specific information booklet and targeted telephone call | Other | Phase PHASE2 | PTSD | UNKNOWN | NCT04635449 |
| Control group | Other | Approved | Blood Pressure | COMPLETED | NCT05299450 |
| Exercise | Other | Approved | Blood Pressure | COMPLETED | NCT05299450 |
| Beet It shots | Other | Approved | Blood Pressure | COMPLETED | NCT05299450 |
| Control group | Other | Approved | Blood Pressure | COMPLETED | NCT05299450 |
| Exercise | Other | Approved | Blood Pressure | COMPLETED | NCT05299450 |
| Beet It shots | Other | Approved | Blood Pressure | COMPLETED | NCT05299450 |
| PET/CT Exam | Other | Preclinical | Carcinoma, Hepatocellular | COMPLETED | NCT04903340 |
| PET/CT Exam | Other | Preclinical | Carcinoma, Hepatocellular | COMPLETED | NCT04903340 |
| Sample collection | Other | Preclinical | Pregnancy of Unknown Location | UNKNOWN | NCT04738370 |
| Sample collection | Other | Preclinical | Pregnancy of Unknown Location | UNKNOWN | NCT04738370 |
| Sample collection | Other | Preclinical | Pregnancy of Unknown Location | UNKNOWN | NCT04738370 |
| SPECT Imaging Test at West Kendall Baptist Hospital | Other | Preclinical | Chest Pain | COMPLETED | NCT02538861 |
| CT Angiography and CT myocardial perfusion at West Kendall Baptist Hospital | Other | Preclinical | Chest Pain | COMPLETED | NCT02538861 |
| SPECT Imaging Test at Baptist hospital | Other | Preclinical | Chest Pain | COMPLETED | NCT02538861 |
| SPECT Imaging Test at West Kendall Baptist Hospital | Other | Preclinical | Chest Pain | COMPLETED | NCT02538861 |
| CT Angiography and CT myocardial perfusion at West Kendall Baptist Hospital | Other | Preclinical | Chest Pain | COMPLETED | NCT02538861 |
| SPECT Imaging Test at Baptist hospital | Other | Preclinical | Chest Pain | COMPLETED | NCT02538861 |
| Radiotherapy before surgery | Drug | Approved | Breast Cancer | COMPLETED | NCT02771938 |
| Radiotherapy before surgery | Drug | Approved | Breast Cancer | COMPLETED | NCT02771938 |
| Radiotherapy before surgery | Drug | Approved | Breast Cancer | COMPLETED | NCT02771938 |
| Additional PET/CT Scan | Other | Approved | Oncology | UNKNOWN | NCT05122715 |
| Additional PET/CT Scan | Other | Approved | Oncology | UNKNOWN | NCT05122715 |
| Additional PET/CT Scan | Other | Approved | Oncology | UNKNOWN | NCT05122715 |
| Blood tests sputum, nasal lavage and brushing | Other | Preclinical | COVID-19 | UNKNOWN | NCT04444609 |
| Blood tests sputum, nasal lavage and brushing | Other | Preclinical | COVID-19 | UNKNOWN | NCT04444609 |
| Monitoring biochemical concentrations during cold machine perfusion | Other | Approved | Transplant;Failure,Kidney | UNKNOWN | NCT04619732 |
| Monitoring biochemical concentrations during cold machine perfusion | Other | Approved | Transplant;Failure,Kidney | UNKNOWN | NCT04619732 |
| Additional pre- and intra-operative imaging | Other | Approved | Glioma Glioblastoma Multiforme | UNKNOWN | NCT05399524 |
| Standard of Care | Other | Approved | Glioma Glioblastoma Multiforme | UNKNOWN | NCT05399524 |
| Additional pre- and intra-operative imaging | Other | Approved | Glioma Glioblastoma Multiforme | UNKNOWN | NCT05399524 |
| Standard of Care | Other | Approved | Glioma Glioblastoma Multiforme | UNKNOWN | NCT05399524 |
| Cardiovascular Magnetic Resonance (CMR) Imaging | Other | Preclinical | Covid19 | COMPLETED | NCT04661657 |
| Transthoracic echocardiogram (TTE) | Other | Preclinical | Covid19 | COMPLETED | NCT04661657 |
| Cardiovascular Magnetic Resonance (CMR) Imaging | Other | Preclinical | Covid19 | COMPLETED | NCT04661657 |
| Transthoracic echocardiogram (TTE) | Other | Preclinical | Covid19 | COMPLETED | NCT04661657 |
| Standard of care | Other | Phase PHASE2 | Gallbladder Cancer | UNKNOWN | NCT04362449 |
| Shortened hydration time and dispensary of Akynzeo | Other | Phase PHASE2 | Gallbladder Cancer | UNKNOWN | NCT04362449 |
| Standard of care | Other | Phase PHASE2 | Gallbladder Cancer | UNKNOWN | NCT04362449 |
| Shortened hydration time and dispensary of Akynzeo | Other | Phase PHASE2 | Gallbladder Cancer | UNKNOWN | NCT04362449 |
| Ripple Mapping guided ischaemic VT ablation | Other | Approved | Ventricular Tachycardia | COMPLETED | NCT03997201 |
| Ripple Mapping guided ischaemic VT ablation | Other | Approved | Ventricular Tachycardia | COMPLETED | NCT03997201 |
| Non invasive blood pressure monitor | Other | Approved | Healthy | COMPLETED | NCT00443001 |
| Non invasive blood pressure monitor | Other | Approved | Healthy | COMPLETED | NCT00443001 |
| None, observational study | Other | Preclinical | Critical Illness | COMPLETED | NCT03238040 |
| None, observational study | Other | Preclinical | Critical Illness | COMPLETED | NCT03238040 |
| Placebo Auto-Injector | Other | Phase PHASE4 | Carotid Artery Stenosis | UNKNOWN | NCT03931161 |
| Evolocumab Auto-Injector [Repatha] | Other | Phase PHASE4 | Carotid Artery Stenosis | UNKNOWN | NCT03931161 |
| Placebo Auto-Injector | Other | Phase PHASE4 | Carotid Artery Stenosis | UNKNOWN | NCT03931161 |
| Evolocumab Auto-Injector [Repatha] | Other | Phase PHASE4 | Carotid Artery Stenosis | UNKNOWN | NCT03931161 |
| PET MRI with PSMA | Other | Approved | Carcinoma, Hepatocellular | UNKNOWN | NCT05580835 |
| PET MRI with PSMA | Other | Approved | Carcinoma, Hepatocellular | UNKNOWN | NCT05580835 |
| Imaging software for 4 dimensional images for Cardiac MRI | Other | Approved | Cardiac Disease | ACTIVE_NOT_RECRUITING | NCT03128268 |
| Imaging software for 4 dimensional images for Cardiac MRI | Other | Approved | Cardiac Disease | ACTIVE_NOT_RECRUITING | NCT03128268 |
| Conventional Fresh Gas | Other | Approved | Et Control Performance in Adult Population Surgery | COMPLETED | NCT02972892 |
| Et Control Feature | Other | Approved | Et Control Performance in Adult Population Surgery | COMPLETED | NCT02972892 |
| Conventional Fresh Gas | Other | Approved | Et Control Performance in Adult Population Surgery | COMPLETED | NCT02972892 |
| Et Control Feature | Other | Approved | Et Control Performance in Adult Population Surgery | COMPLETED | NCT02972892 |
| No drug invervention | Drug | Preclinical | COVID-19 | UNKNOWN | NCT05057260 |
| No drug invervention | Drug | Preclinical | COVID-19 | UNKNOWN | NCT05057260 |
| No drug invervention | Drug | Preclinical | COVID-19 | UNKNOWN | NCT05057260 |
| Contrast-enhanced Spectral Mammography (CESM) | Other | Preclinical | Breast Cancer Screening | COMPLETED | NCT03517813 |
| Contrast-enhanced Spectral Mammography (CESM) | Other | Preclinical | Breast Cancer Screening | COMPLETED | NCT03517813 |
| Investigational ultrasound exam | Other | Approved | Echocardiography | COMPLETED | NCT05340244 |
| Investigational ultrasound exam | Other | Approved | Echocardiography | COMPLETED | NCT05340244 |
| Investigational ultrasound exam | Other | Approved | Echocardiography | COMPLETED | NCT05340244 |
| Saline flushing | Other | Approved | Stroke | UNKNOWN | NCT05146037 |
| CO2 and saline flushing | Other | Approved | Stroke | UNKNOWN | NCT05146037 |
| Saline flushing | Other | Approved | Stroke | UNKNOWN | NCT05146037 |
| CO2 and saline flushing | Other | Approved | Stroke | UNKNOWN | NCT05146037 |
| taxane-based chemotherapy | Drug | Phase PHASE2 | Breast Cancer | WITHDRAWN | NCT02067416 |
| Anthracycline based chemotherapy | Drug | Phase PHASE2 | Breast Cancer | WITHDRAWN | NCT02067416 |
| taxane-based chemotherapy | Drug | Phase PHASE2 | Breast Cancer | WITHDRAWN | NCT02067416 |
| Anthracycline based chemotherapy | Drug | Phase PHASE2 | Breast Cancer | WITHDRAWN | NCT02067416 |
| Questionnaire | Other | Preclinical | Vascular Diseases | UNKNOWN | NCT03668821 |
| Questionnaire | Other | Preclinical | Vascular Diseases | UNKNOWN | NCT03668821 |
| contrast enhanced ultrasonography | Other | Phase PHASE2 | Renal Transplant Rejection | COMPLETED | NCT02733029 |
| Sonazoid | Other | Phase PHASE2 | Renal Transplant Rejection | COMPLETED | NCT02733029 |
| Obeticholic acid | Other | Phase PHASE2 | Primary Bile Acid Malabsorption | COMPLETED | NCT01585025 |
| Obeticholic acid | Other | Phase PHASE2 | Primary Bile Acid Malabsorption | COMPLETED | NCT01585025 |
| Collecting blood pressure measurements with noninvasive blood pressure device | Device | Approved | Blood Pressure | UNKNOWN | NCT05789849 |
| 18F-FSPG | Other | Phase PHASE2 | Cardiac Sarcoidosis | TERMINATED | NCT03103490 |
| 18F-FSPG | Other | Phase PHASE2 | Cardiac Sarcoidosis | TERMINATED | NCT03103490 |
| 18F-FSPG | Other | Phase PHASE2 | Cardiac Sarcoidosis | TERMINATED | NCT03103490 |
| BMS-986413 | Other | Phase PHASE2 | SARS-CoV2 Infection | WITHDRAWN | NCT05393999 |
| BMS-986414 | Other | Phase PHASE2 | SARS-CoV2 Infection | WITHDRAWN | NCT05393999 |
| BMS-986413 | Other | Phase PHASE2 | SARS-CoV2 Infection | WITHDRAWN | NCT05393999 |
| BMS-986414 | Other | Phase PHASE2 | SARS-CoV2 Infection | WITHDRAWN | NCT05393999 |
| BMS-986413 | Other | Phase PHASE2 | SARS-CoV2 Infection | WITHDRAWN | NCT05393999 |
| BMS-986414 | Other | Phase PHASE2 | SARS-CoV2 Infection | WITHDRAWN | NCT05393999 |
| Ultrasound Exam | Other | Approved | Ultrasound Exams | COMPLETED | NCT02946242 |
| Ultrasound Exam | Other | Approved | Ultrasound Exams | COMPLETED | NCT02946242 |
| Liver MRI | Other | Approved | Liver Diseases | UNKNOWN | NCT05182099 |
| Liver MRI | Other | Approved | Liver Diseases | UNKNOWN | NCT05182099 |
| Liver MRI | Other | Approved | Liver Diseases | UNKNOWN | NCT05182099 |
| PET/MRI | Other | Phase PHASE1 | Chronic Pain | COMPLETED | NCT03195270 |
| [18F]FDG | Other | Phase PHASE1 | Chronic Pain | COMPLETED | NCT03195270 |
| PET/MRI | Other | Phase PHASE1 | Chronic Pain | COMPLETED | NCT03195270 |
| [18F]FDG | Other | Phase PHASE1 | Chronic Pain | COMPLETED | NCT03195270 |
| Letter to a friend (autoethnography) | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Survey | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Interview | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Letter to a friend (autoethnography) | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Survey | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Interview | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Letter to a friend (autoethnography) | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Survey | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Interview | Other | Preclinical | Young People With All Long-term Health Conditions | UNKNOWN | NCT05867745 |
| Breast Tomosynthesis | Other | Approved | Breast Cancer | UNKNOWN | NCT05914168 |
| Breast Tomosynthesis | Other | Approved | Breast Cancer | UNKNOWN | NCT05914168 |
| GE200486 0.5M Injection | Other | Phase PHASE1 | Pharmacokinetics | COMPLETED | NCT05569278 |
| Pharmacological stress agents | Other | Phase PHASE3 | Coronary Artery Disease (CAD) | COMPLETED | NCT03354273 |
| SPECT MPI | Other | Phase PHASE3 | Coronary Artery Disease (CAD) | COMPLETED | NCT03354273 |
| PET MPI | Other | Phase PHASE3 | Coronary Artery Disease (CAD) | COMPLETED | NCT03354273 |
| Pharmacological stress agents | Other | Phase PHASE3 | Coronary Artery Disease (CAD) | COMPLETED | NCT03354273 |
| SPECT MPI | Other | Phase PHASE3 | Coronary Artery Disease (CAD) | COMPLETED | NCT03354273 |
| PET MPI | Other | Phase PHASE3 | Coronary Artery Disease (CAD) | COMPLETED | NCT03354273 |
| Psychometric main study testing (Phase 5) | Other | Approved | Anesthesia | UNKNOWN | NCT05668689 |
| Preliminary testing | Other | Approved | Anesthesia | UNKNOWN | NCT05668689 |
| Psychometric main study testing (Phase 5) | Other | Approved | Anesthesia | UNKNOWN | NCT05668689 |
| Preliminary testing | Other | Approved | Anesthesia | UNKNOWN | NCT05668689 |
| [18F]FTC-146 | Other | Phase PHASE1 | Neuropathic Pain | UNKNOWN | NCT03556137 |
| [18F]FTC-146 | Other | Phase PHASE1 | Neuropathic Pain | UNKNOWN | NCT03556137 |
| [18F]FTC-146 | Other | Phase PHASE1 | Neuropathic Pain | UNKNOWN | NCT03556137 |
| Flurpiridaz (18F) Injection | Other | Phase PHASE2 | Coronary Artery Disease (CAD) | COMPLETED | NCT04594941 |
| DaTSCAN™ Ioflupane (123I) Injection | Other | Phase PHASE1 | Healthy Subjects (HS) | COMPLETED | NCT04564092 |
| DaTSCAN™ Ioflupane (123I) Injection | Other | Phase PHASE1 | Healthy Subjects (HS) | COMPLETED | NCT04564092 |
| DaTSCAN™ Ioflupane (123I) Injection | Other | Phase PHASE1 | Healthy Subjects (HS) | COMPLETED | NCT04564092 |
| No intervention | Other | Preclinical | Diabetes Mellitus, Type 1 | COMPLETED | NCT04732780 |
| No intervention | Other | Preclinical | Diabetes Mellitus, Type 1 | COMPLETED | NCT04732780 |
| DNA Nudge | Other | Approved | Gestational Diabetes | UNKNOWN | NCT06022601 |
| DNA Nudge | Other | Approved | Gestational Diabetes | UNKNOWN | NCT06022601 |
| DNA Nudge | Other | Approved | Gestational Diabetes | UNKNOWN | NCT06022601 |
| Percutaneous coronary intervention | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT04280575 |
| Percutaneous coronary intervention | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT04280575 |
| Continuous Glucose Monitoring | Other | Preclinical | Diabetes Mellitus, Type 1 | COMPLETED | NCT05806190 |
| Continuous Glucose Monitoring | Other | Preclinical | Diabetes Mellitus, Type 1 | COMPLETED | NCT05806190 |
| Continuous Glucose Monitoring | Other | Preclinical | Diabetes Mellitus, Type 1 | COMPLETED | NCT05806190 |
| Usual medication | Drug | Phase PHASE3 | Cardiovascular Disease | WITHDRAWN | NCT01326676 |
| Polypill: Red Heart Pill | Other | Phase PHASE3 | Cardiovascular Disease | WITHDRAWN | NCT01326676 |
| Usual medication | Drug | Phase PHASE3 | Cardiovascular Disease | WITHDRAWN | NCT01326676 |
| Polypill: Red Heart Pill | Other | Phase PHASE3 | Cardiovascular Disease | WITHDRAWN | NCT01326676 |
| Usual medication | Drug | Phase PHASE3 | Cardiovascular Disease | WITHDRAWN | NCT01326676 |
| Polypill: Red Heart Pill | Other | Phase PHASE3 | Cardiovascular Disease | WITHDRAWN | NCT01326676 |
| Estimated intraperitoneal pressure | Other | Preclinical | Peritoneal Dialysis | UNKNOWN | NCT06060951 |
| Estimated intraperitoneal pressure | Other | Preclinical | Peritoneal Dialysis | UNKNOWN | NCT06060951 |
| Personalised, holistic follow-up appointments underpinned by self determination theory | Other | Approved | Stroke, Acute | UNKNOWN | NCT05897905 |
| Personalised, holistic follow-up appointments underpinned by self determination theory | Other | Approved | Stroke, Acute | UNKNOWN | NCT05897905 |
| Intra-arterial digital subtraction angiography | Other | Approved | Transplant Renal Artery Stenosis | UNKNOWN | NCT05046496 |
| Intra-arterial digital subtraction angiography | Other | Approved | Transplant Renal Artery Stenosis | UNKNOWN | NCT05046496 |
| REVITIVE® device | Device | Approved | Peripheral Arterial Disease | WITHDRAWN | NCT04109287 |
| REVITIVE® device | Device | Approved | Peripheral Arterial Disease | WITHDRAWN | NCT04109287 |
| No intervention for this study | Other | Preclinical | HIV | COMPLETED | NCT01902693 |
| No intervention for this study | Other | Preclinical | HIV | COMPLETED | NCT01902693 |
| No intervention for this study | Other | Preclinical | HIV | COMPLETED | NCT01902693 |
| DaTSCAN™ Ioflupane (123I) Injection | Other | Phase PHASE3 | Parkinsonian Syndrome | COMPLETED | NCT04193527 |
| Actigraph GT9X Link device | Device | Approved | Hypertension, Pulmonary | TERMINATED | NCT03043976 |
| Actigraph GT9X Link device | Device | Approved | Hypertension, Pulmonary | TERMINATED | NCT03043976 |
| MRI | Other | Preclinical | Brain Diseases | COMPLETED | NCT03847051 |
| Saline flushing | Other | Approved | Stroke | UNKNOWN | NCT03886675 |
| CO2 flushing | Other | Approved | Stroke | UNKNOWN | NCT03886675 |
| Saline flushing | Other | Approved | Stroke | UNKNOWN | NCT03886675 |
| CO2 flushing | Other | Approved | Stroke | UNKNOWN | NCT03886675 |
| Placebo Procedure | Procedure | Approved | Refractory Angina | UNKNOWN | NCT04892537 |
| Coronary Sinus Reducer | Other | Approved | Refractory Angina | UNKNOWN | NCT04892537 |
| Placebo Procedure | Procedure | Approved | Refractory Angina | UNKNOWN | NCT04892537 |
| Coronary Sinus Reducer | Other | Approved | Refractory Angina | UNKNOWN | NCT04892537 |
| Prehabilitation | Other | Approved | Aortic Aneurysm, Abdominal | COMPLETED | NCT04792411 |
| Prehabilitation | Other | Approved | Aortic Aneurysm, Abdominal | COMPLETED | NCT04792411 |
| Video assisted consent | Other | Approved | Regional Anesthesia | UNKNOWN | NCT06115720 |
| Video assisted consent | Other | Approved | Regional Anesthesia | UNKNOWN | NCT06115720 |
| CT Thorax | Other | Preclinical | Chest Pain | UNKNOWN | NCT05058300 |
| CT Thorax | Other | Preclinical | Chest Pain | UNKNOWN | NCT05058300 |
| CT Thorax | Other | Preclinical | Chest Pain | ACTIVE_NOT_RECRUITING | NCT05058300 |
| n/a (non-interventional) | Other | Preclinical | Critical Illness | UNKNOWN | NCT05917574 |
| n/a (non-interventional) | Other | Preclinical | Critical Illness | UNKNOWN | NCT05917574 |
| n/a (non-interventional) | Other | Preclinical | Critical Illness | UNKNOWN | NCT05917574 |
| n/a (non-interventional) | Other | Preclinical | Critical Illness | RECRUITING | NCT05917574 |
| Additional Gemstone Spectral Imaging (GSI) cardiac scan | Other | Preclinical | Cardiovascular Diseases | COMPLETED | NCT05171764 |
| Additional Gemstone Spectral Imaging (GSI) cardiac scan | Other | Preclinical | Cardiovascular Diseases | COMPLETED | NCT05171764 |
| Outpatient MRI | Other | Preclinical | Endometriosis | COMPLETED | NCT04974710 |
| Outpatient MRI | Other | Preclinical | Endometriosis | COMPLETED | NCT04974710 |
| iRes Warmer without ResusView | Other | Approved | Premature Infant | COMPLETED | NCT04587934 |
| iRes Warmer with ResusView | Other | Approved | Premature Infant | COMPLETED | NCT04587934 |
| iRes Warmer without ResusView | Other | Approved | Premature Infant | COMPLETED | NCT04587934 |
| iRes Warmer with ResusView | Other | Approved | Premature Infant | COMPLETED | NCT04587934 |
| Virtual reality online world | Other | Preclinical | Educational Problems | SUSPENDED | NCT04605380 |
| Virtual reality online world | Other | Preclinical | Educational Problems | SUSPENDED | NCT04605380 |
| Motion watch | Other | Preclinical | Chronic Myeloid Leukemia | ACTIVE_NOT_RECRUITING | NCT06233890 |
| Motion watch | Other | Preclinical | Chronic Myeloid Leukemia | ACTIVE_NOT_RECRUITING | NCT06233890 |
| Feasibility of OnTrack | Other | Approved | Cerebrovascular Accident | COMPLETED | NCT03944486 |
| Feasibility of OnTrack | Other | Approved | Cerebrovascular Accident | COMPLETED | NCT03944486 |
| iZephyr hood | Other | Approved | Aerosol Disease | UNKNOWN | NCT04904484 |
| iZephyr hood | Other | Approved | Aerosol Disease | NOT_YET_RECRUITING | NCT04904484 |
| iZephyr hood | Other | Approved | Aerosol Disease | UNKNOWN | NCT04904484 |
| iZephyr hood | Other | Approved | Aerosol Disease | UNKNOWN | NCT04904484 |
| OnTrack Tools | Other | Approved | Research With Clinical Staff in Stroke Rehabilitation | COMPLETED | NCT05330234 |
| OnTrack Tools | Other | Approved | Research With Clinical Staff in Stroke Rehabilitation | COMPLETED | NCT05330234 |
| Biopsy | Other | Preclinical | Breast Cancer | RECRUITING | NCT06182306 |
| Biopsy | Other | Preclinical | Breast Cancer | RECRUITING | NCT06182306 |
| LV pacing | Other | Approved | Heart Failure | RECRUITING | NCT05814263 |
| HIS/LBB pacing | Other | Approved | Heart Failure | RECRUITING | NCT05814263 |
| LV pacing | Other | Approved | Heart Failure | RECRUITING | NCT05814263 |
| HIS/LBB pacing | Other | Approved | Heart Failure | RECRUITING | NCT05814263 |
| LV pacing | Other | Approved | Heart Failure | RECRUITING | NCT05814263 |
| HIS/LBB pacing | Other | Approved | Heart Failure | RECRUITING | NCT05814263 |
| Pittsburgh Compound B [11C]-PIB | Other | Preclinical | Alzheimer's Disease | RECRUITING | NCT02524405 |
| Pittsburgh Compound B [11C]-PIB | Other | Preclinical | Alzheimer's Disease | RECRUITING | NCT02524405 |
| Pittsburgh Compound B [11C]-PIB | Other | Preclinical | Alzheimer's Disease | RECRUITING | NCT02524405 |
| Adjunctive ablation guided by RETRO-Mapping | Other | Approved | Atrial Fibrillation | RECRUITING | NCT06402617 |
| RETRO-Mapping without adjunctive ablation | Other | Approved | Atrial Fibrillation | RECRUITING | NCT06402617 |
| Pulmonary vein isolation | Other | Approved | Atrial Fibrillation | RECRUITING | NCT06402617 |
| Adjunctive ablation guided by RETRO-Mapping | Other | Approved | Atrial Fibrillation | RECRUITING | NCT06402617 |
| RETRO-Mapping without adjunctive ablation | Other | Approved | Atrial Fibrillation | RECRUITING | NCT06402617 |
| Pulmonary vein isolation | Other | Approved | Atrial Fibrillation | RECRUITING | NCT06402617 |
| Optison | Other | Phase PHASE4 | Transthoracic Echocardiography | COMPLETED | NCT03740997 |
| Optison | Other | Phase PHASE4 | Transthoracic Echocardiography | COMPLETED | NCT03740997 |
| Optison | Other | Phase PHASE4 | Transthoracic Echocardiography | COMPLETED | NCT03740997 |
| PET-MRI | Other | Approved | Brain Tumor, Pediatric | RECRUITING | NCT05553899 |
| PET-MRI | Other | Approved | Brain Tumor, Pediatric | UNKNOWN | NCT05553899 |
| Transfer to cardiac arrest centre | Other | Approved | Out-Of-Hospital Cardiac Arrest | COMPLETED | NCT03872960 |
| Transfer to cardiac arrest centre | Other | Approved | Out-Of-Hospital Cardiac Arrest | COMPLETED | NCT03872960 |
| Sonazoid | Other | Phase PHASE2 | Cardiac Catheterization | COMPLETED | NCT03245255 |
| Machine learning | Other | Preclinical | Heart Failure | NOT_YET_RECRUITING | NCT06449079 |
| Machine learning | Other | Preclinical | Heart Failure | NOT_YET_RECRUITING | NCT06449079 |
| Breast scan using the Z-scanner | Other | Preclinical | Breast Cancer | RECRUITING | NCT06264934 |
| Breast scan using the Z-scanner | Other | Preclinical | Breast Cancer | RECRUITING | NCT06264934 |
| ECG-Less Cardiac CT using SmartPhase | Other | Preclinical | Cardiac CT | COMPLETED | NCT05949138 |
| ECG-Less Cardiac CT using SmartPhase | Other | Preclinical | Cardiac CT | COMPLETED | NCT05949138 |
| OMNI PET/CT Scan | Other | Preclinical | Oncology | COMPLETED | NCT05154877 |
| OMNI PET/CT Scan | Other | Preclinical | Oncology | COMPLETED | NCT05154877 |
| Respiratory dual-phase computed tomography. | Other | Preclinical | Elective Thoracic Surgery | RECRUITING | NCT06477458 |
| Single inspiratory phase computed tomography. | Other | Preclinical | Elective Thoracic Surgery | RECRUITING | NCT06477458 |
| Pipelle® endometrial biopsy performed without ultrasound guidance | Other | Approved | Endometrial Cancer | RECRUITING | NCT06501846 |
| Pipelle® endometrial biopsy performed under transabdominal ultrasound guidance | Other | Approved | Endometrial Cancer | RECRUITING | NCT06501846 |
| Pipelle® endometrial biopsy performed without ultrasound guidance | Other | Approved | Endometrial Cancer | RECRUITING | NCT06501846 |
| Pipelle® endometrial biopsy performed under transabdominal ultrasound guidance | Other | Approved | Endometrial Cancer | RECRUITING | NCT06501846 |
| Colchicine | Other | Approved | Hypercholesterolemia | RECRUITING | NCT04073797 |
| 68Ga-DOTATATE PET-MRI | Other | Approved | Hypercholesterolemia | RECRUITING | NCT04073797 |
| Inclisiran | Other | Approved | Hypercholesterolemia | RECRUITING | NCT04073797 |
| Colchicine | Other | Approved | Hypercholesterolemia | RECRUITING | NCT04073797 |
| 68Ga-DOTATATE PET-MRI | Other | Approved | Hypercholesterolemia | RECRUITING | NCT04073797 |
| Inclisiran | Other | Approved | Hypercholesterolemia | RECRUITING | NCT04073797 |
| Cerebral NIRS monitoring at delivery | Other | Preclinical | Pre-Term | RECRUITING | NCT06526091 |
| Cerebral NIRS monitoring at delivery | Other | Preclinical | Pre-Term | RECRUITING | NCT06526091 |
| Echocardiography and ultrasound of arteries | Other | Preclinical | Arterial Stiffness | RECRUITING | NCT04720690 |
| NICaS | Other | Preclinical | Arterial Stiffness | RECRUITING | NCT04720690 |
| Vicorder: pulse wave velocity, pulse wave analysis, stroke volume, cardiac output | Other | Preclinical | Arterial Stiffness | RECRUITING | NCT04720690 |
| Echocardiography and ultrasound of arteries | Other | Preclinical | Arterial Stiffness | RECRUITING | NCT04720690 |
| NICaS | Other | Preclinical | Arterial Stiffness | RECRUITING | NCT04720690 |
| Vicorder: pulse wave velocity, pulse wave analysis, stroke volume, cardiac output | Other | Preclinical | Arterial Stiffness | RECRUITING | NCT04720690 |
| NICAS cardiac output monitor | Other | Preclinical | Cardiac Output, Low | RECRUITING | NCT04064177 |
| NICAS cardiac output monitor | Other | Preclinical | Cardiac Output, Low | RECRUITING | NCT04064177 |
| 18F Fluoroestradiol Radiopharmaceutical with PET/CT | Other | Preclinical | Metastatic Breast Cancer | TERMINATED | NCT05068726 |
| 18F Fluoroestradiol Radiopharmaceutical with PET/CT | Other | Preclinical | Metastatic Breast Cancer | TERMINATED | NCT05068726 |
| Enhanced Diffusion Software | Other | Preclinical | Whole Body Imaging | NOT_YET_RECRUITING | NCT06533189 |
| Enhanced Diffusion Software | Other | Preclinical | Whole Body Imaging | NOT_YET_RECRUITING | NCT06533189 |
| Enhanced Diffusion Software | Other | Preclinical | Whole Body Imaging | NOT_YET_RECRUITING | NCT06533189 |
| Sync VR Medical PICO G2 4K Virtual Reality Technology | Other | Approved | Anxiety | COMPLETED | NCT05307887 |
| Sync VR Medical PICO G2 4K Virtual Reality Technology | Other | Approved | Anxiety | COMPLETED | NCT05307887 |
| Placebo | Other | Phase PHASE4 | Hypoactive Sexual Desire Disorder | COMPLETED | NCT04179734 |
| Bremelanotide | Other | Phase PHASE4 | Hypoactive Sexual Desire Disorder | COMPLETED | NCT04179734 |
| Placebo | Other | Phase PHASE4 | Hypoactive Sexual Desire Disorder | COMPLETED | NCT04179734 |
| Bremelanotide | Other | Phase PHASE4 | Hypoactive Sexual Desire Disorder | COMPLETED | NCT04179734 |
| Spine surgery | Procedure | Preclinical | Spine Fusion | NOT_YET_RECRUITING | NCT06580379 |
| Spine surgery | Procedure | Preclinical | Spine Fusion | NOT_YET_RECRUITING | NCT06580379 |
| Mammography Images | Other | Preclinical | Cancer, Breast | UNKNOWN | NCT06578988 |
| Mammography Images | Other | Preclinical | Cancer, Breast | UNKNOWN | NCT06578988 |
| Placebo | Other | Phase PHASE3 | Secondary Progressive Multiple Sclerosis (SPMS) | COMPLETED | NCT03387670 |
| Simvastatin | Other | Phase PHASE3 | Secondary Progressive Multiple Sclerosis (SPMS) | COMPLETED | NCT03387670 |
| Placebo | Other | Phase PHASE3 | Secondary Progressive Multiple Sclerosis (SPMS) | COMPLETED | NCT03387670 |
| Simvastatin | Other | Phase PHASE3 | Secondary Progressive Multiple Sclerosis (SPMS) | COMPLETED | NCT03387670 |
| Placebo | Other | Phase PHASE3 | Secondary Progressive Multiple Sclerosis (SPMS) | COMPLETED | NCT03387670 |
| Simvastatin | Other | Phase PHASE3 | Secondary Progressive Multiple Sclerosis (SPMS) | COMPLETED | NCT03387670 |
| DE-iPTV | Other | Approved | Brain Metastases, Adult | NOT_YET_RECRUITING | NCT06611306 |
| DE-iPTV | Other | Approved | Brain Metastases, Adult | NOT_YET_RECRUITING | NCT06611306 |
| RSI MRI | Other | Preclinical | Prostate Cancer | RECRUITING | NCT06579417 |
| Remote monitoring | Other | Approved | Interstitial Lung Disease | ACTIVE_NOT_RECRUITING | NCT05662124 |
| Remote monitoring | Other | Approved | Interstitial Lung Disease | ACTIVE_NOT_RECRUITING | NCT05662124 |
| CO2 | Other | Approved | Intubation | COMPLETED | NCT06715410 |
| CO2 | Other | Approved | Intubation | COMPLETED | NCT06715410 |
| CO2 | Other | Approved | Intubation | COMPLETED | NCT06715410 |
| Women with polycystic ovary syndrome | Other | Preclinical | Polycystic Ovary Syndrome | RECRUITING | NCT03911297 |
| Women with polycystic ovary syndrome | Other | Preclinical | Polycystic Ovary Syndrome | RECRUITING | NCT03911297 |
| Session Three Test Battery | Other | Preclinical | Hearing Loss, Noise-Induced | COMPLETED | NCT03878875 |
| Session Two Test Battery | Other | Preclinical | Hearing Loss, Noise-Induced | COMPLETED | NCT03878875 |
| Session One Test Battery | Other | Preclinical | Hearing Loss, Noise-Induced | COMPLETED | NCT03878875 |
| Session Three Test Battery | Other | Preclinical | Hearing Loss, Noise-Induced | COMPLETED | NCT03878875 |
| Session Two Test Battery | Other | Preclinical | Hearing Loss, Noise-Induced | COMPLETED | NCT03878875 |
| Session One Test Battery | Other | Preclinical | Hearing Loss, Noise-Induced | COMPLETED | NCT03878875 |
| Ultrasound | Other | Approved | Healthy | COMPLETED | NCT04622683 |
| Ultrasound | Other | Approved | Healthy | COMPLETED | NCT04622683 |
| Deep Learning-based Vulnerable Plaque Detection and Assessment Tool | Other | Preclinical | Chronic Coronary Syndrome | NOT_YET_RECRUITING | NCT06186336 |
| Deep Learning-based Vulnerable Plaque Detection and Assessment Tool | Other | Preclinical | Chronic Coronary Syndrome | NOT_YET_RECRUITING | NCT06186336 |
| MRI | Other | Approved | Breast Cancer | COMPLETED | NCT03482557 |
| CESM | Other | Approved | Breast Cancer | COMPLETED | NCT03482557 |
| Magnetic Resonance Spectroscopic Imaging | Other | Phase PHASE1 | Recurrent World Health Organization (WHO) Grade II Glioma | RECRUITING | NCT04540107 |
| Magnetic Resonance Imaging | Other | Phase PHASE1 | Recurrent World Health Organization (WHO) Grade II Glioma | RECRUITING | NCT04540107 |
| Hyperpolarized Carbon C 13 Pyruvate | Other | Phase PHASE1 | Recurrent World Health Organization (WHO) Grade II Glioma | RECRUITING | NCT04540107 |
| Rivaroxaban | Other | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT03996772 |
| Edoxaban Tablets | Other | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT03996772 |
| Dabigatran | Other | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT03996772 |
| Apixaban Oral Tablet | Other | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT03996772 |
| Rivaroxaban | Other | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT03996772 |
| Edoxaban Tablets | Other | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT03996772 |
| Dabigatran | Other | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT03996772 |
| Apixaban Oral Tablet | Other | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT03996772 |
| Point of care testing (POCT) | Other | Preclinical | Pregnancy of Unknown Location | COMPLETED | NCT04739956 |
| The Hospital and Anxiety Depression Scale | Other | Preclinical | Pregnancy of Unknown Location | COMPLETED | NCT04739956 |
| Point of care testing (POCT) | Other | Preclinical | Pregnancy of Unknown Location | COMPLETED | NCT04739956 |
| The Hospital and Anxiety Depression Scale | Other | Preclinical | Pregnancy of Unknown Location | COMPLETED | NCT04739956 |
| Clinical Questionnaire | Other | Preclinical | Ovarian Neoplasms | COMPLETED | NCT03994653 |
| Risk Factor Questionnaire | Other | Preclinical | Ovarian Neoplasms | COMPLETED | NCT03994653 |
| Clinical Questionnaire | Other | Preclinical | Ovarian Neoplasms | COMPLETED | NCT03994653 |
| Risk Factor Questionnaire | Other | Preclinical | Ovarian Neoplasms | COMPLETED | NCT03994653 |
| Clinical Questionnaire | Other | Preclinical | Ovarian Neoplasms | COMPLETED | NCT03994653 |
| Risk Factor Questionnaire | Other | Preclinical | Ovarian Neoplasms | COMPLETED | NCT03994653 |
| Oral Stimulant Drink | Other | Approved | Volatile Organic Compounds | RECRUITING | NCT05412758 |
| Oral Stimulant Drink | Other | Approved | Volatile Organic Compounds | RECRUITING | NCT05412758 |
| Pulsenmore device | Device | Approved | Pregnancy, High Risk | COMPLETED | NCT06366711 |
| Pregnabit Pro device and PregnaOne platform | Device | Approved | Pregnancy, High Risk | COMPLETED | NCT06366711 |
| Pulsenmore device | Device | Approved | Pregnancy, High Risk | COMPLETED | NCT06366711 |
| Pregnabit Pro device and PregnaOne platform | Device | Approved | Pregnancy, High Risk | COMPLETED | NCT06366711 |
| Tier 3 weight loss programme | Other | Approved | Obesity | COMPLETED | NCT05249439 |
| I-SatPro weight loss programme | Other | Approved | Obesity | COMPLETED | NCT05249439 |
| Tier 3 weight loss programme | Other | Approved | Obesity | COMPLETED | NCT05249439 |
| I-SatPro weight loss programme | Other | Approved | Obesity | COMPLETED | NCT05249439 |
| Cardiac MRI using Regadenoson and GE-267 | Other | Preclinical | Coronary Artery Disease | NOT_YET_RECRUITING | NCT06246188 |
| ABB-MRI | Other | Approved | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT04097366 |
| CEM | Other | Approved | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT04097366 |
| ABUS | Other | Approved | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT04097366 |
| ABB-MRI | Other | Approved | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT04097366 |
| CEM | Other | Approved | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT04097366 |
| ABUS | Other | Approved | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT04097366 |
| Invasive coronary physiology | Other | Approved | Refractory Angina | RECRUITING | NCT05492110 |
| Sham-procedure | Procedure | Approved | Refractory Angina | RECRUITING | NCT05492110 |
| Coronary sinus reducer | Other | Approved | Refractory Angina | RECRUITING | NCT05492110 |
| Invasive coronary physiology | Other | Approved | Refractory Angina | RECRUITING | NCT05492110 |
| Sham-procedure | Procedure | Approved | Refractory Angina | RECRUITING | NCT05492110 |
| Coronary sinus reducer | Other | Approved | Refractory Angina | RECRUITING | NCT05492110 |
| Iohexol | Other | Preclinical | Colorectal Cancer | COMPLETED | NCT04582500 |
| Iohexol | Other | Preclinical | Colorectal Cancer | COMPLETED | NCT04582500 |
| single photon emission computed tomography | Other | Approved | Coronary Heart Disease | COMPLETED | NCT02280941 |
| single photon emission computed tomography | Other | Approved | Coronary Heart Disease | COMPLETED | NCT02280941 |
| Usual communication strategy | Other | Approved | Behavioural Science Interventions to Improve Health Equity | COMPLETED | NCT06163222 |
| Additional message with behavioural science-informed content and associated web pages | Other | Approved | Behavioural Science Interventions to Improve Health Equity | COMPLETED | NCT06163222 |
| Usual communication strategy | Other | Approved | Behavioural Science Interventions to Improve Health Equity | COMPLETED | NCT06163222 |
| Additional message with behavioural science-informed content and associated web pages | Other | Approved | Behavioural Science Interventions to Improve Health Equity | COMPLETED | NCT06163222 |
| SPECT Imaging with 99mTc-Tetrofosmin Research Imaging | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT03427749 |
| SPECT Imaging with 99mTc-Tetrofosmin Research Imaging | Other | Preclinical | Coronary Artery Disease | COMPLETED | NCT03427749 |
| Ultrasound Pulsed Doppler Imaging System | Other | Approved | Hemostasis | NOT_YET_RECRUITING | NCT06934096 |
| Ultrasound Pulsed Doppler Imaging System | Other | Approved | Hemostasis | NOT_YET_RECRUITING | NCT06934096 |
| SpO2 Sensor Testing | Other | Approved | SpO2 | COMPLETED | NCT06211530 |
| SpO2 Sensor Testing | Other | Approved | SpO2 | COMPLETED | NCT06211530 |
| [18F]-FET-βAG-TOCA | Other | Phase PHASE1 | Neuroendocrine Tumors | COMPLETED | NCT06456723 |
| [18F]-FET-βAG-TOCA | Other | Phase PHASE1 | Neuroendocrine Tumors | COMPLETED | NCT06456723 |
| [18F]-FET-βAG-TOCA | Other | Phase PHASE1 | Neuroendocrine Tumors | COMPLETED | NCT06456723 |
| Salmonella Typhimurium | Other | Approved | Salmonella Infections | ACTIVE_NOT_RECRUITING | NCT05870150 |
| Salmonella Typhimurium | Other | Approved | Salmonella Infections | ACTIVE_NOT_RECRUITING | NCT05870150 |
| Investigational CT Scan | Other | Preclinical | Computed Tomography | RECRUITING | NCT06769594 |
| Investigational CT Scan | Other | Preclinical | Computed Tomography | RECRUITING | NCT06769594 |
| GE ultrasound system with increased acoustic output settings | Other | Approved | Nonalcoholic Fatty Liver | COMPLETED | NCT05792423 |
| GE ultrasound system with increased acoustic output settings | Other | Approved | Nonalcoholic Fatty Liver | COMPLETED | NCT05792423 |
| Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT | Other | Approved | Appendicitis Acute | RECRUITING | NCT05878665 |
| Purastat® | Other | Preclinical | Gastrointestinal Bleeding | COMPLETED | NCT03983707 |
| Purastat® | Other | Preclinical | Gastrointestinal Bleeding | COMPLETED | NCT03983707 |
| Purastat® | Other | Preclinical | Gastrointestinal Bleeding | COMPLETED | NCT03983707 |
| Symptom assessment during experimentally induced ischaemia | Other | Approved | Stable Angina | RECRUITING | NCT06400290 |
| Percutaneous coronary intervention (PCI) | Other | Approved | Stable Angina | RECRUITING | NCT06400290 |
| Symptom assessment during experimentally induced ischaemia | Other | Approved | Stable Angina | RECRUITING | NCT06400290 |
| Percutaneous coronary intervention (PCI) | Other | Approved | Stable Angina | RECRUITING | NCT06400290 |
| [18F]FTC-146 | Other | Phase PHASE1 | Chronic Pain | COMPLETED | NCT04435821 |
| [18F]FTC-146 | Other | Phase PHASE1 | Chronic Pain | COMPLETED | NCT04435821 |
| Monitoring | Other | Approved | Surgery, Intensive Care | ENROLLING_BY_INVITATION | NCT07024459 |
| Monitoring | Other | Approved | Surgery, Intensive Care | ENROLLING_BY_INVITATION | NCT07024459 |
| Monitoring | Other | Approved | Surgery, Intensive Care | ENROLLING_BY_INVITATION | NCT07024459 |
| Cardiovascular magnetic resonance (CMR) | Other | Preclinical | Coronary Artery Disease | ACTIVE_NOT_RECRUITING | NCT05221762 |
| Cardiovascular magnetic resonance (CMR) | Other | Preclinical | Coronary Artery Disease | ACTIVE_NOT_RECRUITING | NCT05221762 |
| Rhinovirus A-16 Infection | Other | Approved | Bronchiectasis Adult | RECRUITING | NCT06931002 |
| Rhinovirus A-16 Infection | Other | Approved | Bronchiectasis Adult | RECRUITING | NCT06931002 |
| Regadenoson | Other | Phase PHASE1 | Myocardial Ischemia | RECRUITING | NCT04604782 |
| Regadenoson | Other | Phase PHASE1 | Myocardial Ischemia | RECRUITING | NCT04604782 |
| Goldcrest Patch and Novii Patch | Other | Preclinical | Fetal Monitoring | COMPLETED | NCT06355453 |
| Goldcrest Patch and Three Patch Coupons | Other | Preclinical | Fetal Monitoring | COMPLETED | NCT06355453 |
| Goldcrest Patch and Novii Patch | Other | Preclinical | Fetal Monitoring | COMPLETED | NCT06355453 |
| Goldcrest Patch and Three Patch Coupons | Other | Preclinical | Fetal Monitoring | COMPLETED | NCT06355453 |
| Goldcrest Patch and Novii Patch | Other | Preclinical | Fetal Monitoring | COMPLETED | NCT06355453 |
| Goldcrest Patch and Three Patch Coupons | Other | Preclinical | Fetal Monitoring | COMPLETED | NCT06355453 |
| Ultrasound Imaging Device | Device | Approved | Pregnancy | RECRUITING | NCT06835647 |
| Investigational Fetal Monitor | Other | Approved | Pregnancy | RECRUITING | NCT06835647 |
| Ultrasound Imaging Device | Device | Approved | Pregnancy | RECRUITING | NCT06835647 |
| Investigational Fetal Monitor | Other | Approved | Pregnancy | RECRUITING | NCT06835647 |
| Ultrasound Imaging Device | Device | Approved | Pregnancy | RECRUITING | NCT06835647 |
| Investigational Fetal Monitor | Other | Approved | Pregnancy | RECRUITING | NCT06835647 |
| Biopsy | Other | Preclinical | Kidney Cancer | TERMINATED | NCT06264479 |
| Biopsy | Other | Preclinical | Kidney Cancer | TERMINATED | NCT06264479 |
| 18F Fluoroestradiol Radiopharmaceutical with PET/CT | Other | Phase PHASE4 | Metastatic Breast Cancer | ACTIVE_NOT_RECRUITING | NCT05486182 |
| 18F Fluoroestradiol Radiopharmaceutical with PET/CT | Other | Phase PHASE4 | Metastatic Breast Cancer | ACTIVE_NOT_RECRUITING | NCT05486182 |
| 18F Fluoroestradiol Radiopharmaceutical with PET/CT | Other | Phase PHASE4 | Metastatic Breast Cancer | ACTIVE_NOT_RECRUITING | NCT05486182 |
| AI Stethoscope | Other | Preclinical | Pulmonary Hypertension | NOT_YET_RECRUITING | NCT07147725 |
| AI Stethoscope | Other | Preclinical | Pulmonary Hypertension | NOT_YET_RECRUITING | NCT07147725 |
| Catheter ablation of atrial tachycardia: Conventional mapping guided. | Other | Approved | Atrial Tachycardia | ACTIVE_NOT_RECRUITING | NCT03915691 |
| Catheter ablation of atrial tachycardia: Ripple Mapping guided. | Other | Approved | Atrial Tachycardia | ACTIVE_NOT_RECRUITING | NCT03915691 |
| Catheter ablation of atrial tachycardia: Conventional mapping guided. | Other | Approved | Atrial Tachycardia | ACTIVE_NOT_RECRUITING | NCT03915691 |
| Catheter ablation of atrial tachycardia: Ripple Mapping guided. | Other | Approved | Atrial Tachycardia | ACTIVE_NOT_RECRUITING | NCT03915691 |
| Static - PET/CT Scan | Other | Phase PHASE1 | Breast Cancer | WITHDRAWN | NCT05634954 |
| Dynamic and Static - PET/CT Scan | Other | Phase PHASE1 | Breast Cancer | WITHDRAWN | NCT05634954 |
| GEH121224 (18F) Injection | Other | Phase PHASE1 | Breast Cancer | WITHDRAWN | NCT05634954 |
| Static - PET/CT Scan | Other | Phase PHASE1 | Breast Cancer | WITHDRAWN | NCT05634954 |
| Dynamic and Static - PET/CT Scan | Other | Phase PHASE1 | Breast Cancer | WITHDRAWN | NCT05634954 |
| GEH121224 (18F) Injection | Other | Phase PHASE1 | Breast Cancer | WITHDRAWN | NCT05634954 |
| Intravenous Urography (IVU) | Other | Approved | Bladder Cancer | ACTIVE_NOT_RECRUITING | NCT00567684 |
| Computed Tomography Urography (CTU) | Other | Approved | Bladder Cancer | ACTIVE_NOT_RECRUITING | NCT00567684 |
| CT Photon-Counting | Other | Preclinical | CT Photon-Counting | RECRUITING | NCT05838482 |
| CT Photon-Counting | Other | Preclinical | CT Photon-Counting | RECRUITING | NCT05838482 |
| Research CCTA | Other | Preclinical | Coronary Computed Tomographic Angiography | RECRUITING | NCT06702917 |
| Standard of Care CCTA | Other | Preclinical | Coronary Computed Tomographic Angiography | RECRUITING | NCT06702917 |
| GSI Cardiac Scan | Other | Preclinical | Coronary Computed Tomographic Angiography | RECRUITING | NCT06702917 |
| Research CCTA | Other | Preclinical | Coronary Computed Tomographic Angiography | RECRUITING | NCT06702917 |
| Standard of Care CCTA | Other | Preclinical | Coronary Computed Tomographic Angiography | RECRUITING | NCT06702917 |
| GSI Cardiac Scan | Other | Preclinical | Coronary Computed Tomographic Angiography | RECRUITING | NCT06702917 |
| Static - PET/CT scan | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| GEH200520 Injection / GEH200521 (18F) Injection - Part B | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| Dynamic and Static - PET/CT scan | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| GEH200520 Injection / GEH200521 (18F) Injection - Part A | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| Static - PET/CT scan | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| GEH200520 Injection / GEH200521 (18F) Injection - Part B | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| Dynamic and Static - PET/CT scan | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| GEH200520 Injection / GEH200521 (18F) Injection - Part A | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| Static - PET/CT scan | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| GEH200520 Injection / GEH200521 (18F) Injection - Part B | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| Dynamic and Static - PET/CT scan | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| GEH200520 Injection / GEH200521 (18F) Injection - Part A | Other | Phase PHASE1 | Malignant Solid Tumor | RECRUITING | NCT05629689 |
| PET | Other | Phase PHASE3 | Parkinson Disease | COMPLETED | NCT04265209 |
| SPECT | Other | Phase PHASE3 | Parkinson Disease | COMPLETED | NCT04265209 |
| Brain Imaging with 18F-FES | Other | Phase PHASE4 | Breast Cancer | RECRUITING | NCT06072807 |
| Investigational Edge-on Silicon Photon Counting CT device | Device | Preclinical | CT Photon Counting | RECRUITING | NCT05835284 |
| CT with a photon-counting detector | Other | Approved | CT Photon-Counting | COMPLETED | NCT04781296 |
| oZTEo | Other | Approved | Inflammatory Arthritis | RECRUITING | NCT06383585 |
| oZTEo | Other | Approved | Inflammatory Arthritis | RECRUITING | NCT06383585 |
| oZTEo | Other | Approved | Inflammatory Arthritis | RECRUITING | NCT06383585 |
| Biopsy of Prostate | Other | Phase PHASE3 | Prostate Carcinoma | NOT_YET_RECRUITING | NCT06024772 |
| Transrectal Ultrasound | Other | Phase PHASE3 | Prostate Carcinoma | NOT_YET_RECRUITING | NCT06024772 |
| Perflutren lipid microsphere | Other | Phase PHASE3 | Prostate Carcinoma | NOT_YET_RECRUITING | NCT06024772 |
| ultiparametric Magnetic Resonance Imaging | Other | Phase PHASE3 | Prostate Carcinoma | NOT_YET_RECRUITING | NCT06024772 |
| Sonazoid | Other | Phase PHASE2 | Melanoma | RECRUITING | NCT07310758 |
| Sonazoid | Other | Phase PHASE2 | Melanoma | RECRUITING | NCT07310758 |
| Sonazoid | Other | Phase PHASE2 | Melanoma | RECRUITING | NCT07310758 |
| Continuous Monitoring | Other | Approved | Monitoring | NOT_YET_RECRUITING | NCT07309809 |
| Continuous Monitoring | Other | Approved | Monitoring | NOT_YET_RECRUITING | NCT07309809 |
| Investigational Fetal Monitoring Device | Device | Approved | Pregnancy | COMPLETED | NCT06726343 |
| Fetal Monitoring Device | Device | Approved | Pregnancy | COMPLETED | NCT06726343 |
| Investigational Fetal Monitoring Device | Device | Approved | Pregnancy | COMPLETED | NCT06726343 |
| Fetal Monitoring Device | Device | Approved | Pregnancy | COMPLETED | NCT06726343 |
| Non-Contrast Ultrasound | Other | Preclinical | Pituitary Adenoma | RECRUITING | NCT07335315 |
| Contrast enhanced ultrasound | Other | Preclinical | Pituitary Adenoma | RECRUITING | NCT07335315 |
| Contrast enhanced pituitary magnetic resonance imaging (MRI) | Other | Preclinical | Pituitary Adenoma | RECRUITING | NCT07335315 |
| CPAP | Other | Approved | Obstructive Sleep Apnea | NOT_YET_RECRUITING | NCT07343362 |
| ZeusOSA | Other | Approved | Obstructive Sleep Apnea | NOT_YET_RECRUITING | NCT07343362 |
| CPAP | Other | Approved | Obstructive Sleep Apnea | NOT_YET_RECRUITING | NCT07343362 |
| ZeusOSA | Other | Approved | Obstructive Sleep Apnea | NOT_YET_RECRUITING | NCT07343362 |
| PET scan of 68Ga-FAPI | Other | Preclinical | Fabry Disease | NOT_YET_RECRUITING | NCT07351136 |
| PET scan of 68Ga-FAPI | Other | Preclinical | Fabry Disease | NOT_YET_RECRUITING | NCT07351136 |
| PET scan of 68Ga-FAPI | Other | Preclinical | Fabry Disease | NOT_YET_RECRUITING | NCT07351136 |
| Questionnaires | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| Physical measurements | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| Blood draw | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| US exam | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| MR exam | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| Questionnaires | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| Physical measurements | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| Blood draw | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| US exam | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| MR exam | Other | Preclinical | MASLD | RECRUITING | NCT06706856 |
| Reverse-transcription polymerase chain reaction (RT-PCR) | Other | Preclinical | COVID-19 | COMPLETED | NCT04355507 |
| Chest computed tomography (CT) | Other | Preclinical | COVID-19 | COMPLETED | NCT04355507 |
| Reverse-transcription polymerase chain reaction (RT-PCR) | Other | Preclinical | COVID-19 | COMPLETED | NCT04355507 |
| Chest computed tomography (CT) | Other | Preclinical | COVID-19 | COMPLETED | NCT04355507 |
| Magnetic Resonance Imaging | Other | Preclinical | Anterior Cruciate Ligament Injuries | RECRUITING | NCT07366619 |
| Magnetic Resonance Imaging | Other | Preclinical | Anterior Cruciate Ligament Injuries | RECRUITING | NCT07366619 |
| Ultrasound Delivery | Other | Approved | Type 2 Diabetes | RECRUITING | NCT05354947 |
| Ultrasound Delivery | Other | Approved | Type 2 Diabetes | RECRUITING | NCT05354947 |
| NMT Technology | Other | Approved | Neuromuscular Blockade Monitoring | NOT_YET_RECRUITING | NCT07394140 |
| NMT Technology | Other | Approved | Neuromuscular Blockade Monitoring | NOT_YET_RECRUITING | NCT07394140 |
| LV pacing | Other | Approved | Heart Failure | COMPLETED | NCT04409119 |
| HIS/LBB pacing | Other | Approved | Heart Failure | COMPLETED | NCT04409119 |
| LV pacing | Other | Approved | Heart Failure | COMPLETED | NCT04409119 |
| HIS/LBB pacing | Other | Approved | Heart Failure | COMPLETED | NCT04409119 |
| Ultrasound Scan | Other | Approved | Type 1 Diabetes (T1D) | RECRUITING | NCT06782568 |
| Ultrasound Scan | Other | Approved | Type 1 Diabetes (T1D) | RECRUITING | NCT06782568 |
| Measurement of the angina threshold | Other | Approved | Angina (Stable) | RECRUITING | NCT07386418 |
| Percutaneous coronary intervention (PCI) | Other | Approved | Angina (Stable) | RECRUITING | NCT07386418 |
| Measurement of the angina threshold | Other | Approved | Angina (Stable) | RECRUITING | NCT07386418 |
| Percutaneous coronary intervention (PCI) | Other | Approved | Angina (Stable) | RECRUITING | NCT07386418 |
| Dual-Energy Contrast-Enhanced Spectral Mammography (CESM) | Other | Approved | Breast Cancer | RECRUITING | NCT05625659 |
| Dual-Energy Contrast-Enhanced Spectral Mammography (CESM) | Other | Approved | Breast Cancer | RECRUITING | NCT05625659 |
| Left bundle optimised cardiac resynchronisation therapy | Drug | Approved | Heart Failure and Reduced Ejection Fraction | RECRUITING | NCT07430553 |
| Conduction system pacing | Other | Approved | Heart Failure and Reduced Ejection Fraction | RECRUITING | NCT07430553 |
| Biventricular pacing | Other | Approved | Heart Failure and Reduced Ejection Fraction | RECRUITING | NCT07430553 |
| Left bundle optimised cardiac resynchronisation therapy | Drug | Approved | Heart Failure and Reduced Ejection Fraction | RECRUITING | NCT07430553 |
| Conduction system pacing | Other | Approved | Heart Failure and Reduced Ejection Fraction | RECRUITING | NCT07430553 |
| Biventricular pacing | Other | Approved | Heart Failure and Reduced Ejection Fraction | RECRUITING | NCT07430553 |
| Contrast-Enhanced Ultrasound | Other | Phase PHASE4 | Focal Liver Lesions | RECRUITING | NCT06639828 |
| Contrast-Enhanced Ultrasound | Other | Phase PHASE4 | Focal Liver Lesions | RECRUITING | NCT06639828 |
| MRI | Other | Approved | Pars Interarticularis Stress Fracture | RECRUITING | NCT07215845 |
| MRI | Other | Approved | Pars Interarticularis Stress Fracture | RECRUITING | NCT07215845 |
| OpRESTORE healthcare navigation | Other | Approved | Veteran | NOT_YET_RECRUITING | NCT07474584 |
| AI-OpRESTORE healthcare navigator | Other | Approved | Veteran | NOT_YET_RECRUITING | NCT07474584 |
| OpRESTORE healthcare navigation | Other | Approved | Veteran | NOT_YET_RECRUITING | NCT07474584 |
| AI-OpRESTORE healthcare navigator | Other | Approved | Veteran | NOT_YET_RECRUITING | NCT07474584 |
| Gadobutrol | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | NOT_YET_RECRUITING | NCT07472491 |
| MRI Scan | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | NOT_YET_RECRUITING | NCT07472491 |
| Mangaciclanol, also known as GEH200486 Injection, 0.5 mmol/mL | Other | Phase PHASE2 | Known or Highly Suspected Central Nervous System (CNS) Lesion | NOT_YET_RECRUITING | NCT07472491 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Breath test | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT07243262 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Collection of matched samples of breath, biofluids and pancreatic tissue | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Breath test | Other | Preclinical | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT05727020 |
| Cases & Controls | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT06447064 |
| Cases & Controls | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT06447064 |
| Renal denervation | Other | Preclinical | Hypertension | TERMINATED | NCT05818813 |
| SPECT | Other | Approved | Lu-177 PSMA | RECRUITING | NCT07169825 |
| Lu-177 | Other | Approved | Lu-177 PSMA | RECRUITING | NCT07169825 |
| General Electric (GE) SIGNA PET/MR | Other | Approved | Metastatic Cancer | RECRUITING | NCT06630845 |
| Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI) | Other | Approved | Metastatic Cancer | RECRUITING | NCT06630845 |
| Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI) | Other | Approved | Metastatic Cancer | RECRUITING | NCT06630845 |
| Fluorodeoxyglucose F18 | Other | Approved | Metastatic Cancer | RECRUITING | NCT06630845 |
| StarGuide NextGen SPECT/CT system | Other | Approved | Nuclear Medicine | ENROLLING_BY_INVITATION | NCT07272161 |
| StarGuide NextGen SPECT/CT system | Other | Approved | Nuclear Medicine | ENROLLING_BY_INVITATION | NCT07272161 |
| PET | Other | Approved | Cancer | ACTIVE_NOT_RECRUITING | NCT07263815 |
| Rhinovirus-A16 | Other | Preclinical | COPD (Chronic Obstructive Pulmonary Disease) | RECRUITING | NCT07112235 |
| Rhinovirus-A16 | Other | Preclinical | COPD (Chronic Obstructive Pulmonary Disease) | RECRUITING | NCT07112235 |
| N/A - Questionnaire based study | Other | Preclinical | Venous Leg Ulcer | COMPLETED | NCT06181708 |
| N/A - Questionnaire based study | Other | Preclinical | Venous Leg Ulcer | COMPLETED | NCT06181708 |
| Myocardial contrast echocardiography molecular imaging for inflammation | Other | Phase EARLY_PHASE1 | Immune Checkpoint Inhibitor Myocarditis | NOT_YET_RECRUITING | NCT07538544 |
| Influenza challenge virus | Other | Approved | Influenza | RECRUITING | NCT06620185 |
| FLUENZ | Other | Approved | Influenza | RECRUITING | NCT06620185 |
| Influenza challenge virus | Other | Approved | Influenza | RECRUITING | NCT06620185 |
| FLUENZ | Other | Approved | Influenza | RECRUITING | NCT06620185 |
| 3D rotational angiography (3DRA) | Other | Approved | Radiation Burn | WITHDRAWN | NCT02894749 |
| Omicron BA.5 SARS-CoV-2 challenge virus | Other | Phase PHASE1 | SARS-CoV-2 Infection | ACTIVE_NOT_RECRUITING | NCT06478420 |
| Omicron BA.5 SARS-CoV-2 challenge virus | Other | Phase PHASE1 | SARS-CoV-2 Infection | ACTIVE_NOT_RECRUITING | NCT06478420 |
Total products: 1268